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ABSTRACT
The mucosal barrier of the small intestine is highly dynamic, enabling the
passage of nutrients that are necessary for the body’s function while
simultaneously preventing a breach by harmful microorganisms that are
damaging to the host. The effectiveness of the mucosal barrier is dependent on
the cohesive relationship established between the luminal mucosal epithelium
and the underlying immune compartment in the small intestine. The epithelium
provides the first line of defense against pathogens by establishing a physical
barrier separating the external environment from the body’s internal milieu, while
the immune system secondarily responds to clear bacteria that have breached
the epithelial barrier. The HECT E3 ubiquitin ligase ITCH is known to regulate
immune responses, and loss of function of ITCH has been associated with
gastrointestinal inflammatory disorders. However, the high level of ITCH
expression within the intestinal epithelium suggests that it may have an important
function(s) in that tissue for maintaining gut homeostasis. Indeed, we identified
that global loss of ITCH (Itcha18H/a18H) in young adult animals influenced intestinal
architecture characterized by increases in both crypt and villus area that were
more prominent in the distal part of the small intestine. Increased crypt area was
found to result from expansion of both the proliferating transit amplifying
progenitor population and terminally differentiated Paneth cells. Lack of ITCH
also resulted in changes in numbers of goblet cells on the villus. Epithelial cell
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turnover was also accelerated in Itcha18h/a18H animals, as evidenced by increases
in both proliferation and apoptosis within the crypt, as well a more rapid cell
migration of bromodeoxyuridine-labeled epithelial cells along the crypt-villus axis.
Consistent with the observed enhancement of cellular migration, Itcha18H/a18H
mice carrying the Min mutation (Itcha18H/a18H; ApcMin/+) displayed a 76% reduction
in tumor burden as compared to ApcMin/+ littermates with normal levels of ITCH.
To identify which aspects of these changes were cell autonomous, intestinal
organoids were generated from the crypts of ITCH sufficient and ITCH deficient
animals. Interestingly, epithelial cell proliferation and differentiation were not
perturbed in ITCH deficient organoids, in contrast to the in vivo phenotype of the
Itcha18H/a18H small intestines. However, increased cell death was observed in
organoids lacking ITCH, which was also consistent with increased cleavedcaspase 3 staining in the intestines of mice lacking ITCH exclusively in the
intestinal epithelium. The failure to recapitulate the Itcha18H/a18H epithelial
phenotype prompted us to investigate how loss of ITCH in immune cells impacts
the intestinal epithelium. Animals lacking ITCH within the myeloid cell lineage
have similar defects in crypt area, as well as increases goblet and Paneth cell
numbers, as compared to the Itcha18H/a18H animals, albeit delayed. These finding
highlight a cell autonomous as well as non-cell autonomous function for ITCH in
mediating epithelial homeostasis, and emphasize the importance of ITCH in
small intestinal barrier function.
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CHAPTER 1
GENERAL INTRODUCTION
Throughout an organism’s life span, many tissues are in a constant state
of flux, varying their cellular composition and function to reflect the internal and
external stimuli that are present at that particular time. While tissues must vary
their internal steady state to appropriately respond to the current environmental
cues, if changes deviate outside of a tissue’s predefined, normal steady state
range, its integrity can be compromised. To prevent major shifts in cell
composition and function from occurring, tissue homeostasis is essential. This
homeostatic process is dependent on cell turnover, or the balanced regulation of
cell death with cell proliferation. As cells become “worn out” or damaged over
time, these functionally insufficient cells must be replaced with functionally
competent cell types that will preserve the tissue’s integrity. Regulation of this
process is initiated by somatic stem cells that reside within a given tissue.
Somatic stem cells are multipotent cells that are defined by their unlimited selfrenewal properties as well by their ability to differentiate into all major cell types
within a given tissue. When a somatic stem cell asymmetrically divides to
produce two daughter cells with different cell fates, one cell will typically retain
the unlimited self-renewal properties of the parental cell, while the other cell
adopts a progenitor cell fate. Progenitor cells, which exhibit limited self-renewal
capabilities, will continue to divide, and, when exposed to the appropriate signals,
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will terminally differentiate into all the cell types that comprise a particular tissue.
Once terminally differentiated cells are generated, these cells must be able to
integrate into the tissue to replace the cell that was lost. If a breakdown in any
component of this highly integrated process does occur, this can have
catastrophic impacts on tissue homeostasis and promote pathologies ranging
from neurological disorders to cancer.
Homeostasis within the small intestine is essential to digestion, nutrient
absorption, and water balance. These processes are mainly dependent on the
epithelium that lines the luminal cavity to separate the external environment from
the internal milieu. The epithelium consists of a single layer of columnar cells
that fold into long, finger-like structures, commonly referred to as villi, which
protrude out into the lumen, and deep invaginations into the underlying
submucosa known as the crypts of Lieberkühn (Fig.1.1). Within the small
intestinal crypts, the rapidly dividing, multipotent crypt base columnar (CBC) stem
cell population resides at the base of the crypt interspersed between the Paneth
cells (van der Flier and Clevers, 2009). An additional slowly-dividing, reserve
stem cell population also exists in the +4 (cell population located directly above
the Paneth cell population) of the small intestinal crypt. During obligate
asymmetrical cell divisions, intestinal stem cells will produce a single intestinal
stem cell to replenish the existing pool of stem cells, as well as give rise to a
progenitor cell, defined as being equivalent to a transit-amplifying (TA) cell, that
is capable of terminally differentiating into one of the five major cell types of the
small intestine (Barker, 2013).
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Terminally differentiated intestinal epithelial cells arise from the highly
proliferative TA cells that are generated during cellular division of the CBC stem
cell population. As TA cells migrate along the crypt-villus axis, dividing
approximately five-to-six times, they eventually specify into the five major
epithelial cell types of the small intestinal epithlium (Potten, 1998). The function
of these five cell types is dependent upon the lineage from which they are
derived. Enterocytes originate from the absorptive cell lineage and are the most
abundant cell type in the small intestine. They comprise approximately 75-80%
of the total post-mitotic cells that are produced and are critical to nutrient
absorption (van der Flier and Clevers, 2009). The secretory cell lineage is
comprised of the remaining four major cells types: enteroendocrine, goblet, tuft,
and Paneth cells (Barker, 2013). The enteroendocrine cells, located along the
villi, produce and secrete hormones that are critical to physiological and
homeostatic functions of the small intestine (Moran et al., 2008). Tuft cells, or
brush cells, are also located on the villi and are hypothesized to play a role in
chemosensitivity. However, emerging evidence suggests that they are also
critical mediators of host defense during enteric infection and inflammation
(Steele et al., 2016). Goblet cells provide a protective shield for the intestines
through the secretion of mucin. Paneth cells reside in the crypt interposed
between the CBC stem cells and contribute to the stem cell niche while
concurrently protecting the small intestine by secreting antimicrobial agents
against foreign microbes.
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Epithelial self-renewal in the small intestine is very rapid, occurring
approximately every four-to-five days (Barker, 2013). To maintain intestinal
homeostasis throughout this rapid process, aged cells must be expeditiously
replaced with newly differentiated cells that arise from the proliferative crypts
(Nunes et al., 2014). Proliferation within the small intestinal crypt of mice has
been established as the principle force governing homeostatic cell migration
(Parker et al., 2017). Reduction or temporary suspension of proliferation in the
crypts of mice directly influences cell migration velocities onto the villi.
Preservation of proliferation and migration is critical to epithelial homeostasis,
and dysregulation of these processes can promote a range of gastrointestinal
pathologies (Fre et al., 2009; Hanahan et al., 2000; Roda et al., 2010).
Cellular adhesion complexes between adjacent small intestinal epithelial
cells can also influence cell migration. Tight junctions, adherens junctions, and
desmosomes line the lateral membranes of intestinal epithelial cells to ensure
cell adhesion and polarity while concurrently preventing the entrance of luminal
pathogens (Garcia et al., 2017). Tight junctions, located near the apical surface
of the cells, prevent the passage of unwanted substrates from the luminal
environment across the epithelium. Adherens junctions are located directly
below tight junctions, and, in combination with tight junctions, they constitute an
apical junctional complex that is directly attached to the actin cytoskeleton of the
cell. Additional intracellular adhesion is provided by desmosomes, which are
located directly under adherens junctions.
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Adherens junctions are composed of the transmembrane glycoprotein Ecadherin that forms homophilic interactions with adjacent cells to mediate cellular
adhesion as well as cell signaling (Bondow et al., 2012; Etienne-Manneville,
2012). To ensure cellular adhesion, E-cadherin proteins are attached to the
catenin family of proteins (β-catenin, p120, and plakoglobin), which secures the
entire junctional complex to the actin cytoskeleton of the cell via its association
with α-catenin (Hartsock and Nelson, 2008). The epithelial-specific loss of Ecadherin in the adult intestine enhances cellular migration along the crypt-villus
axis (Schneider et al., 2010). Further, disruption of cadherins in mice mediated
by overexpression of dominant-negative N-cadherin under the Fabp1 promoter
resulted in accelerated migration (Hermiston et al., 1996). In contrast to loss of
E-cadherin, forced expression of E-cadherin in the intestinal epithelium of mice
slowed cellular migration along the crypt-villus axis (Hermiston et al., 1996).
As terminally differentiated cells migrate along the crypt-villus axis, they
eventually reach the tip of the villus and are sloughed off into the luminal cavity.
In the small intestine, this process is continuous and results in nearly 1,400 cells
from a single villus being shed into the luminal cavity each day (Potten, 1990; J.
M. Williams et al., 2015). A particular type of apoptosis, termed anoikis,
mediates cell extrusion from the villus tip of the intestinal epithelium (Delgado et
al., 2016). Detachment of a cell from the underlying extracellular matrix activates
anoikis either through mitochondrial dysfunction (intrinisic) or cell death receptors
(extrinsic) and converges on caspase 3 before the cell undergoes demise (Paoli
et al., 2013). To ensure that the intestinal barrier is still maintained throughout
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anoikis, both apoptotic cells as well as the neighboring cells redistributes tight
junctions to their basolateral membrane (Guan et al., 2011; Marchiando et al.,
2011). The surrounding cells then extend cytoplasmic processes underneath the
apoptotic cells before the cell is extruded from the epithelium to ensure that tight
junctions are able to reform instantaneously to prevent the passage of bacteria
(J. M. Williams et al., 2015).
As a dividing line between the internal and external compartments, the
epithelium also plays an indispensable role in preventing the entry of foreign
substrates (Bischoff et al., 2014). The epithelium of the small intestine is
generally regarded as the “first line of defense”, hindering the penetration of
bacteria into the internal environment of the host (Peterson and Artis, 2014).
This mainstay barrier is typically an effective deterrent, however, the constant
exposure of noxious substances, antigens, and microorganisms to the surface of
the epithelium along the gastrointestinal tract makes a breach of foreign material
eventually inevitable (Schenk and Mueller, 2008). During this event, the
underlying immune compartment which coexists with the mucosal epithelium
initiates an inflammatory response to contain and destroy the non-native
substrate while concurrently attempting to ameliorate the defective epithelial
barrier by influencing epithelial homeostasis. Since the integrity of the mucosa is
consistently being challenged, synergy between these two compartments is
paramount in providing an adequate level of protection against the external
environment. If a breakdown in any component of this highly integrated mucosal
system does occur, this can have catastrophic impacts on mucosal homeostasis,
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promoting a wide-range of gastrointestinal enteropathies (Catalioto et al., 2011;
Huang and Chen, 2016; Maloy and Powrie, 2011; Nunes et al., 2014).
The subepithelial immune compartment of the intestinal mucosa resides in
the lamina propria, a layer of loose connective tissue that is rich in immune cells
that reside in parallel with an extensive vascular network, lymphatic vessels,
extracellular matrix proteins, and the mesenchyme. Immune cells are in close
proximity to the intestinal epithelium and support the intestinal epithelial barrier
by initiating a targeted response toward a pathogenic substrate that has
circumvented the epithelial mucosal barrier (Okumura and Takeda, 2016).
Intestinal immunity is orchestrated by a heterogonous population of immune cell
types, derived from both the myeloid and lymphoid cell lineages, that are present
in the lamina propria. Dendritic cells (DCs), macrophages, and intraepithelial
lymphocytes are in direct contact with the epithelium and immediately respond to
antigenic material that has permeated the epithelial barrier, while regulatory Tcells (Treg) cells in the subepithelial immune compartment precisely regulate the
inflammatory response and prevent hyper-activation of the immune system to the
pathogen (Okumura and Takeda, 2016). Lastly, naïve CD4+ T-cells present
within the lamina propria differentiate into either memory or effector T cells in
response to a bacterial substrate and exhibit rapid and potent cytotoxic activity if
the same substrate is encountered subsequently. The cell types work in unison
to regulate intestinal immunity by mounting an appropriate inflammatory
response to clear pathogenic material while simultaneously exhibiting tolerance
to macromolecules and to the host’s microbiota (Vindigni et al., 2016).
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The innate immune system contributes to mucosal function and
homeostasis by continuously surveying the gut’s microbiotic landscape (Gross et
al., 2015). Harmful and innocuous bacteria that have breached the epithelium
are first identified by macrophages and DCs that reside in close proximity to the
epithelium, and, as such, mediate immune tolerance within the intestine. Derived
from a common myeloid progenitor in the bone-marrow, macrophages and DCs
exhibit overlapping functions, but also display unique properties that are specific
to each cell type. Traditionally, macrophages and DCs are both potent antigenpresenting cells, presenting antigens from ingested pathogens for recognition by
T-cells to induce acquired immunity (Geissmann et al., 2010). While a potent
inflammatory response is typically initiated by this interaction, resident intestinal
macrophages and DCs have adapted to enteric commensal bacteria by
dampening the inflammatory response to promote immune tolerance over
inflammation (Bain and Mowat, 2014; Smythies et al., 2005).
Macrophages are dispersed throughout the lamina propria of the gut and
are strategically placed to intercept invading microorganisms (Schenk and
Mueller, 2008). Bacteria that have penetrated the epithelial barrier are
phagocytosed and destroyed by macrophages to effectively clear the bacteria.
Unlike monocytes and macrophages from other tissues, intestinal macrophages
respond differently to pathogenic substrates and effectively expunge the bacteria
without inducing a potent inflammatory response (Macpherson and Harris, 2004;
Schenk and Mueller, 2008). Binding of the bacteria to toll-like receptors or
intracellular NOD receptors does not cause the secretion of proinflammatory
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cytokines, such as TNF (Tumor necrosis factor)-α , IL (Interleukin)-1, or IL-6
(Bain and Mowat, 2014; Smythies et al., 2005). However, intestinal
macrophages constitutively secrete IL-10, and low amounts of TNF-α, to
contribute to intestinal homeostasis and barrier function (Gross et al., 2015). IL10 is an anti-inflammatory cytokine that mediates intestinal tolerance to bacteria
by inhibiting pro-inflammatory cytokine secretion from macrophages and T-cell
inflammatory responses, as well as modulating Treg (Mantovani and Marchesi,
2014). Consistent with this assertion, IL-10 deficient mice develop spontaneous
colitis characterized by hyperproliferation of the epithelium and hyperactivation of
the immune system in response to commensal bacteria (Kühn et al., 1993).
DCs are specialized cells that can effectively communicating with T-cells
to induce their activation and differentiation (Stockwin et al., 2000). Similar to
macrophages, they are located in close proximity to the epithelium, which allows
them to expeditiously detect pathogenic bacteria that have gained entry into the
host. Upon bacterial ingestion, DCs will migrate to other secondary lymphoid
tissues to partner with naïve CD4+ T-cells and induce T-cell polarization into
effector cells that will propagate an inflammatory response (Gross et al., 2015).
In the small intestine, DCs also display signs of tolerogenicity. DCs that are
present in mesentery lymph nodes and in the lamina propria secrete retinoic acid
and transforming growth factor (TGF)-β to promote the generation of Treg, which
increase the inhibitory function of other immune cell types to reign in
inflammation (Okumura and Takeda, 2016; Sun et al., 2007).
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The chronic, low-grade inflammatory state within the small intestine is
delicately balanced by the regulatory action of Treg and pro-inflammatory Thelper (Th) 17 cells within the lamina propria (Omenetti and Pizarro, 2015). Treg
and Th17 cells both derive from naïve T-cells that are exposed to the key
mediator TGF-β, but have distinctly opposite biological functions in the immune
system (Eisenstein and Williams, 2009). While Treg potently suppress the
function of other immune cells by secreting inhibitory cytokines, such as IL-10,
TGF-β, and IL-35, that limit the activation and differentiation of immune cells,
Th17 cells promote a robust inflammatory response to the local microbiota,
which, if not restrained, will results in pathogenic inflammation (Omenetti and
Pizarro, 2015). In the small intestine, the secretion of these key mediators by
innate immune cells is critical for establishing a balance between Treg and Th17
to promote an environment that is tolerant to the microbiota. Retinoic acid, which
is produced by DCs in the lamina propria, promotes T-cell specification toward
the Treg lineage, while IL-6 and the transcription factor ROR-λt, promote Th17
development (Mucida et al., 2007). Intestinal macrophages further contribute to
Treg specification by failing to secrete IL-6 upon pathogen binding. If this
balance becomes disrupted, this can promote an inflammatory state that is
difficult to restrain.
The pro-inflammatory Th17 cell type normally resides in the lamina propria
of the small intestine during homeostatic conditions to mediate host defense
extracellular bacteria and fungi that have penetrated the barrier. Secretion of the
cytokine IL-23 from macrophages and dendritic cells activates Th17 cells to
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mount an immune response to pathogenic substrates by secreting the cytokines
IL-17, IL-21, and IL-22 (Symons et al., 2012). However, if IL-23-mediated
activation of Th17 cells is not precisely regulated, their protective function can
become pathological, as is seen in a spectrum of autoimmune diseases
(Langrish et al., 2005; Omenetti and Pizarro, 2015). The transcription factor
ROR-λt induces the secretion of IL-17, an indispensible component of Th17
mediated inflammation. Thus, understanding the regulation of ROR-λt in IL-17mediated colitis is of therapeutic interest.
The highly variable environment within the lumen consistently challenges
the mucosal barrier of the small intestine. In response to this continual flux,
specific and rapid changes within the cellular architecture of the mucosa must
occur to promote barrier integrity and function (Pastorelli et al., 2013). Posttranslational modifications, such as ubiquitylation, regulate cellular responses to
generate appropriate signals by influencing the stability, localization, or function
of a protein substrate (Rotin and Kumar, 2009). Attachment of ubiquitin to a
target protein requires the sequential action of the E1 ubiquitin activating
enzyme, the E2 ubiquitin conjugating enzyme, and the E3 ubiquitin ligase, the
latter of which confers substrate specificity (Popovic et al., 2014). Activation of
ubiquitin, a 76 amino-acid polypeptide, is an ATP dependent process that is
initiated by the E1 enzyme and allows the carboxy terminus of ubiquitin to attach
to an active cysteine residue on the E1 via a thioester bond (Metzger et al.,
2012). The activated ubiquitin is transferred to one of nearly 40 E2s, forming a
similar thioester linkage with a cysteine residue on the E2. The E3 ligase-protein
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complex partners with an ubiquitin-primed E2 enzyme to transfer the ubiquitin to
an ε-amino group of a lysine residue on the protein target (Rotin and Kumar,
2009). With over 600 E3 ligases present within the mammalian genomes, the
diverse repertoire of protein substrates that are targeted for ubiquitylation is
dependent on the E3 ligase (Li et al., 2008). Two major families of E3 ligases
have been identified: the really-interesting new gene (RING)-family and the
homeologous to the E6AP carboxyl terminus (HECT)-family (Metzger et al.,
2012). The catalytic action of the HECT-family of E3 ligases allows ubiquitin to
be transferred to a cysteine residue within the HECT domain before being
directly attached to the protein target. Unlike HECT E3 ligases, the RING-family
does not have catalytic action to accept and transfer ubiquitin to their target
proteins, rather serves as linkers to place the substrate and E2 in close proximity
to facilitate ubiquitylation.
The HECT domain present within this E3 ligase family is positioned at the
C-terminus of the protein, providing a protein-binding motif for the E2 enzyme to
bind to as well as a critical cysteine residue to transfer the activated ubiquitin
(Bernassola et al., 2008). Within this family, the E3 ligases are further classified
into 3 subclasses based on their protein-protein binding domains that allow the
E3 ligase and protein target to interact. Of the three, the Nedd4-like family of E3
ligases has been the best characterized. The structure of the 9 mammalian
family members consists of a N-terminal C2 domain capable of binding Ca2+ and
phospholipids, two to four tryptophan-tryptophan (WW) protein interacting
domains, and a catalytic C-terminal HECT domain (Chen and Matesic, 2007).
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The WW domains of HECT E3 ligases confer substrate specificity and show
preferential binding to PPXY motifs present within proteins.
The HECT E3 ligase ITCH was first identified from a radiation- and 5hydroxyurea- induced paracentric inversion on the distal end of mouse
chromosome 2, which disrupted both the Agouti and Itch loci (W L Perry et al.,
1998). Animals homozygous for this loss of function mutation (Itcha18H/a18H)
developed a spontaneous and progressive, late-onset autoimmune-like
phenotype that was lethal by 6-8 months of age (C M Hustad et al., 1995). On a
C57BL/6J background, Itcha18H/a18H displayed lymphoproliferaton in the spleen,
lymph nodes, and thymus, atopic dermatitis, and pulmonary interstitial
inflammation, the latter of which culminated in animal mortality. The
inappropriate activation of the immune system at the mucosal surfaces of the
skin and lung of ITCH deficient animals was attributed to a decrease in ITCHmediated ubiquitylation of JunB, a transcription factor that drives Th2 polarization
(Fang et al., 2002a). Interestingly, the autoimmune-like phenotype associated
with loss of ITCH function in mice phenotypically recapitulates ITCH deficiency in
humans. The multisystem autoimmune syndrome that humans displayed as a
consequence of a truncating mutation of ITCH is characterized by organomegaly,
failure to thrive, and autoimmune infiltration within the lungs, liver, and the
gastrointestinal tract (Lohr et al., 2010). Further characterization of the
homozygous null a18H mutation of Itch mice also identified an inflammatory
phenotype within the mucosa of the gut (Kathania et al., 2016). Animals deficient
for ITCH developed spontaneous colitis at 6-8 months of age that was
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characterized by mixed inflammatory infiltrate present within that colon as well as
deterioration of the colonic epithelium. The development of colitis within the
Itcha18H/a18H animals was attributed to an increase in IL-17 produced from Th17
helper T-cells, innate lymphoid cells, and λδ T-cells, which was driven by
decreased ITCH-mediated ubiquitylation of ROR-λt.
In addition to the inflammation that is present in the colon of Itcha18H/a18H
animals, mild inflammation is also observed along the small intestinal tract in 5-7
month old Itcha18H/a18H animals. While a role for ITCH in the small intestine has
yet to be defined, the mild inflammation is that is present in this organ suggests
that loss of ITCH function influences small intestinal homeostasis. Consistent
with this assertion, ITCH expression is relatively high within the normal
epithelium of the small intestine in humans as compared to other tissue types,
and its expression is increased in colorectal cancers that develop along an
adenoma-to-carcinoma sequence. Further support for ITCH’s role in the small
intestinal homeostasis is evident from the numerous transcription factors,
receptors, and signaling transducers that are identified as targets of ITCH that
are reviewed below, and also play a signficant role within the small intestinal
mucosa (Table 1.1).
Accumulating evidence supports a regulatory function for the E3 ligase
ITCH within embryonic (ESC) (Liao et al., 2013), somatic (Rathinam et al., 2011),
and cancerous stem cells (Tsui et al., 2017). In ESC, ITCH maintains stemness
by directly interacting with and ubiquitylating OCT4, a transcription factor that
induces pluripotency, to increase its transcriptional activity and stability (Liao et
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al., 2013). Further, loss of ITCH reduced the self-renewal capacity of ESC and
reduced a somatic cell’s ability to be reprogrammed into pluripotent stem cells.
ITCH also promotes cancer cell stemness in the hepatocellular carcinoma (HCC)
cell line Huh-7 by targeting and degrading the phosphorylated form of
Dishevelled-3 (DVL3) (Tsui et al., 2017). Within HCC, two forms of DVL3 exist:
phosphorylated DVL3 and a non-phosphorylated DVL3, the latter of which
promotes cancer cell stemness. Disruption of this balance can be achieved by
ITCH-mediated ubiquitylation of phosphorylated DVL3, which increases the
amount of non-phosphorylated DVL3 as compared to phosphorylated DVL3.
Non-phosphorylated DVL3 promotes cancer stem renewal in HCC by increasing
B-catenin transcriptional activity and increasing LGR5 mRNA levels. In contrast,
the hematopoetic stem cell (HSC) pool, self-renewal is negatively regulated by
ITCH (Rathinam et al., 2011). Loss of ITCH function increased NOTCH1
signaling and resulted in increased proliferation and expansion of the HSC
population within the bone marrow of Itcha18H/a18H animals as compared to Itch+/+
animals. Transplantation of ITCH deficient HSCs into lethally irradiated ITCH
sufficient or ITCH deficient animals demonstrated that the enhanced proliferative
capacity of HSCs was intrinsically regulated. A number of studies report that
increased proliferation in HSCs will compromise the regenerative capacity of
stem cells (K.A. et al., 2015; Yu et al., 2006). Interestingly, ITCH deficient HSCs
did not show signs of stem cell exhaustion even with enhanced proliferation and
increased cell cycle entry.
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WNT signaling contributes to tissue regeneration by influencing stem cell
dynamics, proliferation, and specification. The influence ITCH has in modulating
canonical WNT signaling is highlighted by the recent identification of two, novel
WNT signaling components, DVL2 (Wei et al., 2012) and LRP6 (Vijayakumar et
al., 2017), which are ubiquitylated by ITCH. DVL promotes canonical WNT
signaling by interacting with the LRP5/6 co-receptor and Axin to stabilize the
cytosolic β-catenin pool, which is capable of translocating to the nucleus to
upregulate WNT-responsive genes. In 293T cells, the DVL family of proteins
(DVL1, DVL2, DVL3) were all found to co-precipitate with ITCH. However, the
most robust interaction was with DVL2 (Wei et al., 2012). Exogenous
overexpression of DVL2, a catalytically active or catalytically dead ITCH E3
ligase, and ubiquitin confirmed that ITCH ubiquitylates DVL2 and leads to its
destruction via the proteasome (Wei et al., 2012). This was further substantiated
by the absence of DVL2 ubiquitylation when ITCH was knocked-down via siRNA
treatment. Functionally, ITCH-mediated ubiquitylation of DVL2 negatively
regulated WNT signaling. On the other hand, the targeting of the extracellular
domain of LRP6 by ITCH also promotes WNT signaling in 293T cells
(Vijayakumar et al., 2017). Interestingly, ITCH was found to bind and ubiquitylate
LRP6 by mass spectrometry. Instead of promoting LRP6’s degradation,
ubiquitylation of LRP6 by ITCH promoted endocytosis of the receptor and
increased Wnt3a-mediated canonical WNT signaling. The discrepancy in ITCH’s
function within the WNT signaling pathway is not without precedent. Within the
WNT signaling pathway, GSK3β as well as AXIN can positively or negatively

16

regulate WNT signaling in a context-dependent manner (Vijayakumar et al.,
2017). Thus, ITCH could be an additional player within the regulatory network of
the WNT signaling pathway that has a dual function.
In addition to WNT signaling, the NOTCH signaling pathway also mediates
stem cell decisions and lineage commitment in the intestine and hematopoietic
system (Fre et al., 2009; VanDussen et al., 2012; Vooijs et al., 2011). ITCH
negatively regulates the HSC population by intrinsically down regulating
NOTCH1 signaling in HSCs (Rathinam et al., 2011). Dampening of NOTCH1
signaling by ITCH likely maintains the HSCs in a quiescent state to conserve this
population until mature cell lineages need replenishing. Consistent with this
assertion, ITCH interacts with the intracellular domain of the NOTCH1 receptor to
catalytically attach ubiquitin to NOTCH and target it for degradation (Chastagner
et al., 2008). The interaction between NOTCH and ITCH appears to be highly
conserved. In Drosophila melanogaster, genetic loss of the ITCH ortholog
Suppressor of Deltex rescues Notch signaling (Cornell et al., 1999). Further
evidence that NOTCH and ITCH genetically interact is supported by an
accelerated itchy phenotype that develops in Itcha18H/a18H mice with an activating
mutation of a Notch1 transgene in T-cells (Matesic et al., 2006).
On another note, moribund Itcha18H/a18H animals exhibit signs of barrier
dysfunction (Kathania et al., 2016). When fluorescently conjugated dextran, a
macromolecule that is able to passively diffuse through the intestinal epithelium,
was administered by oral gavage to Itch+/+ or Itcha18H/a18H animals, increased
levels of FITC-dextran were present within the serum of Itcha18H/a18H animals as
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compared to Itch+/+ control animals (Kathania et al., 2016). In contrast, young
adult ITCH deficient animals do not appear to have a compromised intestinal
barrier, suggesting that barrier dysfunction is likely exacerbated by an
inappropriate inflammatory response within these animals (Marino et al., 2014).
On another note, a potential role for ITCH in altering tight junction is highlighted
by the ITCH-mediated degradation of OCCLUDIN (Traweger et al., 2002).
Endogenous ITCH and OCCLUDIN co-immuoprecipitated in embryonic tissue
from a mouse at day 13 of gestation. Further, ITCH was confirmed to
polyubiquitylate OCCLUDIN in 293T cells and alter its stability.
Accumulating evidence highlights a specific role for ITCH in apoptosis.
Among ITCH’s numerous targets are p63 (Rossi et al., 2006) and p73 (Rossi et
al., 2005), essential transcription factors involved in cell cycle regulation and
apoptosis. Both full-length (TA) p63 and p73 are transcriptionally active and can
induce cell cycle arrest that results in apoptosis (Murray-Zmijewski et al., 2006).
Alternatively, dominant-negative (ΔN) isoforms can also be generated from an
alternative promoter within the p63 or p73 genes. The ratio between the TA and
the ΔN isoforms influences the biological outcome. The E3 ligase ITCH has
been demonstrated to target both isoforms of p63 and p73. In HEK293 cells,
ITCH was shown to bind and ubiquitylate both TAp63 and ΔNp63 that
consequently lead to their destruction (Rossi et al., 2006). Additionally, the
primary culture of keratinocytes derived from Itcha18H/a18H animals retained the
expression of ΔNp63 longer during keratinocyte differentiation as compared to
Itch+/+ keratinocytes. As with p63, ITCH also binds, ubquitylates, and degrades
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TAp73 and ΔNp73 (Rossi et al., 2005). In response to DNA damage, ITCH
expression is reduced, which likely leads to the accumulation of TAp73 to induce
cycle arrest and apoptosis.
ITCH also targets and promotes the degradation of other molecules
involved in apoptosis, including TXNIP (Zhang et al., 2010), LATS1 (Ho et al.,
2011), and c-FLIP (Chang et al., 2006). TXNIP is a modulator of cell redox
homeostasis and is induced in response to cell stress, which allows reactiveoxygen species to accumulate and initiate cell death. In vitro and in vivo
ubiquitylation assays confirmed that ITCH can bind, ubiquitylate, and degrade
TXNIP (Zhang et al., 2010). Consequently, loss of ITCH promoted accumulation
of reactive-oxygen species and apoptosis in response to the chemotherapeutic
agent etoposide. Additionally, the targeting of the tumor suppressor LATS1 by
ITCH promotes cell survival by increasing proliferation and decreasing apoptosis
(Ho et al., 2011). Knockdown of endogenous ITCH via shRNA treatment in
MDA-MB231 cells (derived from a human breast adenocarcinoma) decreased
proliferation and increased apoptosis. More importantly, this phenotype can be
reversed by shRNA knockdown of endogenous LATS1 effectively demonstrating
that ITCH is a negative regulator of LATS1.
The presence of ITCH within Tregs controls the inflammatory response of
Th2 cells. Loss of ITCH expression under the control of a Treg specific (Foxp3)
promoter (Itchfl/fl; Foxp3Cre/Cre) resulted in massive lymphocytic infiltrate in the
lung, skin, stomach, and liver, skin lesions, and chronic T-cell activation (H. S. Jin
et al., 2013). Furthermore, severe inflammation was localized to the lungs of
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Itchfl/fl; Foxp3Cre/Cre animals as compared to ITCH sufficient control animals when
subjected to an antigen-induced airway inflammation model of asthma (H. Jin et
al., 2013). Interestingly, Itchfl/fl; Foxp3Cre/Cre Tregs adopted a Th2 phenotype,
secreting IL4-, IL-5, IL-10, and IL-13, while still retaining their suppressive
capacity in an adoptive T-cell transfer model of colitis. Furthermore, IL-4, IL-5,
and IL-10 cytokine levels were also increased in CD4+ T-cells derived from Itchfl/fl;
Foxp3Cre/Cre animals as compared to control animals, suggesting that a Th2mediated inflammatory response was initiated in Itchfl/fl; Foxp3Cre/Cre animals.
In addition to regulating T-cell differentation, ITCH has been found to
influence macrophage signaling. ITCH regulates p38, JNK, and NFκB signaling
within macrophages via its interaction with NOD2 and RIP2 (M. F. Tao et al.,
2009). NOD2 is an intracellular pattern recognition receptor that binds to
fragments of a peptidoglycan that have invaded epithelial cells of the small
intestine. Subsequently, a cytokine response is initiated by NOD2 that precisely
controls the type, amount, and duration of cytokines that are necessary to
effectively clear the bacterial pathogen while, at the same time, limiting this
reaction to prevent an aberrant inflammatory response that could lead to tissue
destruction (Caruso et al., 2014). Generation of the cytokine response hinges on
the interaction of NOD2 with ubiquitylated RIP2 to activate p38, JNK, and NFκB
signaling. In response to a Listeria monocytogenes infection in HT-29 cells, K63linked polyubiquitylaton of RIP2 was mediated by the E3 ligase ITCH, which
facilitated binding with NOD2 (M. F. Tao et al., 2009). Interestingly, ITCHmediated ubiquitylation of RIP2 selectively promoted p38-induced JNK activation
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while compromising NFκB signaling. Further, this interaction was also confirmed
in bone marrow-derived macrophages from Itcha18H/a18H animals that were
stimulated with mumuryl dipeptide (MDP), a peptidoglycan fragment that binds to
NOD2 to initiate cytokine responses. MDP stimulation resulting in increased
expression of NFκB gene targets in the Itcha118H/18H animals as compared to
Itch+/+ bone marrow-derived macrophages. In addition to ITCH’s ability to
downregulate NFκB signaling in response to MDP, ITCH also attenuates NFκB
signaling induced by TNFα (Shembade et al., 2008). Mechanistically, the binding
of ITCH to PPXY consensus sequences of A20, an ubiquitin-editing enzyme,
modifies RIP2 ubiquitylation to inhibit NFκB activation. Further evidence
supporting the importance of ITCH-mediated TNF-α -induced NFκB signaling is
highlighted by phosphorylation of ITCH by the IKK kinase family, an essential
component that is required for NFκB activation, which inhibits its regulation over
NFκB to prolong NFκB duration (Perez et al., 2015).
Expanding on this current body of literature, our studies aim to elucidate
the role of the E3 ligase ITCH in the small intestine. Here we provide evidence
that loss of ITCH function in the small intestine influences epithelial homeostasis
in a cell autonomous and non-cell autonomous manner.
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Figure 1.1. Cell types that comprise the small intestinal mucosa. The
mucosa of the small intestine is composed of the epithelial barrier that
separates the external environment from the body’s internal milieu and the
immune compartment. The epithelium is composed of CBC stem cell and +4
stem cells that reside at the base of the crypt interspersed between Paneth
cells. Enterocytes, goblet cells, and enteroendocrine (EE) cells line the villi of
the small intestine. The immune compartment, which underlies the epithelium,
is composed of immune cells that mediate innate and acquired immune
responses.
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Table 1.1. List of previously described targets of ITCH.

23

CHAPTER 2
THE UBIQUITIN LIGASE ITCH COORDINATES SMALL INTESTINAL
EPITHELIAL HOMEOSTASIS BY MODULATING CELL PROLIFERATION,
DIFFERENTIATION, AND MIGRATION1

1

Heather L. Mentrup, Amanda Hartman, Elizabeth L. Thames, Wassim A.
Basheer, and Lydia E. Matesic. Submitted to Differentation, August 7, 2017.
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2.1 Abstract
Maintenance of the intestinal mucosa is driven by local signals that
coordinate epithelial proliferation, differentiation, and turnover in order to
separate antigenic luminal contents from the host’s immune system. Breaches in
this barrier promote gastrointestinal pathologies ranging from inflammatory bowel
disease to cancer. The ubiquitin ligase ITCH is known to regulate immune
responses, and loss of function of ITCH has been associated with
gastrointestinal inflammatory disorders, particularly in the colon. However, the
small intestine appears to be spared from this pathology. Here we explored the
physiological mechanism that underlies the preservation of mucosal homeostasis
in the small intestine in mice lacking ITCH (Itcha18H/a18H). Histological analysis of
the small intestines from young adult mice revealed architectural changes in
animals deficient for ITCH, including villus blunting with cell crowding, crypt
expansion, and thickening of the muscularis propria relative to age-matched mice
sufficient for ITCH. These differences were more prominent in the distal part of
the small intestine and were not dependent upon lymphoid cells. Underlying the
observed changes in the epithelium were expansion of the Ki67+ proliferating
transit amplifying progenitor population and increased numbers of terminally
differentiated mucus-secreting goblet and anti-microbial producing Paneth cells,
which are both important in controlling local inflammation in the small intestine
and are known to be dysregulated in inflammatory bowel disease. Homeostasis
in the small intestine of Itcha18H/a18H animals was maintained by increased cell
turnover, including accelerated migration of epithelial cells along the crypt-villus
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axis and increased apoptosis of epithelial cells at the crypt-villus junction.
Consistent with this enhanced turnover, Itcha18H/a18H mice carrying the Min
mutation (Itcha18H/a18H; ApcMin/+) displayed a 76% reduction in tumor burden as
compared to ApcMin/+ littermates with normal levels of ITCH. These findings
highlight the role of ITCH as an important modulator of intestinal epithelial
homeostasis.
2.2 Introduction
In the small intestine, the mucosal epithelium is a folded monolayer of
columnar cells that is organized into crypts, which invaginate into the underlying
mesenchyme, and villi, which project into the lumen. This structure is ideally
suited to provide an essential, physical barrier between the host and its
environment that must facilitate the absorption of nutrients while simultaneously
preventing the loss of fluids and electrolytes as well as the entry of
microorganisms into the body (van der Flier and Clevers, 2009). When the
intestinal epithelium is disrupted, commensal and pathogenic microbes gain
access to the host organism, prompting an inflammatory response, which can
itself cause further tissue damage if not appropriately regulated (Turner, 2009).
Thus, communication between mucosal immune cells (particularly those of the
myeloid lineage) and the overlying epithelium is essential in maintaining gut
homeostasis and in controlling intestinal inflammation (Van Der Gracht et al.,
2016). Preservation of barrier function is dependent, in part, upon the continuous
renewal of intestinal epithelial cells (Bischoff et al., 2014). Regeneration of the
small intestinal epithelial architecture is a highly complex process that relies on
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the balanced coordination of cellular proliferation within the crypts of Lieberkühn,
preservation of epithelial function through cellular differentiation, and homeostatic
cell migration along the crypt-villus axis (Pellettieri and Alvarado, 2007).
Dysregulation of any one of these aspects of epithelial maintenance can drive a
diverse collection of pathologies, ranging from improper nutrient absorption to
inflammatory bowel disease (IBD) to intestinal carcinogenesis (J. M. Williams et
al., 2015).
The rapid and constant renewal of the intestinal epithelium is initiated by
the multipotent crypt base columnar (CBC) stem cells that reside at the bottom of
the crypts (Barker et al., 2007a). Upon cellular division, the CBC stem cells give
rise to a rapidly dividing transit-amplifying (TA) population that will commit and
differentiate into the five major post-mitotic cells of the small intestinal epithelium
(Barker, 2013). The most abundant of these is the absorptive enterocyte. The
remaining four post-mitotic cell types originate from the secretory cell lineage and
include the mucus secreting goblet cells, anti-microbial secreting Paneth cells,
hormone producing enteroendocrine cells, and tuft cells (Barker, 2013). With the
exception of Paneth cells, which migrate deeper into the crypt, the other four
post-mitotic cell types normally move onto the villus where they continue to travel
upward along this axis, eventually being sloughed off at the tip into the lumen.
Because of the rapid turnover of the small intestinal epithelium, both spatial and
temporal timing of signals are paramount. Accumulating evidence suggests that
post-translational modifications such as ubiquitylation are essential in the
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regulation of these signals to promote tissue homeostasis (Strikoudis et al.,
2014).
Protein ubiquitylation is a highly conserved process characterized by the
attachment of an ubiquitin molecule to a lysine residue within a target protein via
the sequential action of three enzymatic/scaffolding proteins: the ubiquitinactivating enzyme (E1), the ubiquitin-conjugating enzyme (E2), and the ubiquitin
ligase (E3). Ubiquitylation of a target substrate can lead to its degradation in the
proteasome or lysosome, to its altered function, or to a change in its subcellular
localization (Popovic et al., 2014). The E3 ubiquitin ligase ITCH was originally
identified when the molecular etiology of the radiation- and 5-hydroxyureainduced a18H mutation was elucidated, revealing a paracentric inversion on the
distal end of mouse chromosome two, the breakpoints of which disrupted both
the Itch and Agouti loci (William L. Perry et al., 1998). Animals homozygous for
this null mutation of Itch (Itcha18H/a18H) display lymphoproliferation in the spleen,
lymph nodes, and thymus, atopic dermatitis, and pulmonary interstitial
inflammation with alveolar proteinosis which culminates in death around 6-8
months of age on a C57BL/6J background (C. M. Hustad et al., 1995) whereas
animals heterozygous for this mutation appear relatively unaffected with a normal
lifespan (C. M. Hustad et al., 1995; Parravicini et al., 2008). The skin and lung
inflammation in these animals occurs in the absence of known pathogen
exposure, implying that immune activation may result from inappropriate
inflammatory responses to environmental antigens at mucosal surfaces.
Consistent with this assertion, loss of ITCH function has also been associated
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with a gastrointestinal inflammatory phenotype in both mice and humans
(Kathania et al., 2016; Lohr et al., 2010; Ramon et al., 2011; M. Tao et al., 2009).
In mice, this appears to be more severe in the colon with moribund Itcha18H/a18H
mice developing spontaneous colitis characterized by an increase in mixed
inflammatory infiltrate and colonic epithelial destruction that was not observed in
their age- and gender- matched wild type counterparts and has been
hypothesized to be lymphoid-driven (Kathania et al., 2016). However, only mild
inflammation has been observed in the small intestine of similarly aged (i.e., 5-7
month old) animals lacking ITCH (Kathania et al., 2016; Ramon et al., 2011).
This led us to hypothesize that, owing to differences in architecture, function, and
microbiota composition, additional compensatory pathways may be activated in
animals lacking ITCH in order to better maintain homeostasis in the small
intestine as compared to what has already been described for the colon. Using
the previously characterized Itcha18H/a18H mouse model, we found that, in the
distal small intestines of Itcha18H/a18H animals, there were increased numbers of
goblet and Paneth cells which correlated with increased proliferation of
progenitor cells and expansion of the crypts. However, overall, homeostasis and
cell number was maintained in these animals by accelerated migration and
increased apoptosis of epithelial cells as compared to wild type animals.
Furthermore, these changes in epithelial cell dynamics were associated with a
76% reduction in small intestinal tumor burden in animals lacking Itch expression
on an ApcMin/+ background as compared to ITCH-sufficient ApcMin/+ littermates.
Collectively, these data demonstrate a previously unappreciated role for ITCH in
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the regulation of intestinal epithelial homeostasis, and provide further insight into
regional differences in this process along the intestines.
2.3 Materials and Methods
Animals
Animals homozygous for a null allele of Itch (Itcha18H/a18H) have been
previously described (C. M. Hustad et al., 1995). For this line, the a18H allele was
backcrossed to C57BL/6J for 27 generations. Therefore, age-matched male and
female C57BL/6J mice were used as referent controls (Itch+/+) in the indicated
experiments. To study the effect of this mutation on APC-induced tumorigenesis,
a two generation intercross was performed. Specifically, Itcha18H/a18H mice were
bred to ApcMin/+ animals (JAX stock #002020) to produce Itcha18H/+; ApcMin/+ and
Itcha18H/+; Apc+/+ offspring, which were interbred to generate Itch+/+; Apc+/+,
Itcha18H/a18H; Apc+/+, Itcha18H/a18H; ApcMin/+, and Itch+/+; ApcMin/+ animals for analysis.
To assess the contribution of lymphocytes to the loss of function ITCH
phenotype, Itcha18H/a18H animals were bred to B6.129S7-Rag1tm1Mom/J (Rag1-/-)
mice (Jackson Laboratories stock number #002216) as previously described
(Shembade et al., 2008). Since the Rag1-/- mice are severely
immunocompromised, all animals from this cross were reared and maintained
under high barrier conditions, following the recommendations of Jackson
Laboratories. For all experiments, both genders were represented in each
genotype in all experiments. All experiments were conducted in full compliance
with the Institutional Animal Care and Use Committee of the University of South
Carolina.
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Histology and Staining
Small intestines derived from young adult animals were flushed with
phosphate-buffered saline (PBS) after being cut into three equally sized
segments (designated proximal, middle and distal), opened longitudinally, and
fixed overnight with either 4% paraformaldehyde or with 10% neutral buffered
formalin. Swiss-rolled intestinal tissues or were paraffin-embedded and
sectioned at 5µm. Hematoxylin and eosin (H&E) staining was performed to
assess tissue morphology. Alcian blue and nuclear fast red staining was
performed by applying alcian blue, pH 2.5 for 30 minutes at 25°C followed by
0.1% nuclear fast red for 5 minutes. The Grimelius stain was performed
according to previously published methodology (Grimelius, 2004). Briefly, tissue
sections were treated with a 0.03% silver nitrate staining solution (Fisher
Scientific, S181) for 3 hours at 60°C followed by a 2 minute treatment with a
silver reducing solution (5% Sodium Sulfite/1% Hydroquione) that was prewarmed to 58°C. Alkaline phosphatase (AP) staining was carried as previously
described (Burstone, 1958). Specifically, a 2% naphthol AS-MX phosphate
solution diluted in N,N-dimethyformamide was added to a 50%/50% mixture of
Tris buffer, pH 8.74 and distilled water to create a final solution containing 0.5%
napththol AS-MX phosphate in Tris buffer. This was then filtered through a
0.45µm filter. Slides were placed in the solution for 45 minutes at 37°C and
washed before counterstaining with hematoxylin.
Immunohistochemistry and Immunofluorescence
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For immunohistochemistry (IHC), antigen unmasking was performed using
target retrieval solution for Ki67 (Dako # S1699) or 10 mM Tris-HCl/ 1 mM
ethylenediaminetetraacetic acid (EDTA), pH=9 for 30 minutes at 95°C for
cleaved-caspase 3. Sections were blocked in a solution containing 10% normal
goat serum, 2% bovine serum albumin, and 0.2% Triton X-100 in Tris buffered
saline (10mM Tris-HCL, pH 7.6, 150mM NaCl). An additional hydrogen
peroxidase block was performed for 20 minutes at 25°C. The primary antibodies
recognizing either Ki67 (B56, BD Pharmingen, 1:100) or cleaved-caspase 3 (Cell
Signaling Technologies, #9664, 1:100) were diluted in Tris buffered saline
containing 1% normal goat serum and 0.1% Triton X-100 and incubated on
sections in a humidified chamber overnight at 4°C. The antibody was visualized
using the EnVision+ system-HRP per the manufacturer’s instructions (Dako #
K4006). Brightfield images were acquired on a Zeiss Axio Imager A1 equipped
with an AxioCam MRc5 camera.
Tissue immunofluorescence for lysozyme was performed as previously
described (Basheer et al., 2015) with the following modifications: 5 µm paraffin
sections were blocked for 1 hour before applying an anti-lysozyme antibody
(RP028, Diagnostic BioSystems, 1:100) overnight at 4ºC. AlexaFluor659conjugated goat anti-rabbit secondary (Jackson ImmunoResearch) was applied
at a 1:500 dilution for 1 hour before mounting sections in Fluoro-gel II with DAPI
(17985-51, Electron Microscopy Sciences). Phase contrast-coupled fluorescent
images were acquired on a Leica DMI6000B epifluorescence microscope
equipped with a Hamamatsu ORCA-R2 CCD camera.
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Quantitative Measurements: Histological Measurements, Cell Proliferation, and
Post-Mitotic Cell Differentiation
All parameters quantified by histological examination were assessed in the
distal segment from four or five 8-10 week old animals of each genotype (i.e.,
Itch+/+, n=4 or 5 and Itcha18H/18H, n=4 or 5). Crypt and villus areas were quantified
using a minimum of 25 well-oriented crypt or villus structures from at least seven
different 10x fields per animal. The crypt or villus unit was outlined using the
polygon tool in ImageJ, and the areas were quantified in µm2. Cell proliferation
was measured by first manually counting the total number of Ki67+ cells stained
by IHC in 25 well-oriented crypts from a minimum of nine 20x fields per animal.
Then, the total number of cells in those same crypts was determined by
enumerating the nuclei stained with Ki67 and/or hematoxylin. To calculate the
average percentage of Ki67+ cells in a crypt, the number of Ki67+ cells was
normalized to total cell number for that crypt and expressed as a percentage.
Phase contrast-coupled fluorescence images immunostained with an
anti-lysozyme antibody were used to determine average Paneth cell number. In
particular, individual Paneth cells were delineated using the cell membrane
highlighted by phase-contrast microscopy, the DAPI-stained nucleus, as well as
reactivity with the anti-lysozyme antibody. Paneth cells were counted in 30
crypts from a minimum of twelve 20x fields per animal. Average goblet cell and
enterocyte number was determined by staining sections with alcian blue and a
nuclear fast red counterstain. Goblet cells were recognized on the basis of the
reactivity of their cytoplasm with alcian blue and by their characteristic shape,
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while enterocytes were not reactive with alcian blue and were instead identified
by their typical columnar appearance. Both types of cells were counted on 30
villi in at least eight different 10x fields per animal. Similarly, enteroendocrine
cells identified through Grimelius stain were counted from 30 villi in eight different
10x fields per animal.
Bromodeoxyuridine (BrdU) Migration Assay
Twelve young adult Itch+/+ and twelve young adult Itcha18H/a18H animals
were intraperitoneally injected with 100 mg/kg BrdU (B5002, Sigma) dissolved in
sterile PBS. Three animals of each genotype were randomly assigned to one of
three cohorts and euthanized at 2, 24, 48, or 72 hours post-injection. The small
intestines from these animals were cut into equally sized proximal, middle, and
distal segments and flushed with PBS prior to 4% paraformaldehyde fixation,
paraffin-embedding, and sectioning at 5 µm. IHC was performed as described
above using anti-BrdU (3D4, BD Pharmingen, 1:8000). Images were acquired by
bright field microscopy on a Zeiss Axio Imager A1 equipped with an AxioCam
MRc5 camera and subsequently analyzed using ImageJ to determine migration
and villus lengths. Percent cell migration was assessed from 25 villi in at least
five different 10x fields per animal and calculated by normalizing the length of the
furthest migrated epithelial BrdU+ cell from the base of the villus to the entire
length of the villus from BrdU immunostained sections and converting to a
percentage.
For figure presentation, brightfield images of sections immunostained with
an anti-BrdU antibody were transformed to a spectral image using ImageJ. This
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was accomplished by first inverting the images and then converting them to 8-bit
gray scale. In order to specifically highlight cells that had taken up the BrdU
label, the pixel intensity for those nuclei staining only for hematoxylin was
subtracted out by calculating their background values. Specifically, for each
converted image, a minimum of six different BrdU- nuclei were identified
throughout the image and the pixel value for each was determined using a
constant, ImageJ pre-defined area for the cursor. These values were averaged
and considered the background level for each image. A similar background level
was calculated in all the images except the 72 hour Itcha18H/18H image, which was
higher. To account for this discrepancy, 55 pixels were subtracted from all the
images except the 72 hour image captured from the Itcha18H/a18H animal in which
67 pixels were subtracted due to high background. Finally, the royal look-up
table was applied to all images to re-colorize them.
Transmission Electron Microscopy
The small intestine from four young adult animals of each genotype was
cut into three equally sized segments, flushed with PBS, and then opened
longitudinally. The proximal segment was dissected into 4mm2 pieces which
were fixed in 2% glutaraldehyde/2% paraformaldehyde and secondarily postfixed in buffered 1% osmium tetroxide/1.5% potassium ferricyanide. After
dehydrating in ethanol, the samples were infiltrated and embedded in PolyBed
812 epoxy and allowed to polymerize for at least 48 hours at 60°C. At that time,
blocks were sectioned at approximately 90 nm on a Leica UltraCut R and post
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stained with 2% uranyl acetate (aq) and Hanaichi’s calcined lead citrate. Images
were obtained on a JEM 1400+ with an AMT mid-mount camera.
Polyp counts
The small intestines from 15 week-old male and female Itch+/+; Apc+/+,
Itcha18H/a18H; Apc+/+, Itcha18H/a18H; ApcMin/+ , and Itch+/+; ApcMin/+ animals were cut
into 4 equally sized segments, flushed with PBS, opened longitudinally, and fixed
overnight in 10% neutral buffered formalin. The samples were stained with 0.1%
methylene blue to identify tumors. Total tumor number for each animal was
assessed by counting and tabulating the polyp number along the entire axis of
the small intestine by an observer blinded to genotypes.
Isolation of Mouse Intestinal Villi
Isolation of the villus fraction was performed as previously described
(Huang et al., 2017) with the following modifications. To isolate adequate protein
levels from just the villus fraction, the proximal most 10 cm of small intestine from
two age-, gender- and genotype-matched animals was pooled. The small
intestines from 8-10 week old Itch+/+ and Itcha18H/a18H animals were washed in
PBS (containing Mg2+ and Ca2+) before opening longitudinally to expose crypts
and villi. The proximal segment was cut into 3 to 5 mm pieces and incubated in
ice-cold Dulbecco’s PBS (DPBS, Cellgro # 21-031-CV). The DPBS was
decanted from the previous step prior to incubating the intestinal pieces in icecold DPBS supplemented with 1 mM EDTA for 10 minutes at 4°C on a rocking
platform. The 1mM EDTA was discarded, and the intestinal pieces were
resuspended in fresh DPBS before being shaken vigorously 10-15 times to
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dislodge the attached cells. The cells contained in the DPBS were labeled
Fraction 1. To isolate cells from the villi, the fraction was filtered through a 70-µm
nylon filter (VWR, #10199-656). The cells that remained on the filter were
deemed the villus fraction. This process was subsequently followed for a total of
6 fractions, replacing each solution with fresh 1mM EDTA or DPBS prior to
filtration. Fractions 3-6 contained pure villi and were pooled together before
protein extraction. To isolate villi from the small intestines from Itcha18H/a18H
animals, the EDTA incubation time was amended to 5 minutes for Fractions 1-6.
All steps were performed at 4°C.
Protein Extraction and Western Blotting
Isolated villi were lysed in ice-cold RIPA buffer (150mM NaCl, 1% Triton X
-100, 0.5% sodium deoxycholate,0.1% SDS, 50mM Tris pH 8.0) supplemented
with 5mM EDTA,10mM NaF, 2mM NaVO4, and protease inhibitors (P8340,
Sigma, 1:100). For Western blotting, 40 µg of protein per sample were separated
using a 4%-15% Mini-PROTEAN TGX gel (Biorad, #456-1084) then transferred
to a PVDF membrane (Biorad, # 162-0177). The membrane was blocked in 5%
milk in TBST (10mM Tris-HCL, pH8, 150mM NaCl, 0.05% Tween-20) for 1 hour
at 25ºC. The following primary antibodies were incubated overnight at 4°:
GAPDH (Santa Cruz, 6C5, 1:2000), Itch (BD Transduction, 611198, 1:1000), Ncadherin (Cell Signaling Technology, D4R1H, 1:1000), and Vimentin (Cell
Signaling Technology, D21H3, 1:1000). Following primary antibody incubation,
the appropriate HRP-conjugated rabbit (Biorad, #STAR208P,1:30,000) or mouse
IgG secondary (Biorad, #STAR207P,1:20,000. was incubated for 1 hour at 25°C.
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Signals were visualized using ECL reagent (Millipore, Immobilon Western,
WBKLS0500) and the FluorChem E Chemiluminescent Western Blot Imaging
System (ProteinSimple). Normalization and quantification of band intensities was
performed with AlphaView software (ProteinSimple).
Statistics
Statistical comparisons of Ki67+ cells, Paneth cells, goblet cells,
enteroendocrine cells, enterocytes, BrdU migration, and tumor counts (reported
as mean and standard deviation (SD) or standard error of the mean (SEM), as
indicated, 2-tailed unpaired t-test for mean comparisons, Mann-Whitney test for
comparing non-parametric medians of non-normally distributed enteroendocrine
cells, and one-way ANOVA with a post hoc Tukey correction for tumor counts)
were performed in Microsoft Excel or Prism Software (GraphPad Software, Inc)
and plotted using Prism software. A p-value < 0.05 was considered statistically
significant.
2.4 Results
Itcha18H/a18H animals have altered small intestinal morphology
Using a previously described loss of function mouse model (C M Hustad
et al., 1995), the role of ITCH in intestinal homeostasis was examined by first
characterizing the impact that loss of ITCH has on the morphology of the small
intestines in young adult animals. This was accomplished by harvesting the
small intestines from four or five 8-10 week old mice of each genotype and
separately examining the architecture of the proximal, middle, and distal thirds of
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the intestine to account for known regional variations in structure. Interestingly,
examination of H&E stained sections from the various segments revealed
hyperplasia of the crypts which became more prominent caudally along the small
intestinal tract of Itcha18H/a18H animals as compared to ITCH sufficient referent
controls (Fig. 2.2.A). Additionally, villus blunting (with more disorganized
epithelial cell organization) as well as thickening of the muscularis propria were
observed in the distal portion of animals lacking ITCH (asterisk, Fig. 2.2.A) and
was associated with occasional mild mucosal inflammation (arrow, Fig. 2.2.A).
These phenotypes were also noted in Itcha18H/a18H; Rag1-/- animals which lack
functional lymphoid cells (Fig. 2.3 and (M. Tao et al., 2009)) indicating that these
changes were dependent on cues garnered from epithelial and/or innate immune
cells. To quantify the changes in size of the crypts and villi in Itcha18H/a18H
animals, we measured the area of 25 crypts and 25 villi from Itch+/+ and
Itcha18H/a18H animals in each region of the small intestine. Consistent with the
apparent crypt expansion noted microscopically, the crypt area was significantly
increased in the middle and distal segments of Itcha18H/a18H intestine as compared
to age-matched wild type animals (19,772.23 µm2 vs 11,165.53.12 µm2 and
22,653.25 µm2 vs. 15,780.51 µm2, respectively) as determined by 2-tailed,
unpaired t-test (Fig. 2.2.B). While there was a trend toward increased villus area
across the entire small intestine, only in the distal segment was a statistically
significant increase noted in animals lacking ITCH relative to those that were
sufficient for ITCH (62,056.18 µm2 vs. 47,144.47 µm2, Fig. 2.2.C). Therefore, for
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our subsequent analyses, we focused on changes in the distal segment of the
small intestine.
Expansion of the crypt in adult Itcha18H/a18H animals is associated with an increase
in the number of proliferating cells and Paneth cells in the distal small intestine
As there was a statistically significant increase in the crypt area of
Itcha18H/a18H animals relative to Itch+/+ controls, we hypothesized that an increase
in cell number might underlie this expansion. Indeed, when the total number of
cells in the crypts was calculated in tissues derived from five young adult animals
of each genotype, a statistically significant increase in cell number was found in
animals lacking ITCH (Fig. 2.4). To determine which cell populations might be
expanded in the crypt, we first performed IHC using an antibody that recognizes
the proliferation marker Ki67 since crypts are mostly composed of rapidly
proliferating progenitor TA cells (Fig. 2.5.A). Upon evaluation of 25 well-oriented
crypts from a minimum of nine 20x fields per animal (n=5 for each genotype),
40.14±4.91 (SD) Ki67+ cells on average were found in the crypts of the
Itcha18H/a18H animals whereas 29.056±2.91 (SD) Ki67+ cells on average were
found in the crypts of Itch+/+ controls, and this difference was found to be
statistically significant by 2-tailed, unpaired student t-test (Fig. 2.5.B). Although
there was an increase in the absolute number of Ki67+ cells detected in
Itcha18H/a18H animals, there was no difference in the percentage of proliferating
cells within the crypt when compared to Itch+/+ controls (Fig. 2.5.B), suggesting
that progenitors cells were not the only cell type contributing to this increase in
total cell number within the crypt.
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In addition to stem and progenitor cells, Paneth cells also reside in the
crypt. To test whether increased numbers of Paneth cells might be contributing
to the increased crypt area observed in Itcha18H/a18H mice, small intestinal
sections from five animals of each genotype were immunostained with an
antibody recognizing lysozyme, a mature Paneth cell maker (Fig. 2.5.C), allowing
for the enumeration of Paneth cells in 30 crypts from a minimum of twelve 20x
fields per animal. Interestingly, there was a significant increase in Paneth cells in
the crypts of Itcha18H/a18H animals (6.82±0.64, SEM) compared to Itch+/+ controls
(5.17±0.19, SEM). When the means were compared by unpaired, 2-tailed
student t-test, the difference was found to be statistically significant (Fig. 2.5.D).
Taken together, these results indicate that increases in the number of
proliferating progenitor cells and differentiated Paneth cells contributed to the
crypt expansion observed in Itcha18H/a18H animals.
Itcha18H/a18H animals have increased numbers of goblet cells along the villi of the
distal small intestine
The epithelium of the small intestine is comprised of a variety of different
cell types that arise from the rapidly dividing TA progenitor population found
within the crypt. Since there was an expansion of proliferating cells in the crypts
of mice lacking ITCH and since Paneth cells are only one of several different
kinds of differentiated cells contributing to the epithelial architecture of the small
intestine, it was a distinct possibility that other classes of post-mitotic cells which
localize to the villi could also be altered in Itcha18H/a18H animals. To determine if
goblet and enteroendocrine cells were also affected in Itcha18H/a18H animals, we
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stained small intestinal tissue sections obtained from four animals of each
genotype to specifically highlight each type of post-mitotic secretory cell. In
particular, goblet cells were visualized using alcian blue, a stain identifying
glycosylated mucins (Fig. 2.6.A), and the cell number determined by counting
positively stained cells on 25 villi in at least eight different 10x fields per animal.
Interestingly, there was a 48% increase in the number of goblet cells on the villus
of Itcha18H/18H animals as compared to Itch+/+ animals (10.93±0.98 (SEM) vs.
7.37±0.69 (SEM)), and this difference was statistically significant by 2-tailed,
unpaired t-test (Fig. 2.6.D). However, no statistically significant difference in the
number of enteroendocrine cells (visualized by Grimelius stain, which reacts with
the hormones in the secretory granules, and quantified in 30 villi from eight
different 10x fields per animal) was observed in the distal small intestine derived
from Itcha18H/18H mice as compared to those derived from age-matched ITCH
sufficient controls. Because of the left-shifted distribution of enteroendocrine
cells in animals of both genotypes, a Mann-Whitney comparison of nonparametric medians was performed to determine significance for this population
(Fig. 2.6.B and 2.6.D).
In addition to the post-mitotic cells derived from the secretory lineage, the
absorptive enterocyte (the most abundant cell type in the small intestine) is
essential to the structure and function of the small intestine. For this reason,
mature enterocytes were characterized by staining distal intestinal tissues
derived from young adult mice of both genotypes with AP in order to visualize the
brush boarder (which is critical in nutrient absorption). When examining the
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sections of Itch+/+ and Itcha18H/a18H derived tissues, no appreciable difference in
AP staining was seen, suggesting that the overall architecture and functionality of
the enterocytes was preserved even in the absence of ITCH (Fig. 2.6.C). To
determine whether there was instead a difference in enterocyte number between
the two genotypes, the number of enterocytes was determined using alcian
blue/nuclear fast red stained distal intestinal sections from four animals of each
genotype. For this analysis, enterocytes were identified on the basis of their
nuclear morphology and typical columnar cell profile and were counted from 25
villi in at least eight different 10x fields per animal. Although there was a trend
towards reduced enterocyte number in the ileum of Itcha18H/a18H animals
(48.52±2.38, SEM) as compared to the control (54.67±3.13, SEM, Fig. 2.6.D),
this difference was not statistically significant by two-tailed unpaired t-test
(p=0.07). Additionally, there was no statistically significant difference between
genotypes in the total number of epithelial cells on those same villi (Fig. 2.7).
Collectively, these data suggest that proliferating progenitor cells in the
Itcha18H/a18H animals still retain the ability to give rise to both the absorptive and
secretory cell lineage, albeit the percentage of the cell types are altered.
Itcha18H/a18H animals have increased epithelial cell turnover
Because Itcha18H/a18H animals have an increase in the number of
proliferating progenitor cells within the crypt compartment yet still have
comparable numbers of post-mitotic cells on the villus as age-matched ITCH
sufficient controls, we speculated that animals lacking ITCH might have
increased apoptosis of epithelial cells. To evaluate steady-state apoptosis levels,
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IHC was performed on sections derived from the distal small intestines of four
young adult animals of each genotype using an antibody that recognizes
cleaved-caspase 3, a critical executioner for apoptosis. As would be expected
under normal conditions, very few apoptotic cells could be detected in Itch+/+
intestines, except for the rare epithelial cell at the tip of a villus that was
presumably in the process of being sloughed off (Fig. 2.8). In addition to the
occasional cleaved-caspase 3+ cell at the tip of a villus, there were a number of
apoptotic cells at the crypt-villus junction in Itcha18H/a18H animals that were never
seen in the intestines derived from Itch+/+ mice (second row of images, Fig. 2.8).
Thus, there was increased apoptosis of epithelial cells in the distal small
intestines derived from animals lacking ITCH, even without some sort of stress or
stimulus.
Another potential mechanism for more rapid turnover of the epithelium
would be enhanced homeostatic epithelial cell migration along the crypt-villus
axis, particularly since this is known to be influenced by proliferation within in the
small intestinal crypt, wherein an increase or reduction in cell proliferation can
enhance or slow migration respectively (Parker et al., 2017). Given the observed
increase of proliferative cells within the crypts of Itcha18H/a18H animals, we sought
to evaluate intestinal epithelial cell migration by intraperitoneally injecting twelve
young adult Itcha18H/a18H and twelve young adult Itch+/+ animals with 100 mg/kg
BrdU, and three animals of each genotype were euthanized 2, 24, 48 or 72 hours
post injection. IHC was performed on sections from the distal small intestines of
these animals using an anti-BrdU antibody in order to localize the cells that had
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taken up the BrdU pulse. As illustrated in Fig. 2.9.A, at 2 hours, all labeled cells
were contained within the crypts of both ITCH sufficient and ITCH deficient mice.
By 24 hours following injection, there were distinct differences between the two
genotypes. In particular, mice lacking ITCH showed accelerated exodus of the
label from the proliferating cells in the crypt at 24 hours, increased migration up
the villus at 48 hours, and nearly complete elimination by 72 hours. To quantify
the difference in cell migration along the villus while simultaneously accounting
for the influence of ITCH on the crypt-villus architecture, a normalized measure of
cell migration was calculated by dividing the measured length of the furthest
migrated BrdU+ cell on the villus to the entire length of the villus from 25 welloriented villi in at least five different 10x fields per animal and expressed as a
percentage (Fig. 2.9.B). Consistent with our qualitative observations, cell
migration in the Itcha18H/a18H animals was more than double that of the Itch+/+
animals at the 24 hour time point (33.46±3.64%, SD, vs. 15.47±4.68%, SD),
which was statistically significant. A similar trend was apparent at both the 48
and 72 hour time points, though the difference between genotypes was not as
drastic due to the sloughing of cells from the villus tip. In particular, at 48 hours,
the edge of the BrdU label front had migrated 58.57±1.91% (SD) up the villus in
Itcha18H/a18H animals whereas, on average, in Itch+/+ animals, the leading edge
had not yet reached the midway point (47.15±2.02%, SD). At 72 hours post
injection, the BrdU pulse was nearly completely shed in animals lacking ITCH,
and those labeled cells that remained were at the very tip of the villi
(97.58±0.09%, SD). In contrast, in those animals sufficient for ITCH, the vast
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majority of the labeled cells were present with the farthest migration point being
90.39±4.36% the length of the villus. Collectively, our data suggest that
expansion of the proliferating progenitor cell population leads to accelerated cell
migration along the crypt-villus axis in Itcha18H/a18H animals.
In the small intestine, the intercellular junctions of epithelial cells have
been noted to be highly dynamic in order to accommodate the rapidly dividing
tissue while still maintaining tissue integrity (Peglion et al., 2014). Further,
alterations in adherens junctions and desmosomes are known to influence cell
migration in the small intestine (Schneider et al., 2010). Since Itcha18H/a18H
animals have increased proliferation and cell migration compared to Itch+/+
animals, we hypothesized the cell-cell junctions might be affected in mice lacking
ITCH. To test this hypothesis, small intestinal tissues derived from four young
adult Itcha18H/a18H and four age-matched Itch+/+ mice were examined by
transmission electron microscopy. This analysis revealed several differences in
the ultrastructure of these junctions. In particular, while tight junctions could be
readily identified in both Itcha18H/a18H and Itch+/+ derived tissue (Fig. 10, asterisks),
adherens junctions were less discernable in small intestines derived from
Itcha18H/a18H animals (Fig. 10, arrow) and the associated actin cytoskeleton
appeared to be less organized. In addition, there was a complete absence of
desmosomes in the small intestines of Itcha18H/a18H mice (Fig. 10, arrow head).
Collectively, these data are consistent with a role for ITCH in regulating intestinal
epithelial turn over.
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Loss of ITCH significantly decreases intestinal adenoma formation in the small
intestine of ApcMin/+ animals
As the epithelium of the small intestine is under rapid and continuous
renewal, stringent regulation of epithelial cell turnover is essential to prevent the
growth of intestinal adenomas (Wong et al., 1996). In fact, increases in
homeostatic cell migration have been associated with reduced ApcMin/+ -induced
tumorigenesis in the small intestine (Sansom et al., 2007). Since Itcha18H/a18H
animals have enhanced epithelial cell migration, we hypothesized that loss of Itch
would decrease intestinal adenoma formation. To test this hypothesis, the Min
mutation (ApcMin/+) was moved onto the Itcha18H/a18H background via a two
generation intercross. This allowed for polyp assessment in Itch+/+; Apc+/+ (ITCH
and APC sufficient), Itcha18H/a18H; Apc+/+ (ITCH deficient but APC sufficient),
Itcha18H/a18H; ApcMin/+ (ITCH deficient and carrying the mutant Apc allele), and
Itch+/+; ApcMin/+ (ITCH sufficient and carrying the mutant Apc allele) littermates.
Total polyp number in the small intestines derived from 11 animals of each
genotype (with approximately equal numbers of males and females) was
determined when the animals reached 15 weeks of age. Consistent with
previous reports (Tucker et al., 2005, 2002) a total of 115.7±52.49 (SD) polyps
were observed in Itch+/+; ApcMin/+ animals at this age (Fig. 11). Interestingly, the
Itcha18H/a18H; ApcMin/+ animals examined had only 27.36±19.62 (SD) polyps (Fig.
11). This represents a 76% reduction in tumor burden as compared to the
Itch+/+;ApcMin/+ cohort, which was statistically significant (p<0.001). However, the
number of polyps found in Itcha18H/a18H; ApcMin/+ animals was not statistically
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different from that of either wild type animals (Itch+/+; Apc+/+) or from animals
lacking ITCH (Itcha18H/a18H; Apc+/+) as assessed by one-way ANOVA with post
hoc Tukey correction. Further, despite the altered cell-cell junctions seen in mice
lacking ITCH (Fig. 2.10), this accelerated migration appeared to be physiological
and was not associated with a pathological epithelial to mesenchymal transition
(EMT) process as EMT markers N-cadherin and vimentin could not be detected
by western blot on villus protein extracts from either Itch+/+ or Itcha18H/a18H animals
but were detected in positive controls (heart tissue lysate for N-cadherin and
HeLa lysate for vimentin, Fig. 2.12). Thus, as a whole, these data suggest
increased cell turnover in Itcha18H/a18H mice protects from the initiation of small
intestinal adenoma formation in ApcMin/+ animals.
2.5 Discussion
As a dividing line between self and non-self, the mucosal surface of the
intestine is essential to maintaining homeostasis, and its breach is associated
with pathologies like IBD (Mankertz and Schulzke, 2007), chronic viral infections
(Brenchley et al., 2006; Sandler et al., 2011), and extra-intestinal autoimmune
diseases such as type 1 diabetes (Wen et al., 2008), rheumatoid arthritis (Wu et
al., 2010), and multiple sclerosis (Berer et al., 2011; Lee et al., 2011). However,
the intestine is far from being a single homogeneous organ; rather, it consists of
a number of anatomically and functionally specialized segments, each with
distinct environmental pressures (Agace and McCoy, 2017). Here, we have
identified a novel role for the E3 ubiquitin ligase ITCH in the proliferation,
migration, and differentiation of small intestinal epithelial cells, and, in so doing,
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offer a putative physiological mechanism for the attenuated inflammatory
phenotype in the small intestine vs. what has been previously reported in the
large intestine of animals lacking ITCH (Kathania et al., 2016; Ramon et al.,
2011). Consistent with those studies, we found little inflammation in the mucosa
of the small intestine of young adult Itcha18H/a18H mice despite the chronic
inflammation that is known to accumulate with age at other mucosal surfaces like
the lungs and skin (C. M. Hustad et al., 1995). Even though there was a lack of
inflammatory infiltrate, distinct architectural changes (including villus blunting with
some cellular disarray, crypt expansion, and thickening of the muscularis propria)
were present along the length of the small intestine, and these were most
pronounced in the distal portion. Many of these same alterations were seen in
the small intestines of Itcha18H/a18H; Rag1-/- mice which lack a functional lymphoid
compartment of the immune system. This suggests that these changes result
from altered programs in non-hematopoietic cells, in the resident innate immune
cells, or a combination thereof.
Animals lacking ITCH also displayed increased numbers of Paneth and
goblet cells in the distal small intestine. Paneth cells are normally only found in
the small intestinal epithelium and play an important protective role in intestinal
homeostasis by secreting antimicrobial peptides (Mukherjee et al., 2008;
Vaishnava et al., 2008). Further, defects in Paneth cell function have been
described in IBD patients (Elphick and Mahida, 2005; Wehkamp et al., 2008) as
well as in a number of mouse lines that develop spontaneous intestinal
inflammation including Casp8IEC-KO (Günther et al., 2011), FADDIEC-KO (Welz et
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al., 2011), NEMOIEC-KO (Nenci et al., 2007), and IKK2caIEC-KO (Vlantis et al.,
2011). While the phenotypes in these lines result from intestinal epithelialspecific loss of proteins, the effects of Paneth cell function are far from cell
autonomous as they help shape the microbiome, modulate the mucosal immune
response, and provide important signaling cues in the intestinal stem cell niche
(Okumura and Takeda, 2017). Similarly, the mucins secreted by goblet cells in
the small and large intestine offer a protective barrier against commensal and
pathogenic bacterial contact with the immune system. However, the composition
of the mucous layer is different in the small and large intestine. In the former,
there is a loose, more porous mucus that better facilitates the absorption of
nutrients and depends on peristaltic actions to propel trapped microbes down the
digestive tract whereas in the large intestine, the mucus is made of two discrete
layers (an upper, thinner layer and a thicker lower layer) that has more
permanence and thus more resident bacteria (Johansson and Hansson, 2016).
As with defects in Paneth cell function, goblet cell depletion or dysfunction is a
frequent histopathological feature of IBD (Gersemann et al., 2009). Thus,
increased numbers of goblet and Paneth cells in the small intestine of animals
lacking ITCH may protect it from the more severe inflammation observed in the
colon.
In Itcha18H/a18H mice, increases in Paneth and goblet cells were associated
with increased proliferation of progenitor cells in the crypt. It is tempting to
speculate that either cell intrinsic or local cues promote secretory cell
specification towards these cells fates. Differentiation within the secretory cell
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lineage is highly complex wherein a heterogeneous population of precursors
exists to direct lineage specification toward enteroendocrine cells or a common
goblet and Paneth progenitor cell (Basak et al., 2017). While loss of ITCH was
associated with an increase in goblet and Paneth cell numbers, enteroendocrine
lineage specification and maturation appeared unaffected since there were
equivalent numbers of these cells in the distal small intestine of mice sufficient
and deficient for ITCH. Thus, ITCH may influence goblet and Paneth cell
differentiation downstream of this specification step, potentially through the
regulation of transcription factors such as SPDEF (Gregorieff et al., 2009).
While changes in epithelial differentiation might be driven by epithelialintrinsic factors, it is also a formal possibility that they result secondarily from
signals from the surrounding stroma. In fact, both mesenchymal and immune
cells that normally reside in the lamina propria also contribute to intestinal selfrenewal. Secretion of Hedgehog (Hh) ligands from the epithelium activates this
signaling pathway within the mesenchyme, which, in turn, can influence intestinal
homeostasis by altering cell proliferation, differentiation, inflammation, and
turnover (Buller et al., 2012; Powell et al., 2011). Interestingly, ITCH has also
been shown to negativity influence Hh signaling by targeting the downstream
transcription factor GLI1 (Di Marcotullio et al., 2011), but it remains to be
determined how loss of ITCH might impact Hh signals in the mesenchyme and
innate immune system. In addition to their capacity as potential targets for Hh
signals, inflammatory cells within the lamina propria can influence epithelial
homeostasis via the release of proinflammatory cytokines that are capable of
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feeding back onto the intestinal epithelium to modulate renewal (Garrett et al.,
2010). Interestingly, ITCH deficient animals have an increase in the mucosal
production (particularly in the colon) of the proinflammatory cytokines TNF-α, IL1β, IL-6, and IL- 17 (Kathania et al., 2016; M. Tao et al., 2009; Theivanthiran et
al., 2015), which are similarly dysregulated during gastrointestinal inflammation
and barrier dysfunction (Schenk and Mueller, 2008). In order to pinpoint the
initiating signals for the altered intestinal homeostasis observed in ITCH deficient
mice, future studies employing the recently generated floxed allele of Itch (H. Jin
et al., 2013) are necessary to delineate the tissue-specific contribution of ITCH in
the epithelium, immune system, and mesenchyme in isolation from the other
genes potentially influenced by the a18H inversion to gain important additional
insight into the multifaceted role ITCH plays in mucosal barrier function.
Increased proliferation in the small intestinal crypts of animals lacking
ITCH was balanced by increased apoptosis at the crypt/villus junction and by the
enhanced migration and shedding of epithelial cells. Renewal of the small
intestinal epithelium is very rapid, and complete epithelial turnover occurs every
4-5 days (van der Flier and Clevers, 2009). Turnover in Itcha18H/a18H animals is
accelerated even further, with approximately 98% of cells being shed from the
villus after 3 days. This increased migration correlated with the presence of
altered cell-cell junctions between intestinal epithelial cells. In particular, ITCH
deficient mice lacked desmosomes and had disorganized adherens junctions
while the tight junctions appeared to remain intact. Interestingly, E-cadherin, a
critical component of adherens junctions, has been shown to influence intestinal
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homeostasis. Its loss in the intestinal epithelium was associated with altered
differentiation and maturation of Paneth and goblet cells, induction of cell death,
loss of adherens junctions and desmosomes, and mislocalization of Paneth cells
along the crypt-villus axis of the small intestine, and this phenotype was more
severe in the colonic epithelium despite the fact that more residual E-cadherin
expression was retained there (Schneider et al., 2010). Further, overexpression
of E-cadherin within the intestinal epithelium resulted in suppression of
proliferation and a reduction in migration along the crypt-villus axis (Hermiston et
al., 1996). As mice lacking ITCH still have adherens junctions (albeit
disorganized ones), it is possible that there might be a slight decrease in Ecadherin within epithelial cells that is sufficient to contribute to increased
proliferation, accelerated migration, and increased apoptosis of epithelial cells
within the small intestine which does not affect maturation programs. Because of
the reported disparity in response to loss of E-cadherin between the epithelium of
the small intestine and that of the colon, it is tempting to speculate that this might
contribute to the different inflammatory profiles of the small and large intestine in
Itcha18H/a18H mice.
Further evidence that homeostasis is more appropriately regulated in the
small intestine than in the colon of mice lacking ITCH comes from our
observation that Itcha18H/a18H; ApcMin/+ animals had a 76% reduced tumor load as
compared to Itch+/+; ApcMin/+ littermates (Fig. 7), whereas ITCH deficient mice
have been reported to be more susceptible to the induction of colitis-associated
cancer which develops in the context of chronic inflammation of the colon

53

(Kathania et al., 2016). This likely reflects, in part, the different initiating events in
these types of tumors. Specifically, while the ApcMin/+ mouse more closely
parallels what occurs in sporadic colon cancers where there is a sequential
accumulation of genetic mutations that promotes a progressively more malignant
phenotype in what has been dubbed the “adenoma-carcinoma sequence” (Cho
and Vogelstein, 1992), colitis associated cancer is driven by the activation of
completely different pathways, usually without constitutive activation of the APCβ-catenin-TCF axis (Foersch and Neurath, 2014). Furthermore, the increased
cell turnover in the small intestine of ITCH deficient animals potentially
contributes to the decrease in adenoma initiation observed in Itcha18H/a18H;
ApcMin/+ mice. Previous studies have shown that increased homeostatic
epithelial migration was associated with reduced ApcMin/+ -induced tumorigenesis
in the small intestine (Sansom et al., 2007), suggesting that perturbations in the
intestinal epithelial cell migration observed in Itcha18H/a18H mice potentially
influence intestinal adenoma formation by limiting the anchorage of cancerinitiating cells needed for adenoma induction and growth. However, there was
no evidence that animals lacking ITCH had a switch from E-cadherin to Ncadherin expression which is observed in EMT and promotes the invasive
capabilities of cancer cells (Halbleib and Nelson, 2006), though this possibility
needs to be more thoroughly evaluated in a more aggressive colorectal cancer
model than the ApcMin/+ mouse because the tumors in those animals rarely
become invasive (Nalbantoglu et al., 2016).
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In conclusion, the differences observed in the homeostasis of the intestinal
epithelium of the small vs. the large intestines in Itcha18H/a18H animals provide
physiological insight into regional specificities of these segments of the
gastrointestinal tract. Further studies aimed at defining the molecular pathways
downstream of ITCH and determining whether the phenotype of the Itcha18H/a18H
small intestine resembles that of “mucosal healing” in IBD following the
abatement of inflammation may allow for the identification of novel biomarkers
associated with long-term remission and low risk of surgical treatment in IBD as
well as potential new avenues for therapeutic intervention.
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2.6 Figures

Figure 2.1. Itcha18H/a18H intestines have increased rostral-to-caudal length
and decreased circumference. The entire length of the small intestine from 9
week old Itch+/+ (n=12) and Itcha18H/a18H (n=12) animals were removed and the
length along the x-axis was measured in cm. Itcha18h/a18H small intestines are
significantly longer (***p<0.001) than Itch+/+ animals. The proximal, middle, and
distal segments from the small intestine of 9-week old Itch+/+ (n=10) and
Itcha18H/a18H (n=10) were opened longitudinally to quantify the width of the small
intestine in mm. The small intestine from Itcha18H/a18H animals had a significantly
shorter width proximally (**p<0.005), middle (**p<0.005), and distally (*p<0.05)
when compared to Itch+/+ animals.
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Figure 2.2. Small intestinal architecture is altered in Itcha18H/a18H animals.
(A) Representative H&E stained paraffin-embedded small intestinal sections
derived from the proximal (left most column), middle (center column), and
distal (right hand column) segments of young adult Itch+/+ and Itcha18H/a18H
animals accentuate an enlargement of the intestinal crypt in Itcha18H/a18H
animals, becoming more pronounced distally. Scale bars = 200 µm. (B) Small
intestinal crypt and villus areas from young adult Itch+/+ (n = 4 or 5) and
Itcha18H/a18H (n = 5) were measured in µm2 using ImageJ. A minimum of 25
well-orientated crypts or villi from at least seven different 10x fields were
measured per animal. Average crypt area was significantly increased
(*p<0.005) in the middle and distal small intestine of Itcha18H/a18H compared to
Itch+/+. (C) Average villus area was significantly increased (*p<0.05) distally in
the small intestine of Itcha18H/a18H animals compared to Itch+/+.
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Figure 2.3. Small intestinal architectural changes observed in ITCH
deficient mice are lymphoid independent. Representative H&E stained
paraffin-embedded distal small intestinal sections from 12 week old Itch+/+;
Rag1+/+ (wild type, far left), Itch+/+; Rag1-/- (RAG1 deficient, middle left),
Itcha18H/a18H; Rag1-/- (RAG1 and ITCH deficient, middle right), and
Itcha18H/a18H; Rag1+/+ (ITCH deficient, far right) animals are shown. Animals
lacking both ITCH and RAG1 produce no functional lymphocytes, yet still
develop crypt hyperplasia (height of bracketed bar), villus blunting, and
expansion of the muscularis propria (asterisk), suggesting that these
phenotypes arise as a consequence of signals produced by epithelial and/or
resident innate immune cells. However, the cellular disorganization seen in
Itcha18H/a18H; Rag1+/+ animals was not observed in Itcha18H/a18H; Rag1-/- mice.
Scale bars = 100 µm. Magnification= 20x.
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Figure 2.4. Alterations in Itcha18H/a18H crypt morphology
is reflective of increased total cell numbers within the
crypt. Total cell numbers within the crypt were manually
counted from paraffin-embedded adult Itch+/+ and
Itcha18H/a18H intestinal sections immunostained for Ki67 and
counterstained with hematoxylin. The average total cell
number within the crypts were assessed by counting the
total number of cells from 25 well-oriented crypts in a
minimum of nine different 20x fields from each adult Itch+/+
(n = 5) or Itcha18H/a18H (n = 5) animal. Itcha18H/a18H animals
had a statistically significant increase (49.46±6.03, SD) in
total cell number (*p<0.005) within the crypt compared to
Itch+/+ animals (35.90±34.86, SD) when analyzed by a 2tailed, unpaired t-test. Error bars represent SD.
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Figure 2.5. Crypt expansion in Itcha18H/a18H animals is accompanied by an
increase in proliferating TA cells and differentiated Paneth cells. (A)
Pictured are representative micrographs of IHC performed on paraffinembedded distal intestinal sections derived from young adult Itch+/+ and
Itcha18H/a18H animals (n = 5 for each genotype) using an anti-Ki67 antibody and
subsequently counterstained with hematoxylin. Animals lacking ITCH appear to
have increased cellular proliferation in the crypt. Scale bars = 50 µm. (B)
Average number and average percentage of Ki67+ cells in the crypts from adult
Itch+/+ (n = 5) and Itcha18H/a18H (n = 5) animals. Ki67+ cells and total cell numbers
were counted from 25 well-oriented crypts in a minimum of nine different 20x
fields per animal. Itcha18H/a18H animals had, on average, 13 more Ki67+ cells per
crypt which was statistically significant (*p<0.01). No difference was observed in
the percentage of proliferating cells within the crypt. Error bars represent SD.
(C) Representative phase contrast-coupled immunofluorescent images of
paraffin-embedded sections of distal intestine from five adult Itch+/+ and five agematched Itcha18H/a18H animals stained with anti-lysozyme (red) and DAPI (blue).
Scale bars = 100 µm. (D) Average number of Paneth cells per crypt from adult
Itch+/+ (n = 5) and Itcha18H/a18H (n = 5) animals. Paneth cells from 30 crypts in a
minimum of 12 different 20x fields were averaged to determine that Itcha18H/a18H
animals have significantly more Paneth cells (*p<0.05) than Itch+/+ animals.
Error bars represent SEM.
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Figure 2.6. Loss of ITCH promotes goblet cell differentiation. (A) Paraffinembedded intestinal sections stained with alcian blue, pH 2.5 and counterstained
with nuclear fast red distinguish goblet cells from adult Itch+/+ and Itcha18H/a18H
animals. Scale bars = 200 µm. (B) Pictured are representative Itch+/+ and
Itcha18H/a18H derived paraffin-embedded sections stained with 1% silver nitrate to
identify enteroendocrine cells in the small intestine. Scale bars = 200 µm. (C)
Paraffin-embedded sections stained with AP highlights the brush boarder of
enterocytes on the villi of Itch+/+ and Itcha18H/a18H animals. Scale bars = 200 µm.
(D) Average number of goblet cells, enteroendorcine cells, and enterocytes
located on the villus of Itch+/+ (n = 4) and Itcha18H/a18H (n = 4) animals. Indicated
type of cells were counted on 30 villus structures from a minimum of eight
different 10x fields per animal. Enteroendocrine cell counts are presented as a
histogram of the total number of villus structures bearing no, one, two or three
cells in Itch+/+ (n = 4) and Itcha18H/a18H (n = 4) animals. Itcha18H/a18H animals have a
statistically significant increase (*p<0.05) in goblet cells. There was no
statistically significant difference in enteroendocrine or enterocyte cell number.
Error bars represent SEM for goblet cell counts.
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Figure 2.7. Loss of ITCH influences specification without altering total
epithelial cell numbers on the villus. Average total epithelial cell number on
the villus was determined by adding the means from enterocytes, goblet cells,
and enteroendocrine cells that were counted on 25 to 30 separate villus
structures in a minimum of eight different 10x fields from each adult Itch+/+ (n = 4)
or Itcha18H/a18H (n = 4) animal. To determine significance, the mean total cell villus
numbers from adult Itch+/+ (n = 4) or Itcha18H/a18H (n = 4) animals were compared
using a 2-tailed, unpaired t-test, which showed no statically significant difference
between the Itch+/+ and Itcha18H/a18H groups (62.04±3.43, SD versus 59.45±5.18,
SD). Error bars represent SD of total cell number.
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Figure 2.8. Loss of ITCH promotes epithelial apoptosis in
the small intestine. Paraffin embedded sections from the
distal small intestine of young adult Itch+/+ and Itcha18H/a18H
animals (n = 4 for each genotype) were immunostained for
cleaved-caspase 3 and counterstained with hematoxylin.
Representative photomicrographs are shown. While rare
apoptotic cells could be found at the tips of villi in animals of
both genotypes (arrowheads, top row of micrographs),
increased apoptosis was seen at the crypt-villus junctions in
only those animals lacking ITCH (bottom row, 63x). Scale
bars = 100 µm (top row) or 50 µm (bottom row).
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Figure 2.9. Epithelial turnover is increased in animals that lack ITCH. (A)
IHC with an anti-BrdU antibody was conducted on paraffin-embedded sections
obtained from young adult Itch+/+ and Itcha18H/a18H animals intraperitoneally
injected with 100mg/kg of BrdU. Brightfield images were taken 2, 24, 48, and 72
hours post injection and representative examples from each genotype and time
point were converted to spectral images using the lookup tables available in
ImageJ as seen here. These images demonstrate enhanced migration of
epithelial cells in Itcha18H/a18H animals with complete sloughing by 72 hours
following the BrdU pulse. Scale bars = 200µm. (B) Average cell migration of
BrdU-labeled cells along the villus axis in Itch+/+ (n = 3) and Itcha18H/a18H (n = 3)
animals at 24, 48, and 72 hours after BrdU incorporation was calculated by
dividing the measured distance of the furthest migrated labeled cell from the
base of the villus by the entire length of the villus from 25 villi in a minimum of
five different 10x fields per animal. Since all cells were localized to the crypt in
both genotypes at the 2-hour timepoint, this data point is not shown. A
statistically significant increase in cell migration at was detected in Itcha18H/a18H
derived tissues at 24 (**p<0.005), 48 (**p<0.005), and 72 hours (*p<0.05) versus
tissues derived from Itch+/+ animals. Error bars represent SD.
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Figure 2.10. Itcha18H/a18H animals have altered cell-cell
junctions. Representative transmission electron
micrographs of cell-cell junctions (tight junctions marked by
asterisks, adherens junctions by arrows, and desmosomes by
arrow head) from the proximal small intestine of nine weekold Itch+/+ and Itcha18H/a18H animals are depicted here. In total
samples from 4 animals of each genotype were examined.
Itcha18H/18H animals lack identifiable desmosomes and
adherens junctions appeared more disorganized than the
ITCH sufficient control samples. Scale bar = 200 nm.
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Figure 2.11. Loss of ITCH is protective in ApcMin/+
tumorigenesis. Polyps from the small intestine of 15 week-old
Itch+/+; Apc+/+ (n = 11), Itcha18H/a18H; Apc+/+ (n = 11), Itch+/+; ApcMin/+
(n = 11), and Itcha18H/a18H; ApcMin/+ (n = 11) animals were
visualized by staining the flushed and fixed small intestine with
0.1% methylene blue. Polyps from the entire length of the
intestine were counted under a dissecting scope. The graph
shown here depicts the average number of small intestinal polyps
per animal. Itcha18H/a18H; ApcMin/+ animals were observed to have
a significant reduction in tumor burden compared to Itch+/+;
ApcMin/+ littermates (*p<0.001, NS = not significant). Error bars
represent SD.
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Figure 2.12. Loss of ITCH promotes epithelial migration without
leading to an epithelial-to-mesenchymal transition (EMT). 40 µg
of protein lysate isolated from the villi of Itch+/+ (n = 6) and Itcha18H/a18H
(n = 8) animals separated by SDS-PAGE was transferred to a PVDF
membrane prior to immunblotting for ITCH, N-cadherin, Vimentin and
GAPDH. Protein lysate from HeLa cells or murine heart was used as
a positive control for markers of EMT. As expected, protein derived
from ITCH deficient animals expressed no ITCH protein (arrow in top
panel) while all samples expressed GAPDH. EMT markers Ncadherin or Vimentin could not be detected in either Itch+/+ or in
Itcha18H/a18H villus lysates, indicating that loss of ITCH in the small
intestine likely does not promote EMT. Each lane represents one
villus isolation from two pooled animals of the same age and
genotype.
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CHAPTER 3
INTESTINAL MUCOSAL HOMEOSTASIS IS DEPENDENT ON THE TISSUE
SPECIFIC FUNCTIONS OF ITCH IN BOTH THE EPITHELIUM AND IMMUNE
SYSTEM
3.1 Introduction
With the advent of new extracellular matrices, in combination with the
identification of the Lgr5+ intestinal stem cell population, the ability to culture 3dimensonal (3D) epithelial organoids ex vivo without the surrounding stroma
recently became an actuality (T. Sato and Clevers, 2013). Through the years,
the term “organoid” has evolved from its originally meaning, which was
synonymous with oncogenic teratomas, to its current form being defined as the
growth of ex vivo structures from pluripotent stem cells or tissue-specific adult
stem cells that adopt a near native 3-D architecture reminiscent of the tissue
architecture in vivo. In the presence of growth factors and morphogens specific
to the intestinal stem cell niche, single crypts isolated from the small intestine can
develop and grow into small intestinal organoids. These 3-D “mini guts” form a
highly stereotypical layout wherein a continuous layer of cells is organized into a
central, spherical lumen surrounded by a monolayer of differentiated epithelial
cells that arise from the highly proliferative budding structures that jut outward
from the central lumen (T. Sato and Clevers, 2013). Consistent with the
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definition of “organoid”, the intestinal organoids (or enteroids) reconstitute the
intestinal epithelial architecture in the absence of the mesenchyme. The base of
the budding structure in the organoid houses the Lgr5+ stem cell population and
differentiated Paneth cells, similar to the anatomy of the in vivo intestinal crypt.
As the stem cells divide, the progeny migrate along the bud to give rise to the
transit-amplifying population, which continue to migrate eventually differentiating
into epithelial post-mitotic cells that will line the central lumen. At the end of the
differentiated cell’s lifespan, the apoptotic cell will be sloughed off in to the lumen
where it will remain indefinitely (Grabinger et al., 2014), in contrast to what
occurs in vivo, wherein the continual peristaltic motion and passage of chyme
eliminate the extruded epithelial cells. Thus, in the 3-D intestinal organoid
system, all apoptotic cells that have been discarded from the inception of the
organoid can be quantified, making it a more accurate measure of apoptosis
compared to in vivo, which relies on capturing a “snap-shot” of a continual
process via pro-apoptotic markers as a surrogate for cell death.
The continued growth and expansion of the enteroid is promoted by the
enormous self-renewal capacity of the Lgr5+ intestinal stem cell population that
resides in the budding structures, thereby providing a proxy to assess the
regenerative capacity of the intestinal organoid ex vivo (Kretzschmar and
Clevers, 2016). Growth of the spherical organoid into a mature mini-gut is
initiated by the formation of a bud, which occurs at a location where intestinal
stem cells and Paneth cells are both present. The proliferative stem cell
population surrounded by the WNT-producing Paneth cells propels itself outward
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to initiate a bud, likely mediated by the repulsive forces established from the
EphB-EphrinB gradient that is influenced by WNT signaling (Batlle et al., 2002a;
T. Sato and Clevers, 2013). In vivo, as progenitor cells migrate down the WNT
gradient, they differentiate and slowly replace EphBs with EphrinBs, which
establishes the crypt-villus boundary and the proper positioning of cells (Fig.3.1).
It is thought that similar signaling pathways operate ex vivo (T. Sato and Clevers,
2013). Once mature crypts are formed in the enteroid, the continued growth and
expansion of crypts is driven by crypt fission, a process that increases crypt
number through the bifurcation of a crypt into two daughter crypts (Baker et al.,
2014). While this homeostatic process occurs in vivo at a fairly low basal rate,
the destruction of the crypt by chemical, immunological, or radiological means,
exponentially increases crypt fission to promote tissue regeneration (Pin et al.,
2015). Postnatally, crypt fission is also increased to expand the existing
population of crypts to generate the appropriate number required to preserve
intestinal homeostasis in the adult. Though the mechanisms driving this process
remain unclear, it has been postulated that the mechanical forces from the
underlying mucosa, which establishes a buckle at the base of the crypt to
promote crypt division, are influenced by the spatial orientation of both Lgr5+
stem cells and Paneth cells in the crypt (Langlands et al., 2016; Pin et al., 2015).
Thus, the importance of stem and Paneth cell numbers as well as their spatial
distribution appear paramount in driving this process.
Previously, we showed that global loss of the E3 ligase ITCH (Itcha18H/a18H)
alters intestinal epithelial homeostasis by promoting intestinal epithelial cell
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proliferation, secretory cell differentiation, and migration, which could be intrinsic
to the epithelium (Chapter 2). However, since ITCH is known to have important
functions within the immune system (Aki et al., 2015), in combination with the
high level of interplay between the epithelium and the immune system in the
small intestine (Vindigni et al., 2016), loss of ITCH in this compartment likely
contributes the epithelial defects observed in the Itcha18H/a18H animals.
Interestingly, the potential dual role of ITCH in both the epithelium and immune
system is comparable to the complex role described for NFκB signaling in the
small intestine (Wullaert et al., 2011). While activation of this pathway within the
immune system promotes intestinal epithelial inflammation and altered intestinal
homeostasis, NFκB is required in the epithelium to limit the response of the
immune system (M. F. Tao et al., 2009; Wullaert et al., 2011). To this end, we
hypothesize that loss of ITCH in the epithelium and immune compartment plays a
dual role in promoting intestinal mucosal inflammation that leads to altered
intestinal homeostasis.
To identify whether an intrinsic function for ITCH exists in the intestinal
epithelium independent of the influence of the immune compartment, small
intestinal organoids sufficient and deficient for ITCH were established.
Surprisingly, a significant decrease in both the number of nonbudding organoids
and in the average number of buds (in those colonies that do bud) was observed
in ITCH deficient as compared to ITCH sufficient isolates. Despite the defects in
budding observed in organoids lacking ITCH, comparable numbers of intestinal
Lgr5+ stem cells were present in the organoids sufficient and deficient for ITCH.
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Further, proliferation and cell differentiation were not perturbed in ITCH deficient
enteroids, in contrast to the in vivo phenotype of the Itcha18H/a18H small intestines
(Chapter 2). However, increased apoptosis was observed in enteroids lacking
ITCH, which was also detected in mice lacking ITCH in only the intestinal
epithelium, thus identifying an epithelial specific role for ITCH in the intestine.
Interestingly, at six months of age, animals with a myeloid-specific loss of ITCH
(Itchfl/fl; LysMCre/Cre), displayed alterations in the epithelial architecture similar to
those seen in two month old mice constitutively lacking ITCH (Chapter 2). Thus,
the delay in the presentation of this phenotype in Itchfl/fl; LysMCre/Cre animals
highlights a potential synergistic role for ITCH in the intestinal epithelium and in
the immune system to fine-tune mucosal immune responses and maintain
homeostasis.
3.2 Materials and Methods
Animals
Animals homozygous for a null allele of Itch (Itcha18H/a18H) have been
previously described (Hustad et al., 1995). For developmental staging, the
day a copulatory plug was detected was designated E0.5 while the date of
birth was considered P0.
To generate Itcha18H/a18H animals in which intestinal stem cells were
labeled with eGFP (B6.129P2-Lgr5 tm1(cre/ERT2)Cle/J, stock #008875, hereafter
referred to as Lgr5eGFP/+), Itcha18H/a18H mice were bred to Lgr5eGFP/+ animals to
produce Itcha18H/+; Lgr5eGFP/+ and Itcha18H/+; Lgr5+/+ offspring. Subsequently,
Itcha18H/+; Lgr5eGFP/+ mice were backcrossed to Itcha18H/a18H animals to produce
Itcha18H/a18H; Lgr5eGFP/+ animals used for analysis. Controls animals (Itch+/+;
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Lgr5eGFP/+) for age-matched male and female Itcha18H/a18H; Lgr5eGFP/+ mice were
obtained from the original Lgr5eGFP/+ line used to establish the Itcha18H/a18H ;
Lgr5eGFP/+ colony. To generate mice lacking Itch in the myeloid cell lineage,
animals heterozygous for a floxed Itch allele (Fig.3.2) were bred to LysMCre/Cre
animals (JAX stock #004781). A series of intercrosses and backcrosses were
performed to generate Itchfl/fl; LysMCre/Cre animals. Age-matched animals from
C57BL/6J or Itchfl/fl; LysM+/+ animals were used as experimental controls and
are designed as wild-type (WT) in the indicated experiment. A similar
breeding scheme using VillinCre/Cre animals was applied to generate animals
lacking Itch in the intestinal epithelium (Itchfl/fl; VillinCre/+). All experiments were
conducted in full compliance with the Institutional Animal Care and Use
Committee of the University of South Carolina or the University of Central
Florida.
Establishment of Murine Small Intestinal Organoids
Small intestinal organoids were established from 9-11 week old Itch+/+;
Lgr5eGFP/+ and Itcha18H/a18H; Lgr5eGFP/+ animals. To establish a single isolate of
intestinal organoids, approximately 10 cm from the most proximal segment of the
small intestines from two age-, gender- and genotype-matched animals were
placed in a petri dish containing 10 mL of ice-cold Dulbecco’s PBS (DPBS,
Corning, # 21-031-CV). Before flushing the small intestine with 1 mL of DPBS,
the tissue was cut into 2 equal size segments to facilitate the removal of the
luminal content. Flushing of the small intestine was performed 3 times before
longitudinally opening the small intestine and transferring the tissue to a new
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petri dish containing 5 mL of DPBS. To remove any residual waste, the small
intestinal segments were gently agitated before cutting them into 2 mm size
pieces that were collected in a 50 mL conical tube containing 15 mL of fresh, icecold DPBS. To isolate crypts, the small intestinal pieces were placed on ice
before pipetting all intestinal pieces up and down in 12 mL of fresh, ice-cold
DPBS three times using a 10 mL pipet. Once the tissue settled to the bottom of
the tube, the supernatant was carefully removed using a 10 mL pipet. This
process was repeated 14 times with fresh, ice-cold DPBS to gently remove
debris as well as villi before placing the tissue in 25 mL of Gentle Cell
Dissociation Buffer (25°C) (Stem Cell Technologies # 07174) on a rocking
platform at 20 rpm for 15 minutes at 25°C. The tissue was placed back on ice to
allow the intestinal pieces to settle to the bottom of the tube. At that time, the
Gentle Cell Dissociation Buffer was removed and the cells were resuspended in
10 mL of ice-cold DPBS supplemented with 0.1% fetal bovine serum. The
intestinal tissue was pipetted up and down three times to dissociate intestinal
crypts from the tissue prior to removing and filtering the supernatant through a 70
µm filter, which was labeled as Fraction 1. This process was repeated with three
additional 10 mL aliquots of ice-cold DPBS plus 0.1% fetal bovine serum was to
generate Fractions 2-4. Once all four fractions were collected, the supernatant
was centrifuged at 290 x g for 5 minutes at 4°C. The supernatant was decanted
and the pellet was resuspended in 10 mL of ice-cold DPBS supplemented with
0.1% fetal bovine serum. To assess the quality of the crypt isolation, 1 mL from
each fraction was placed in an individual well of a 6-well plate and crypt
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enrichment was ascertained using bright-field microscopy. The two fractions with
the highest crypt-to-cell debris ratio were selected (usually fractions 3 and 4) to
carry out the remaining steps. Before centrifuging the 2 selected fractions at 200
x g for 3 minutes at 4°C, the 1 mL used to assess crypt quality was returned to
the appropriate fraction. After centrifugation, the supernatant was decanted and
the pellets were resuspended in 10 mL of ice-cold Dulbecco’s Modification of
Eagle’s Medium (DMEM)/Ham’s F-12 50/50 media (Corning, # 21-031-CV) each.
To determine total crypt number, 10 µL of each fraction was placed in a
hemacytometer, and the total number of crypts was quantified. A total of 3,000
crypts were transferred to a new tube and supplemented with DMEM/Ham’s F-12
50/50 media to produce a final volume of 10 mL. After centrifuging the crypts at
200 x g for 5 minutes at 4°C, the media was gently removed using a pipet and
the crypts were resuspended in 150 µL of pre-warmed IntestiCult organoid
growth media (Stem Cell Technologies, #06005) followed by 150 µL of matrigel
(Corning #356234) that had been thawed on ice. Crypts were plated in 50 µL
drops into a pre-warmed 24-well plate and placed in an incubator at 37°C/5%
CO2 for a minimum of 10 minutes to allow the matrigel to solidify before adding
750 µL of pre-warmed organoid growth media to each well. Media was changed
every 2-3 days and organoid plugs were passaged every 6-9 days (as described
below) to allow for optimal growth conditions. All organoids were passaged at
least twice before being used in the indicated experiments to mitigate the
contribution of the surrounding stroma on the epithelium. A total of 2 isolates (1
male and 1 female) from Itch+/+; Lgr5eGFP/+ and Itcha18H/a18H; Lgr5eGFP/+ animals
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were used for all intestinal organoid experiments with the exception of the
intestinal budding experiments in which 3 isolates (2 male, and 1 female) per
genotype were used for quantification.
Passaging of Intestinal Organoids
Organoid growth media from 5-9 day old organoids was removed and 1
mL of ice-cold Gentle Cell Dissociation Buffer was placed in each well to be
passaged for 1 minute at room temperature. The matrigel plug was gently
pipetted up and down 20 times to disassociate the pellet before placing it in a 15
mL conical tube. Each well was washed with 1 mL of the gentle dissociation
buffer and collected in the appropriate 15 mL conical tube. Disassociation of the
organoids was accomplished by placing organoids on a rocking platform at 20
rpm for 10 minutes at 25°C before centrifugation at 290 x g for 5 minutes at 4°C.
The supernatant was decanted and the organoids were resuspended in 10 mL of
DMEM/Ham’s F-12 50/50 media prior to centrifuging at 200 x g for 5 minutes at
4°C. The supernatant was gently removed using a pipet, and the organoids were
resuspended at a 1:1 ratio in pre-warmed organoid growth media followed by the
addition of matrigel that had been thawed on ice using a volume sufficient for the
proper split according to density of the culture (i.e., 1:3 to 1:6). Organoids were
plated in 50 µL drops into a pre-warmed 24-well plate and placed in an incubator
at 37°C/5% CO2 for a minimum of 10 minutes to allow the matrigel to solidify
before adding 750 µL of pre-warmed organoid growth media to each well.
Organoids used for the experiments described here were passaged a minimum
of 3 times prior to analysis but no more than eight times total.
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Quantification of Intestinal Organoid Budding
Three isolates for age- and gender-matched Itch+/+; Lgr5eGFP/+ (n = 3, 2
male-derived and 1 female-derived isolates) and Itcha18H/a18H; Lgr5eGFP/+ (n = 3, 2
male-derived and 1 female-derived isolates) were seeded in triplicate, and
numbers of nonbudding versus budding organoids were quantified from a
minimum of eight 10x phase contrast images acquired on a Leica DMI6000B
microscope equipped with a Hamamatsu ORCA-R2 CCD camera. To assess
significance, a chi-squared analysis of a 2x2 contingency table was performed
and plotted using Prism software (GraphPad Software, Inc).
Intestinal Organoid Growth Characterization
Two independent age- and gender-matched isolates from each
genotype (consisting of 1 male-derived and 1 female-derived isolate) were
seeded in duplicate on a 4-chambered slide, and growth was monitored by
phase-contrast microscopy. Specifically, images were acquired one, three and
five days following plating for all 8 matrigel plugs. Day 1 images were
acquired using a 40x objective while day 3 and day 5 images were acquired
using a 20x objective on a Leica DMI6000B microscope equipped with a
Hamamatsu ORCA-R2 CCD camera.
Sample Prep Fluorescent Confocal Microscopy
To obtain frozen sections, organoid growth media from five to six day
intestinal organoids was removed and replaced with 1 mL of ice-cold DPBS for 1
minute before gently disassociating the plug mechanically by pipetting up and
down. Organoids were placed in a 1.5 mL microfuge tube and centrifuged at 100
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x g for 1 minute at 4°C to pellet organoids. The intestinal organoids were
resuspended in 4% PFA and fixed for 20 minutes at 25°C. To remove PFA,
organoids were centrifuged at 100 x g for 1 minute at 4°C and resuspended in 1
mL of PBS. Organoids were centrifuged as above a total of three times. To
facilitate visualization of the organoids, the organoids were incubated with 250 µL
Alcian Blue, pH 2.5 for a minimum of 5 minutes, but not longer than 20 minutes,
centrifuged (100 x g for 1 minute at 4°C), and resuspended in 1 mL PBS.
Organoids were washed as previously described a total of three times before
cryoprotecting the organoids by incubating them sequentially in a 15% and 30%
sucrose/PBS solution at 4°C in each solution for a day. The organoids were
washed once in PBS before embedding the samples in Optimal Cutting
Temperature (OCT) compound and freezing in an 100% ethanol:dry ice bath. To
embed organoids in OCT compound, the enteroids were resuspended in
approximately 30 µL of PBS and transferred to the center of a mold before
forming a circular well surrounding the organoids with OCT compound. The
remaining mold was filled with OCT compound to the desired level. 40 µm thick
frozen sections were brought to 25°C before being post-fixed in 4% PFA for 10
minutes. The PFA was removed and the samples were allowed to air dry for 10
minutes at 25°C before 3 sequential washes in PBS for 3 minutes each. The
samples were blocked for 1 hour in a solution containing 10% normal goat
serum, 2% bovine serum albumin, and 0.2% Triton X-100 in PBS. The primary
antibodies Chromogranin A (C-12, Santa Cruz, 1:200) and Lysozyme (RP028,
Diagnostic BioSystems, 1:100) were diluted in PBS containing 1% normal goat
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serum and 0.1% Triton X-100 and incubated on sections in a humidified chamber
overnight at 4°C. Before incubation with the appropriate secondary antibody, the
samples were washed 3 times in PBS for 3 minutes each wash. AlexaFluor659conjugated goat anti-mouse secondary (Jackson ImmunoResearch, 1:500) or
Cy3-conjugation goat anti-rabbit secondary (1:200) was applied for an hour
before mounting sections in ProLong Gold Antifade Mountant with DAPI
(P36931, Molecular Probes). To identify goblet cells, 40 µm frozen sections that
were post-fixed in 4% PFA for 10 minutes were mounted in ProLong Gold
Antifade Mountant (P36930, Molecular Probes) and DIC images were acquired to
identify goblet cells by morphology. DIC coupled fluorescent images and DIC
images were acquired on a Leica SP8X confocal microscope equipped with HyD
detectors and conventional photomultiplier tubes (PMTs).
Visualization of endogenous eGFP-marked Lgr5+ stem cells was carried
out using whole mount intestinal organoids fixed in 4% PFA for 20 minutes at
25°C after isolation of intestinal organoids from the matrigel as above. Samples
were incubated in block containing 10% normal goat serum, 2% bovine serum
albumin, and 0.2% Triton X-100 in PBS for 1 hour before mounting whole
organoids in ProLong Gold Antifade Mountant with DAPI (P36931, Molecular
Probes). 40x fluorescent images were acquired on a Leica SP8X confocal
microscope equipped with HyD detectors and conventional PMTs.
EdU Incorporation in Intestinal Organoids
Two independent intestinal organoid isolates (1 male and 1 female) for
both Itch+/+; Lgr5eGFP/+ and Itcha18H/a18H; Lgr5eGFP/+ genotypes were seeded in
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triplicate in a 4-chamber slide, and, six days later, 10 µM EdU was applied to
each plug for 1 hour at 37°C. Upon removal of EdU supplemented media, the
organoids were washed in DPBS at 25°C for 3 minutes, which was repeated an
additional 2 times. The organoids were fixed in 4% PFA for 20 minutes at 25°C
and washed in DPBS at 25°C, three times for three minutes each wash. Samples
were blocked for 1 hour at 25°C before applying the Click-IT reaction cocktail
contained in Click-IT AlexuFluor Kit (ThermoFisher Scientific, C10337)
supplemented with an AlexaFluor 594 Azide anitbody (ThermoFisher Scientific,
A10270). The Click-IT reaction cocktail was applied to the organoids for 30
minutes at 25°C in the dark. The samples were washed twice for two minutes
each wash in PBS before applying DAPI (Invitrogen, C10457, 1:2000) diluted in
PBS for 10 minutes at 25°C. Prior to mounting (50% glycerol/50% PBS medium)
the organoids contained within the 4-chambered slides, the organoids were
washed once in PBS for 5 minutes. Fluorescent images were acquired on a
Leica SP8X confocal microscope equipped with HyD detectors and conventional
photomultiplier tubes (PMTs).
Propridum Iodide (PI) Staining
Two isolates of age- and gender- matched Itch+/+; Lgr5eGFP/+ (1 male and 1
female isolate) and Itcha18H/a18H; Lgr5eGFP/+ (1 male and 1 female isolate) intestinal
organoids were seeded in duplicate in a 4-chamber slide, and, four days later,
intestinal oragnoids were incubated with 100 µg/mL propridium iodide (PI)
(Sigma, stock #81845) for 30 minutes at 37°C/5%CO2. Organoids were washed
three times with pre-warmed DPBS before placing 750 µL of pre-warmed
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DMEM/Ham’s F-12 50/50 media on the matrigel plugs. Phase contrast-coupled
fluorescent images were acquired on a Leica DMI6000B epifluorescence
microscope equipped with a Hamamatsu ORCA-R2 CCD camera. Quantification
of fluorescent and organoid surface area was measured using ImageJ software
from eight 10x images from each matrigel plug. A total of 94 and 84 organoids
were counted for ITCH sufficient and deficient organoids, respectively. An
unpaired, two-tailed student t-test was used to assess significance.
Immunohistochemistry
Paraffin sections (4-6 µm) from the distal small intestine of Itchfl/fl ;
VillinCre/+ and WT controls were subjected to IHC. In particular, antigen
unmasking was performed using 10 mM Tris-HCl/ 1 mM EDTA, pH=9 for 30
minutes at 95°C. Subsequently, slides were cooled for 1 hour at 25°C in the
antigen unmasking solution before being washed three times in PBS for three
minutes each. Sections were blocked in a solution containing 10% normal goat
serum, 2% bovine serum albumin, and 0.2% Triton X-100 in PBS. An additional
hydrogen peroxidase block (50% hydrogen peroxide of a 3% solution) / 50%
methanol) was performed for 20 minutes at 25°C. The primary antibody cleavedcaspase 3 (Cell Signaling Technology #9664, 1:100) was diluted in PBS
containing 1% normal goat serum and 0.1% Triton X-100 and incubated on
sections in a humidified chamber overnight at 4°C. The antibody was visualized
using the EnVision+ system-HRP (Dako # K4006) with the following
modifications: the samples were incubated with the HRP-conjugated anti-rabbit
secondary for 1 hour before being washed three times three minutes.
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Localization of antibody staining was visualized by incubating the samples for
five minutes in 37.5 µM DAB chromagen diluted in 1 mL of DAB substrate.
Brightfield images were acquired on a Zeiss Axio Imager A1 equipped with an
AxioCam MRc5 camera.
Histology
Decapitated embryos were fixed whole in 4% paraformaldehyde/2%
glutaraldehyde. Postnatal day 7 (P7) and adult small intestines were flushed with
PBS after being cut into three equally sized segments (designated proximal,
middle and distal), opened longitudinally, and fixed overnight with either 4%
paraformaldehyde or with 10% neutral buffered formalin. Whole embryos or
Swiss-rolled intestinal tissues were paraffin-embedded and sectioned at 5µm.
Hematoxylin and eosin staining was performed to assess tissue morphology.
3.3 Results
Intestinal organoids lacking ITCH have more viable, nonbudding organoid
structures and less intricate growth patterns
To investigate the epithelial-specific contribution of ITCH in the small
intestine, 3-D enteroid cultures were established ex vivo from the intestinal crypts
of 9-11 week old Itch+/+; Lgr5eGFP/+ and Itcha18H/a18H; Lgr5eGFP/+ animals. After
passaging these cultures a minimum of three times to mitigate the signaling
contributions of the mesenchyme, the 3-D structures of the enteroid cultures
were assessed using phase contrast microscopy. This analysis revealed that
ITCH deficient organoids, though viable, were not as intricate, and there seemed
to be a greater number of nonbudding enteroids present in the Itcha18H/a18H;
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Lgr5eGFP/+ culture as compared to the Itch+/+; Lgr5eGFP/+ culture (Fig.3.3.A). To
determine if this shift toward a nonbudding phenotype was statistically significant,
the number of nonbudding organoids versus budding organoids was quantified
from three independent isolates (independent culture preps) from each genotype.
Out of a total of 184 ITCH sufficient and 199 ITCH deficient enteroids assessed,
13 ITCH sufficient organoids versus 29 ITCH deficient organoids lacked buds
(Fig. 3.3.B). This difference was determined to be statistically significant using a
chi-squared analysis with a 2x2 contingency table wherein the null hypothesis
stated that no difference in the number of nonbudding versus budding organoids
existed between the ITCH sufficient and ITCH deficient organoids (chi-square =
5.519, df = 1, and p = 0.0188).
Even though lack of ITCH compromised the initiation of crypt regeneration
in enteroid culture, there were a considerable number of colonies lacking ITCH
that did develop buds. Since it is thought that the continued growth and
expansion of crypts/buds is driven by crypt fission in organoids (Baker et al.,
2014), we sought to determine whether ITCH had any impact on this process.
To that end, we reanalyzed the budding data after removing the counts for
nonbudding colonies for each genotype. This revealed that while Itch+/+;
Lgr5eGFP/+-derived budding enteroids (n=167) displayed a median of 7 buds with
an interquartile range (IQR) of 6, budding enteroids derived from Itcha18H/a18H;
Lgr5eGFP/+ animals (n=160) had a median of 6 buds with an IQR of 5 (n=160),
and this difference was statistically significant (p < 0.05) by Mann-Whitney U-test
(Fig. 3.3.C). This result suggested that ITCH may influence crypt fission to
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promote branching of buds in organoid culture. Thus, it would be predicted that
organoids lacking ITCH should have less intricate, branching structures. To test
this hypothesis, organoid growth and morphology were qualitatively assessed in
ITCH deficient and ITCH sufficient enteroids (n=2 independent isolates per
genotype) using phase contrast microscopy at day 1, day 3, and day 5 after
plating (Fig. 3.4). The general trend that was noted was that at day 1 no budding
was observed in cultures of either genotype, whereas at day 3 and day 5, buds
were present and continuing to increase in number in both ITCH sufficient and
deficient organoids. However, when comparing the morphology of the organoids
at day 5, the ITCH deficient cultures appeared more compact and less intricate
with regards to branching as compared to the ITCH sufficient cultures (Fig 3.4.).
Collectively, these data emphasize that while loss of ITCH does not impact the
growth kinetics of the organoids, it does influence the intricacy of the budding
structures of the organoids.
Lack of ITCH does not grossly alter epithelial cell differentiation in enteroid
culture
The subtleties in growth dynamics of those organoid cultures deficient for
ITCH relative to those sufficient for ITCH prompted us to examine the Lgr5+ CBC
stem cell population, which is known to promote the expansion of budding
structures within enteroids (Sato et al., 2009). Because, in our enteroid system,
Lgr5-expressing intestinal stem cells are endogenously labeled with eGFP, green
fluorescence can be utilized as a proxy to assess intestinal stem cell dynamics.
However, only 17% of CBC stem cells are expected to be labeled because of the
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mosaic nature of this construct (Dehmer et al., 2011). This, coupled with the
loss of organoids during processing, resulted in the examination of only 3 GFP+
organoids from two independent isolates of each genotype. If these particular
samples are viewed as representative of budding organoids at day 6, no
difference in location of the eGFP signal, eGFP intensity, or number of eGFP+
cells was readily discernable within the budding structures of ITCH sufficient and
ITCH deficient organoids (Fig. 3.5.A), though this certainly warrants further
investigation.
Even though a robust cell intrinsic role for ITCH does not seem apparent
in intestinal stem cells, global loss of ITCH in the small intestine does impact both
intestinal epithelial progenitors as well as cell differentiation (Chapter 2). Thus,
we hypothesized that epithelial-specific loss of ITCH would result in similar
defects observed in the Itcha18H/a18H animals, skewing cell specification toward the
goblet and Paneth cell lineages. To investigate this hypothesis, confocal
fluorescence images coupled with phase-contrast microscopy were captured
from day 6, Itch+/+; Lgr5eGFP/+ and Itcha18H/a18H; Lgr5eGFP/+ intestinal organoids
immunostained for chromagranin A and lysozyme to identify enteroenocrine cells
and Paneth cells, respectively. Surprisingly, no gross difference in number of
Paneth or enteroendocrine cells was detected in Itch deficient organoids
compared to Itch sufficient organoids (Fig. 3.5.B). To assess goblet cell
differentiation, the distinctive cell shape of goblet cells was identified using
phase-contrast microscopy revealing no marked defects in goblet cell
differentiation between the two genotypes (Fig. 3.5.B). Collectively, these data
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demonstrate that loss of ITCH in organoid culture does not recapitulate the
observed phenotype associated with global loss of ITCH in the Itcha18H/a18H
animal, suggesting that the role of ITCH in epithelial cell specification is cell nonautonomous and is likely influenced by ITCH deficient signals from other tissue
types (most likely the immune system) in the small intestine in vivo.
Itcha18H/a18H; Lgr5eGFP/+ intestinal organoids have increased apoptosis
Despite not observing a change in intestinal homeostasis with regards to
intestinal stem cell dynamics and cell fate specification within the ITCH deficient
organoids, it is possible that ITCH may influence the integrity of the intestinal
mucosal by regulating the turnover of the epithelium in the small intestine. Within
the Itcha18H/a18H small intestine, an increase in the proliferating progenitor
population within the crypt leads to an acceleration of intestinal epithelial
migration along the crypt-villus axis, thus, making it tempting to speculate that
Itcha18H/a18H; Lgr5eGFP/+ intestinal organoids might display an increase in
proliferation compared to Itch+/+; Lgr5eGFP/+ intestinal organoids. To investigate
this possibility, we assessed EdU incorporation from three replicates of whole
mount intestinal organoids that were derived from 2 independent isolates of
sufficient and deficient for ITCH. Organoids plated for six days were pulsed with
10 µM EdU for 1 hour before evaluating EdU incorporation by click chemistry.
Upon the acquisition of fluorescent images captured by confocal microscopy, no
difference in proliferation was observed between the two genotypes (Fig. 3.6.A).
While the continued replacement of differentiated cells is an important
component of intestinal cell turnover, proliferation must be balanced with the
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extrusion of cells via the apoptotic process of anoikis in order to maintain
intestinal epithelial function (J. M. Williams et al., 2015). Since an increase in
cleaved-caspase 3 staining was observed in the small intestine of young adult
Itcha18H/a18H animals (Chapter 2), we hypothesized that lack of ITCH in just the
intestinal epithelium would result in an increase in apoptosis. Therefore, ITCH
sufficient and ITCH deficient intestinal organoids were incubated with PI for 30
minutes and then evaluated by epifluorescence microscopy. Micrographs were
taken from a minimum of eight 20x fields and the ratio of the surface area of the
PI fluorescence to the total organoid surface area was measured from two ageand gender- matched isolates from each genotype using Image J. Consistent
with what was observed in whole animal studies, a significant increase (p<0.05)
in percent surface area of PI staining was observed in the Itcha18H/a18H; Lgr5eGFP/+
intestinal organoids (30.9% ± 3.53%, SEM) compared to Itch+/+; Lgr5eGFP
intestinal organoids (20.9% ± 2.42%, SEM) (Fig. 3.6.B). This suggests a cell
autonomous role for ITCH in intestinal epithelial apoptosis.
To corroborate the results obtained from the intestinal organoid assay,
apoptosis was also assessed in vivo using animals deficient for ITCH within the
intestinal epithelium (Itchfl/fl; VillinCre/+). For this analysis, cellular apoptosis was
assessed by immunohistochemistry via the pro-apoptotic marker cleavedcaspase 3. Cleaved-caspase 3 staining was assessed from paraffin-embedded
tissues that were derived from the distal small intestines of one Itchfl/fl;
VillinCre/+and WT animal at 3 months of age. Consistent with the ex vivo results,
Itchfl/fl; VillinCre/+ animals had an increase in cleaved-caspase 3 staining, which
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was most prevalent on the villi, compared to WT animals where a minimal
amount of apoptosis was observed (Fig. 3.7). Since global loss of ITCH results
in altered differentiation programs on the villi (Chapter 2), images were acquired
at a higher power magnification (63x) to determine if apoptosis in the small
intestines from Itchfl/fl; VillinCre/+ animals was specific to enterocytes.
Interestingly, cleaved caspase 3 staining was observed in both enterocytes and
goblet cells present on the villi (Fig. 3.7), emphasizing that ITCH’s role in
apoptosis is not cell type specific, but seems to act in differentiated cells of both
the absorptive and secretory lineages.
Myeloid-derived cells lacking ITCH influence epithelial cell specification within the
small intestine in a time dependent manner
Contrary to the described role for ITCH we observed in intestinal epithelial
homeostasis in vivo, no difference in cell proliferation (Fig. 3.6.A) or specification
(Fig. 3.5.B) was observed between ITCH sufficient and deficient organoids.
Further support for this phenotype is evidenced from histological evaluation of
Itchfl/fl; VillinCre/+ and WT small intestines. In particular, no marked deviation in
cell type specification (i.e., comparable numbers of goblet and Paneth cells), as
well as crypt and villus size were present in Itchfl/fl; VillinCre/+ intestines when
compared to the WT controls histologically at 2 months of age (Fig. 3.7). Thus,
the global loss of ITCH function phenotype likely results from the combined
actions of cell types outside of just the epithelium. The most likely suspect for
non-cell autonomous function of ITCH influencing epithelial homeostasis would
be the immune system due to its immunosurveillance function within the small
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intestine. Recently, ITCH was determined to attenuate NOD2:RIP2 induced
NFκB signaling in primary macrophages derived from Itcha18H/a18H animals (M. F.
Tao et al., 2009). Thus, in combination with the presence of neutrophils (Ramon
et al., 2011) and eosinophils (Ramon et al., 2011) within the lamina propria of the
small intestine in 5-6 month old Itcha18H/a18H animals, we hypothesized that loss of
ITCH within the myeloid cell lineage could contribute to the altered epithelial
homeostasis in the small intestine.
To analyze the contribution of ITCH in the innate immune system, animals
lacking ITCH within the myeloid cell lineage (Itchfl/fl; LysMCre/Cre) , Itcha18H/a18H and
WT animals were compared at 2 and 6 months of age. Formalin-fixed, paraffinembedded sections dervived from all three genotypes were stained with H&E to
assess tissue morphology (Fig. 3.8). At two months of age, the Itchfl/fl;
LysMCre/Cre-derived small intestines looked comparable to the small intestines of
the WT controls. However, this was in stark contrast to the small intestines from
Itcha18H/a18H animals, which displayed signs of crypt hyperplasia that was
accompanied by an increase in goblet and Paneth cells. Interestingly, the
intestine from 6-month-old Itchfl/fl; LysMCre/Cre animals more closely resembled the
intestines of the Itcha18H/a18H at 2 months of age in that crypt area was increased,
as well as goblet and Paneth cell numbers. Furthermore, the Itcha18H/a18H
intestines from 6-month-old animals appeared progressively worse with regards
to goblet cell differentiation. Collectively, these data highlight the fact that loss of
ITCH in the small intestine, whether ubiquitous or myeloid-specific, drives a
progressive shift in epithelial homeostasis.
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3.4 Discussion
Here, we have delineated epithelial- and myeloid-specific roles for ITCH
that collectively contribute to the preservation of adult intestinal epithelial
homeostasis and mucosal function by regulating crypt formation, cellular
differentiation, and apoptosis. When mature intestinal organoids sufficient and
deficient for ITCH were established, loss of ITCH had no impact on temporal
cell growth (Fig. 3.4), proliferation (Fig. 3.6.A), or cell fate specification (Fig.
3.5.B). However, an increase in apoptosis was observed in ITCH deficient
organoids compared to ITCH sufficient organoids (Fig. 3.6.B), which was
further substantiated by an increase in cleaved-caspase 3 staining within the
small intestine of Itchfl/fl ; VillinCre/+ animals (Fig. 3.7). Among ITCH’s numerous
substrates, c-FLIP, the p53 family members, p63 and p73, LATS1, and TXNIP,
have been implicated in cell apoptosis (Aki et al., 2015). With the exception of
the anti-apoptotic protein c-FLIP, loss of ITCH stabilizes these protein
substrates to promote apoptosis. Thus, we anticipate that Itcha18H/a18H and
Itchfl/fl; VillinCre/+ would have increased expression in one or more of these proapoptotic targets. With the limited expression of p73 in the small intestine, and
complete absence of p63, the likelihood of this family that one of these
proteins is driving the observed apoptosis in the small intestine. In contrast,
the tumor suppressor, LATS1 (Ho et al., 2011), and the cellular redox inhibitor,
TXNIP (Zhang et al., 2010) are both expressed in the small intestine, offering a
potentially mechanism by which cell demise could be mediated in both ITCH
deficient organoids as well as Itchfl/fl; LysMCre/Cre animals.
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In the highly proliferative small intestine, the Lgr5+ CBC stem cell
population is a critical driver of self-renewal. There is mounting evidence to
support a cell-autonomous contribution for ITCH in the cellular dynamics of
embryonic (ESC) and hematopoietic (HSC) stem cells. Specifically, ITCH has
been shown to downregulate the transcription factor OCT4 in ESCs,
compromising ESC renewal capacity as well as somatic cell reprogramming
(Liao et al., 2013). Furthermore, ITCH deficient HSCs were shown to have a
hyperproliferative phenotype, which was attributed to accelerated cell cycle entry,
as compared to ITCH sufficient HSCs (Rathinam et al., 2011). When intestinal
organoids deficient for ITCH were cultured, a significant decrease in the average
number of buds per organoid was observed in Itcha18H/a18H; Lgr5eGFP/+ organoids
versus Itch+/+ ; Lgr5eGFP/+ organoids (Fig. 3.3.A), suggesting that a cellautonomous role for ITCH in the epithelium likely influences the stem cell niche.
Though a decrease in the average number of buds in mature ITCH deficient
organoids was noted, a reduction in eGFP-labeled Lgr5+ intestinal stem cells was
not readily apparent, indicating that a depletion of the rapidly cycling stem cell
population is not necessarily the driving factor of this phenotype. However, due
to the mosaic nature of this construct (Dehmer et al., 2011) and the limited
number of samples assessed, a decrease in Lgr5+ stem cells within ITCH
deficient organoids still remains a formal possibility. Due to the similarities in
EdU incorporation between the ITCH sufficient and ITCH deficient organoid
cultures, it seems unlikely that a decrease in proliferation underlies the observed
decrease in average budding number associated with ITCH deficiency.
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Alternatively, p53-independent spontaneous apoptosis of epithelial cells within
the crypts of the small intestine has been suggested to influence homeostatic
stem cell dynamics (Renehan et al., 2001), and provides a potential mechanistic
link between increased epithelial cell apoptosis associated with loss of ITCH and
the defects observed in crypt fission within mature, budding ITCH deficient
organoids.
While loss of ITCH alters crypt fission in mature, budding intestinal
organoids, an additional role for ITCH upstream of this process is suggested by
the significant expansion of the nonbudding population in the Itcha18H/a18H;
Lgr5eGFP/+ organoid cultures as compared to Itch+/+; Lgr5eGFP/+ organoid cultures
(Fig 3.3.B). Interestingly, the nonbudding Itcha18H/a18H; Lgr5eGFP/+ organoids did
not adopt a hyperproliferative, cyst-like phenotype that typically appears either
with organoids disrupted for APC (Germann et al., 2014) or those with
constitutive β-catenin signaling (T. Sato and Clevers, 2013), minimizing the
possibility that an expansion in stem and/or progenitor cell populations, at the
expense of differentiation, is the impetus behind this phenotype. A failure to bud
in the ITCH deficient organoids could result from improperly integrating signals
necessary for the initiation budding. Normally the Lgr5+ stem cell population and
the surrounding WNT-producing Paneth cells propel themselves outward, likely
mediated by the repulsive force established from the EphB-EphrinB gradient
along the budding structure (Toshiro Sato and Clevers, 2013), similar to what has
been described in vivo (Batlle et al., 2002b). Establishment of the EphB-EphrinB
gradient is dependent on β-catenin and TCF, a transcription factor that mediates
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canonical WNT signaling (Fig. 3.1) (Batlle et al., 2002b). In the small intestine of
Itcha18H/a18H animals, we observed a decrease in β-catenin levels within the crypt
of the small intestine (Fig.3.9). Thus, we speculate that a decrease in β-catenin
within the budding structure of the organoid could disrupt the gradients of WNT
and EphB-EphrinB to compromise bud initiation. While defects in bud initiation
and budding numbers are observed ex vivo in Itcha18H/a18H; Lgr5eGFP/+ organoids,
accelerated crypt formation is observed in Itcha18H/a18H intestines at E18.5 and P7
(Fig. 3.10), suggesting loss of ITCH function in additional cell types could
influence crypt development. Thus, identifying the molecular signatures
associated with loss of ITCH within the crypts of Itcha18H/a18H animals and budding
defects in ITCH deficient organoids will provide insight into the contribution of
ITCH to mucosal homeostasis.
The failure of ITCH deficient intestinal organoids and Itchfl/fl ; VillinCre/+
animals to completely recapitulate the altered intestinal epithelial phenotype in
Itcha18H/a18H animals emphasizes the contribution of ITCH within the immune
compartment of mucosa. Support for this crosstalk between the immune system
and epithelium is derived from the comparable intestinal phenotype between 6month-old Itchfl/fl; LysMCre/Cre and Itcha18H/a18H animals at 2 months of age (Figure
3.8). Within the innate immune system, ITCH influences the proinflammatory
response of macrophages by regulating NOD2-dependent NFκB (M. F. Tao et
al., 2009). We anticipate that the macrophage population within the lamina
propria drives alterations in intestinal epithelial homeostasis within the small
intestine of Itchfl/fl; LysMCre/Cre animals. Interestingly, tissue-resident intestinal

96

macrophages are highly tolerogenic of the external environment and are capable
of employing a variety of mechanisms that effectively clear pathogens while
tempering the immunological response (Bain and Mowat, 2014). Thus, it is
tempting to speculate that ITCH deficient macrophages within the small intestine
generate an inappropriate immunological response to the local environment,
which likely promotes intestinal inflammation and altered epithelial homeostasis.
While a novel myeloid-specific role for ITCH in intestinal epithelial
homeostasis is highlighted by an expansion in crypt area, and goblet and Paneth
cell hyperplasia, a delay in the presentation of the phenotype in Itchfl/fl; LysMCre/Cre
compared to Itcha18H/a18H animals emphasizes the multifaceted role ITCH plays in
the integration of intestinal mucosal functionality and integrity. Thus, it is
tempting to speculate that an increase in apoptosis associated with loss of ITCH
in the epithelium could contribute to the inflammatory response by allowing
bacteria to more easily interact with the immune compartment. Since apoptosis
of intact intestinal epithelium alone does not increase intestinal inflammation
(Hausmann, 2010), the altered inflammatory response in ITCH deficient immune
cells, both within the myeloid and lymphoid compartments, is likely required to
drive the altered intestinal epithelial phenotype. However, a formal possibility
remains wherein additional tissue types, such as surrounding mesenchyme,
could influence intestinal homeostasis. Thus, the continued examination of the
tissue-specific functions for ITCH as well as the synergistic roles of ITCH within
the epithelium and the immune system in the intestinal mucosa is vital to
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identifying novel therapeutic avenues to explore in the treatment of mucosal
enteropathies.
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3.5 Figures

Figure 3.1. EphrinB-EphB gradients within the crypt of the small intestine.
Interactions between EpherinB ligands and EphB receptors influence cellualer
spatial localization and migration within the crypt. Both WNT and EphrinB
ligands within the intestinal epithelium establishes the location and migration of
epithelial cells along the crypt-villus axis. The absence of EphrinB ligands in the
crypt, despite the presence of the EphB recpetors, anchors both CBC stem cells
and Paneth cells to the base of the crypt. Adapted from (Scoville et al., 2008).
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Figure 3.2. Generation of Itchfl/fl; LysMCre/Cre animals. (A) Itchfl/fl aniamls were
generated by placing flanked LoxP cite into intron 5 and intron 7 of the Itch locus.
(B) Breeding scheme employed to generate Itchfl/fl; LysMCre/Cre animals. Due to
diffucultes with genotyping, a non-trandiitonal breeding scheme was utilized.
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Figure 3.3. Itch deficient intestinal organoids have alterations in budding
initiation and budding fission. (A) Representative phase contrast images of
Itch+/+; Lgr5eGFP/+ and Itcha18H/a18H; Lgr5eGFP/+ intestinal organoids at day 5
following plating highlights an increase in the number of nonbudding organoids
in Itch deficient organoids compared to Itch sufficient organoids. Scale bars =
200 µm. (B) Graphical representation of a chi-squared analysis of a 2x2
contingency table (chi-square=5.519, df=1) demonstrating a statistically
significant difference (p =0.0188) in the number of nonbudding versus budding
organoids between Itch+/+; Lgr5eGFP/+ (n=184) and Itcha18H/a18H; Lgr5eGFP/+
(n=199). Organoids were counted from 3 independent wells per Itch+/+;
Lgr5eGFP/+ and Itcha18H/a18H; Lgr5eGFP/+ intestinal crypt isolate. Data represents a
total of 3 isolates per genotype. (C) A significant reduction (*p<0.05) in the
average number of buds per intestinal organoid was observed when comparing
only budding structures in Itch+/+; Lgr5eGFP/+ (n=167, median = 7, IQR = 6) to
Itcha18H/a18H; Lgr5eGFP/+ (n=162, median = 6, IQR = 5) derived enteroids at day 5.
Organoids were counted from 3 independent wells per Itch+/+; Lgr5eGFP/+ and
Itcha18H/a18H; Lgr5eGFP/+ intestinal crypt isolate. Data represents a total of 3
isolates per genotype.
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3.4. Loss of ITCH results in more compact and less intricate organoids.
Representative phase contrast images of Itch+/+; Lgr5eGFP/+ and Itcha18H/a18H;
Lgr5eGFP/+ intestinal organoids at day 1, day 3, and day 5. No difference in
growth kinetics was observed between mature Itch sufficient and Itch deficient
organoids. Scale bars = 50 µm.
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Figure 3.5. Itch deficient organoids are capable of producing differentiated
cell types from Lgr5eGFP/+ stem cells. (A) Confocal fluorescent imaging of
endogenous eGFP expression of whole-mount Itch+/+; Lgr5eGFP/+ and Itcha18H/a18H
; Lgr5eGFP/+ intestinal organoids fixed in 4% PFA and co-stainined with DAPI.
ITCH deficiency does not appear to impact the number or location of intestinal
Lgr5eGFP+ stem cells within the budding structures of the intestinal organoids
when compared to ITCH sufficient organoids. Scale bar = 50µm. (B) Confocal
fluorescent-phase contrast images of 4% PFA-fixed, frozen sections stained with
anti-chromagranin A (enteroendocrine cell marker) or anti-lysozyme (Paneth cell
marker). Goblet cells were identified by cell morphology using phase-contrast
microscopy. No difference was observed in ITCH deficienct organoids compared
to ITCH sufficient organoids, suggesting that loss of ITCH in the intestinal
epithelium does not markedly impact epithelial cell differentation. Scale bar = 50
µm (Chromagranin A and Lysozyme) and 10 µm for goblet cells.
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Figure 3.6. Loss of ITCH in intestinal organoids impacts cell apoptosis in
budding organoids. (A) Confocal fluorescent imaging of EdU incorporation
within proliferating cells from whole-mount Itch+/+; Lgr5eGFP/+ and Itcha18H/a18H;
Lgr5eGFP/+ intestinal organoids fixed in 4% PFA and co-stainined with DAPI.
ITCH deficiency does not appear to impact cell proliferation when compared to
ITCH sufficient organoids. Scale bar = 100 µm. (B) Epifluorescent-phase
contrast images of whole mount Itch+/+ ; Lgr5eGFP/+ and Itcha18H/a18H ; Lgr5eGFP/+
intestinal organoids stained with propridium iodide (PI). A 10% statisctically
significant increase (*p<0.05) in the surface area of PI fluorescence is observed
in Itcha18H/a18H ; Lgr5eGFP/+ intestinal organoids (n=84) compared to Itch+/+;
Lgr5eGFP/+ (n=94). Organoids were counted from 2 independent wells per Itch+/+;
Lgr5eGFP/+ and Itcha18H/a18H;Lgr5eGFP/+ intestinal crypt isolate. Data represents a
total of 2 isolates per genotype. Scale bar = 100 µm. Error bars represent SEM.
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Figure 3.7. Epithelial specific loss of ITCH in the small
intestine promotes epithelial apoptosis. Paraffin-embedded
sections from the distal small intestine of 3 month old WT and
Itchfl/fl ; VillinCre/+ animals immunostained for cleaved-caspase 3
and counterstained with hematoxylin. Animals lacking ITCH in
the intestinal epithelium have increased apoptosis on the villi of
the small intestine compared to WT controls. Higher power
magnification (bottom) highlights apoptotic goblet (*) and
enterocytes (arrows), indicating that apoptosis is not cell-type
dependent. Scale bars = 100 µm (top) and 50 µm (bottom).

108

Figure 3.8. Loss of ITCH in the myeloid lineage leads to late-onset
alterations in intestinal epithelial morphology that is similar to
Itcha18H/a18H at 2 months. H&E paraffin-embedded sections from the distal
small intestine of 2 month and 6 month old WT, Itchfl/fl; LysMCre/Cre , and
Itcha18H/a18H animals. At 2 months, no histological abnormalities are
observed in the epithelium of the small intestine from Itchfl/fl; LysMCre/Cre
animals. By 6 months, the intestinal epithelium from Itchfl/fl; LysMCre/Cre
looks similar to Itcha18H/a18H animals at 2 months of age with an expanded
crypt compartment and increased goblet and Paneth cell numbers
suggesting that loss of ITCH in the myeloid cell lineage contributes to the
epithelial alterations observed in the small intestine of Itcha18H/a18H animals.
However, a delay in the presentation of altered intestinal morphology
suggests that loss of ITCH in additional tissue types (i.e., epithelium) likely
accelerates the epithelial defects that are observed in Itcha18H/a18H animals at
2 months of age. Scale bars = 100 µm.
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Figure 3.9. β-catenin expression is reduced in
Itcha18H/a18H animals. Paraffin-embedded sections from
the distal small intestine of young adult Itch+/+ and
Itcha18H/a18H animals immunostained for β-catenin and
counterstained with hematoxylin. Animals lacking ITCH in
the intestinal epithelium have reduced levels of β-catenin
at the membrane of cells in the crypt of the small intestine
compared to WT controls. Scale bars = 50µm.
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Figure 3.10. Loss of ITCH accelerates epithelial maturation during
development. (A) Representative H&E stained paraffin-embedded small
intestinal sections from E18.5 (left) and P7 (right) Itch+/+ and Itcha18H/a18H
animals show precocious crypt emergence in the Itcha18H/a18H animals. Black
dashed lines in the insets outline crypt borders. Scale bars = 200 µm. Original
magnification of insets = 63x. (B) Intracellular vacuoles (arrows) located within
distal enterocytes from P7 Itch+/+ and Itcha18H/a18H animals highlight a difference
in the apical canalicular system in the Itcha18H/a18H animals, consistent with
accelerated epithelial maturation. Scale bars = 20 µm.
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CHAPTER 4
CONCLUDING REMARKS
The small intestine is a highly dynamic tissue that plays a vital role in
digestion, nutrient absorption, and water balance while simultaneously preventing
the entry of foreign substrates (Bischoff et al., 2014). The mucosal barrier is an
integral component of this process, effectively separating the external
environment from the body's internal milieu. Preservation of the mucosal barrier
is, in part, established by the concerted effort between the epithelium and the
immune system (Rescigno, 2011.) Bacteria that colonize the small intestine are
constantly challenging the efficacy of the barrier. The epithelium that lines the
luminal cavity provides an initial physical barrier that prevents the passage of
bacteria into the internal compartment of the host. While this mainstay barrier is
typically an effective deterrent, the constant exposure of noxious substances,
antigens, and microorganisms to the surface of the epithelium makes a breach in
foreign material eventually inevitable (Schenk and Mueller, 2008). In this event,
resident intestinal macrophages and dendritic cells that encounter the bacteria
will cytotoxically destroy the bacteria without initiating an inflammatory response,
which preserves the architecture and function of the epithelium (intestinal
epithelial homeostasis). However, if the innate immune cells fail to remain
tolerogenic, an inappropriate inflammatory response is generated which can lead
to epithelial destruction and compromised small intestinal function.
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Here we present evidence of both cell autonomous and non-cell
autonomous roles for the ubiquitin ligase ITCH in epithelial homeostasis in the
small intestine. Increased cell death was noted in both ITCH deficient
organoids and in Itchfl/fl; VillinCre/+ animals, supportive of an epithelial-specific
function for ITCH in cell demise. As previously discussed, increased ITCHmediated epithelial apoptosis could be driven by the disorganization of
adherens junctions (Chapter 1) or by the increased expression of the ITCHtargeted substrates LATS1 or TXNIP (Chapter 3). However, an additional role
for ITCH in the regulation of apoptosis, most likely associated with
inappropriate activation of the immune system, is emphasized by a shift in
apoptotic cells from the villus of Itchfl/fl; VillinCre/+ animals towards the upper
region of the crypt in the Itcha18H/a18H small intestine. TNF-α, a proinflammatory cytokine that is produced by both innate and acquired immune
responses, enhances epithelial apoptosis in the intestine (Nunes et al., 2014;
Watson and Hughes, 2012). We anticipate that the aberrant activation of the
immune system within the gastrointestinal tract of the Itcha18H/a18H animal will
promote TNF-α mediated apoptosis, and, in combination with ITCH’s cell
autonomous role in epithelial apoptosis, increased stress is placed on the
epithelium to initiate apoptosis at an earlier point in the epithelial turnover
process. Alternatively, cell death within the crypt has been suggested as a
homeostatic mechanism to control the number of terminally differentiated cells
that will migrate onto the villus by controlling the number of progenitor cells
within the crypt (Hall et al., 1994). The prevalence of apoptotic cells in the
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upper crypt of Itcha18H/a18H animals may represent an attempt to limit the
number of transit-amplifying cells to maintain homeostasis.
It is interesting to note that additional signaling pathways within the
epithelium, such as NFκB, can influence the outcome of TNF-α mediated
apoptosis (Chang et al., 2006; Wullaert et al., 2011). Active NFκB signaling in
the intestinal epithelium is protective against TNF-α mediated apoptosis, and the
absence of NFκB signaling in the presence of this cytokine promotes cell death.
(Wullaert et al., 2011). Accumulating evidence supports that ITCH is a negative
regulator of NFκB signaling (Chang et al., 2006; Shembade et al., 2008; M. Tao
et al., 2009). We anticipate that loss of ITCH function promotes NFκB signaling
in the epithelium, which could protect the epithelium from TNF-α induced
apoptosis. Thus, loss of ITCH in the epithelium in the presence of inflammation
might serve as a protective mechanism to counteract inflammation-driven
apoptosis in an attempt to preserve barrier function.
The fact that the epithelial-specific loss of ITCH fails to recapitulate the
small intestinal epithelial phenotype in the ubiquitous loss of function ITCH
animals suggests that ITCH plays an important role in immune tissue to
contribute to epithelial homeostasis. Loss of ITCH function in the myeloid cell
compartment of 6-month-old animals resulted in crypt hyperplasia as well as
increased specification toward goblet and Paneth cells, similar to the young
adult Itcha18H/a18H small intestinal phenotype. Evidence supports a cell
autonomous function for ITCH in macrophages to fine tune the
proinflammatory response in macrophages by modulating NFκB signaling (M.
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Tao et al., 2009). To prevent an inappropriate response to the luminal
bacteria, macrophages in the small intestine are tolerogenic and do not induce
pro-inflammatory cytokines in the presence of antigenic substrates (Gross et
al., 2015). Due to the aberrant activation of the immune system in the
absence of a known pathogen in Itcha18H/a18H animals, we suspect ITCH
deficient macrophages are less tolerogenic and initiate an NFκB-dependent,
pro-inflammatory response that influences epithelial homeostasis.
Additionally, the heightened immune response of ITCH deficient macrophages
likely activates effector T cells, which, in turn, will feed back onto the
epithelium to further influence tissue homeostasis. Consistent with assertion,
the delayed development of an epithelial phenotype in Itchfl/fl; LysMCre/Cre
animals as compared to Itcha18H/a18H animals supports that additional tissue
types contribute to the shift in epithelial homeostasis. While the epithelium is a
likely contributor to this phenotype (Chapter 2 Discussion), loss of ITCH in
lymphoid tissues might contribute as well, which is evidenced by the lack of
epithelial disarray that is observed in Itcha18H/a18H animals on a Rag1-/background as compared to Itcha18H/a18H animals.
The inability of the tissue-specific losses of ITCH in either the epithelium
or in the immune system to recapitulate the global loss of ITCH phenotype
characterized by increased cell proliferation and apoptosis within the crypt,
enhanced terminal differentiation of goblet and Paneth cells, and accelerated cell
migration along the crypt-villus axis, suggests that loss of ITCH in both epithelial
and immune tissues contributes to this phenotype. We hypothesize the loss of
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ITCH in the epithelium enhances apoptosis, which promotes the translocation of
commensal bacteria into the host more readily. The presence of bacteria in the
lamina propria prompts a response from the resident innate immune cells.
However, due to loss of ITCH function in this tissue as well, this likely decreases
the tolerance of the innate immune cells to the bacteria and leads to a
heightened inflammatory response, which feeds back onto the epithelium and
influences homeostasis. Because the epithelium response by increasing
migration, as well as goblet and Paneth cell differentiation, which are considered
protective measures against pathogen invasion. This shift in epithelial
homeostasis attempts to minimize further bacteria invasion and epithelial
destruction. Similar to NFκB signaling in the small intestine, we propose that
ITCH has dual functions in regulating small intestinal mucosal homeostasis that
is context-dependent. Further elucidation of how ITCH influences mucosal
homeostasis in the epithelium and the immune system, as well as the cross-talk
between this two tissue types, will provide insight how ITCH impacts a range of
gastrointestinal enteropathies, including inflammatory bowel diseases, celiac
disease, and cancer.
Interestingly, our data support that loss of ITCH is protective in sporadic
colorectal cancer. With the numerous tumor suppressor targets that are
substrates for ITCH, it is not surprising that ITCH expression is robustly
increased in intestinal adenocarcinomas (Uhlen, 2005). While we have proposed
that loss of ITCH function in ApcMin/+ tumorigenesis significantly reduces tumor
burden by driving cells toward a differentiated state and leads to a reduction in
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anchorage dependent growth of transformed cells (Chapter 2), it is tempting the
speculate that apoptosis contributes as well. We anticipate that loss of ITCH
would enhance apoptosis in ApcMin/+ small intestinal adenomas. Alternatively, the
altered inflammatory state that is present in the small intestine of the Itcha18H/a18H
animals could also contribute to decreased tumor burden. In colorectal cancer,
the activation of the immune system establishes a pro-inflammatory environment
which promotes tumor growth (Ellyard et al., 2007). Thus, we anticipate that loss
of ITCH function either does not produce a pro-inflammatory environment or the
immune system’s response is modified. γδ T-cells are subset of specialized Tcells that primarily localize to the lamina propria of the intestine and contribute to
innate immunity by destroying epithelial cells that have been invaded or
damaged by pathogenic material as well as by producing multifunctional memory
T-cells that rapidly response if re-exposure occurs (Sheridan et al., 2013; van
Wijk and Cheroutre, 2010). In Itcha18H/a18H animals, elevated levels of serum IgE,
an immunoglobulin that promotes allergic reactions, is secreted by the γδ T cell
population (Parravicini et al., 2008). However, accumulating evidence also
suggests a role for IgE in anti-tumor immunity (Leoh et al., 2015). Thus, it is
tempting to speculate that loss if ITCH promotes antibody-dependent cellmediated cytotoxicity toward intestinal adenomas by generating IgEs targeted
against a tumor-associated antigen. Further, the aberrant activation of the
immune system in ITCH deficient animals may provide a more robust
inflammatory response to effectively destroy the tumor. IgE induces a robust
inflammatory response by recruiting key effector mediator cells, such as
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eosinophils, basophils, and mast cells, to destroy the target. The increased
presence of eosinophils is a hallmark of the IgE inflammatory response, and the
degranulation of these cells contributes to cytotoxic destruction of their targets
(Leoh et al., 2015). In 5-month-old Itcha18H/a18H animals, an increased number of
eosinophils are present in the small intestine (Ramon et al., 2011), potentially
providing support for IgE-mediated destruction of ApcMin/+ intestinal adenomas.
The activation of the host’s immune system has proven extremely
effective in the adjuvant treatment of cancer. Since 2013, the FDA has approved
15 monoclonal immunotherapies for the treatment of cancer (Farkona et al.,
2016). The potential ability of ITCH deficient γδ T-cells to secrete IgE antibodies
targeted against tumor-specific antigens could be of therapeutic interest in the
treatment of colorectal cancer. While passive immunotherapy has proven
extremely effective, endogenous activation of the immune system to induce
immunoglobulins that are specifically directed at tumor-associated antigens will
provide a more personalized approach in the treatment of colorectal cancer.
Furthermore, the endogenous activation of the immune system will likely
generate memory effectors cells that can induce a more rapid immune response
if subsequent exposure occurs. Thus, the continued examination of ITCH in
epithelial and immune tissues in the intestine, as well as how these tissue
interact to maintain mucosal homeostasis, will likely identify novel therapeutic
avenues that will provide personalized treatment in a range of gastrointestinal
enteropathies.

118

REFERENCES
Agace, W.W., McCoy, K.D., 2017. Regionalized Development and Maintenance
of the Intestinal Adaptive Immune Landscape. Immunity.
doi:10.1016/j.immuni.2017.04.004
Ahern, P.P., Schiering, C., Buonocore, S., McGeachy, M.J., Cua, D.J., Maloy,
K.J., Powrie, F., 2010. Interleukin-23 Drives Intestinal Inflammation through
Direct Activity on T Cells. Immunity 33, 279–288.
doi:10.1016/j.immuni.2010.08.010
Aki, D., Zhang, W., Liu, Y.C., 2015. The E3 ligase Itch in immune regulation and
beyond. Immunol. Rev. 266, 6–26. doi:10.1111/imr.12301
Al-Sadi, R., Khatib, K., Guo, S., Ye, D., Youssef, M., Ma, T., 2011. Occludin
regulates macromolecule flux across the intestinal epithelial tight junction
barrier. Am. J. Physiol. Gastrointest. Liver Physiol. 300, G1054–G1064.
doi:10.1152/ajpgi.00055.2011
Armbruster, N.S., Stange, E.F., Wehkamp, J., 2017. In the Wnt of Paneth cells:
Immune-epithelial crosstalk in small intestinal Crohn’s disease. Front.
Immunol. doi:10.3389/fimmu.2017.01204
Bain, C.C., Mowat, A.M., 2014. Macrophages in intestinal homeostasis and
inflammation. Immunol. Rev. doi:10.1111/imr.12192
Baker, A.M., Cereser, B., Melton, S., Fletcher, A.G., Rodriguez-Justo, M.,
Tadrous, P.J., Humphries, A., Elia, G., McDonald, S.A.C., Wright, N.A.,

119

Simons, B.D., Jansen, M., Graham, T.A., 2014. Quantification of crypt and stem
cell evolution in the normal and neoplastic human colon. Cell Rep. 8, 940–
947. doi:10.1016/j.celrep.2014.07.019
Barker, N., 2013. Adult intestinal stem cells: critical drivers of epithelial
homeostasis and regeneration. Nat. Rev. Mol. Cell Biol. 15, 19–33.
doi:10.1038/nrm3721
Barker, N., Ridgway, R.A., van Es, J.H., van de Wetering, M., Begthel, H., van
den Born, M., Danenberg, E., Clarke, A.R., Sansom, O.J., Clevers, H., 2009.
Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457, 608–
611. doi:10.1038/nature07602
Barker, N., Van De Wetering, M., Clevers, H., 2008. The intestinal stem cell.
Genes Dev 22, 1856–1864.
Barker, N., van Es, J.H., Kuipers, J., Kujala, P., van den Born, M., Cozijnsen, M.,
Haegebarth, A., Korving, J., Begthel, H., Peters, P.J., Clevers, H., 2007a.
Identification of stem cells in small intestine and colon by marker gene Lgr5.
Nature. doi:10.1038/nature06196
Barker, N., Van Es, J.H., Kuipers, J., Kujala, P., Van Den Born, M., Cozijnsen,
M., Haegebarth, A., Korving, J., Begthel, H., Peters, P.J., Clevers, H.,
2007b. Identification of stem cells in small intestine and colon by marker
gene Lgr5. Nature 449, 1003–1007.
Barker, N., Van Oudenaarden, A., Clevers, H., 2012. Identifying the stem cell of
the intestinal crypt: Strategies and pitfalls. Cell Stem Cell.
doi:10.1016/j.stem.2012.09.009

120

Basak, O., Beumer, J., Wiebrands, K., Seno, H., van Oudenaarden, A., Clevers,
H., 2017. Induced Quiescence of Lgr5+ Stem Cells in Intestinal Organoids
Enables Differentiation of Hormone-Producing Enteroendocrine Cells. Cell
Stem Cell. doi:10.1016/j.stem.2016.11.001
Basheer, W.A., Harris, B.S., Mentrup, H.L., Abreha, M., Thames, E.L., Lea, J.B.,
Swing, D.A., Copeland, N.G., Jenkins, N.A., Price, R.L., Matesic, L.E., 2015.
Cardiomyocyte-specific overexpression of the ubiquitin ligase Wwp1
contributes to reduction in Connexin 43 and arrhythmogenesis. J. Mol. Cell.
Cardiol. 88. doi:10.1016/j.yjmcc.2015.09.004
Batlle, E., Henderson, J.T., Beghtel, H., Van den Born, M.M.W., Sancho, E.,
Huls, G., Meeldijk, J., Robertson, J., Van de Wetering, M., Pawson, T.,
Clevers, H., 2002a. β-catenin and TCF mediate cell positioning in the
intestinal epithelium by controlling the expression of EphB/EphrinB. Cell.
doi:10.1016/S0092-8674(02)01015-2
Batlle, E., Henderson, J.T., Beghtel, H., Van den Born, M.M.W., Sancho, E.,
Huls, G., Meeldijk, J., Robertson, J., Van de Wetering, M., Pawson, T.,
Clevers, H., 2002b. β-catenin and TCF mediate cell positioning in the
intestinal epithelium by controlling the expression of EphB/EphrinB. Cell 111,
251–263. doi:10.1016/S0092-8674(02)01015-2
Berer, K., Mues, M., Koutrolos, M., Rasbi, Z. Al, Boziki, M., Johner, C., Wekerle,
H., Krishnamoorthy, G., 2011. Commensal microbiota and myelin
autoantigen cooperate to trigger autoimmune demyelination. Nature 479,
538–541. doi:10.1038/nature10554

121

Bernassola, F., Karin, M., Ciechanover, A., Melino, G., 2008. The HECT Family
of E3 Ubiquitin Ligases: Multiple Players in Cancer Development. Cancer
Cell. doi:10.1016/j.ccr.2008.06.001
Birchenough, G.M.H., Johansson, M.E., Gustafsson, J.K., Bergström, J.H.,
Hansson, G.C., 2015. New developments in goblet cell mucus secretion and
function. Mucosal Immunol. 8, 712–719. doi:10.1038/mi.2015.32
Bischoff, S.C., Barbara, G., Buurman, W., Ockhuizen, T., Schulzke, J.-D., Serino,
M., Tilg, H., Watson, A., Wells, J.M., 2014. Intestinal permeability – a new
target for disease prevention and therapy. BMC Gastroenterol. 14, 189.
doi:10.1186/s12876-014-0189-7
Bondow, B.J., Faber, M.L., Wojta, K.J., Walker, E.M., Battle, M.A., 2012. Ecadherin is required for intestinal morphogenesis in the mouse. Dev. Biol.
371, 1–12. doi:10.1016/j.ydbio.2012.06.005
Brand, S., Beigel, F., Olszak, T., Zitzmann, K., Eichhorst, T., Otte, J., Diepolder,
H., Marquardt, A., Jagla, W., Popp, A., Herrmann, K., Seiderer, J.,
Ochsenku, T., Auernhammer, C.J., Dambacher, J., Mar-, A., Herr-, K., Go,
B., 2006. IL-22 is increased in active Crohn’s disease and promotes
proinflammatory gene expression and intestinal epithelial cell migration. Am
J Physiol Gastrointest Liver Physiol 290, G827-838.
doi:10.1152/ajpgi.00513.2005.
Brenchley, J.M., Price, D. a, Schacker, T.W., Asher, T.E., Silvestri, G., Rao, S.,
Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., Blazar, B.R.,
Rodriguez, B., Teixeira-Johnson, L., Landay, A., Martin, J.N., Hecht, F.M.,

122

Picker, L.J., Lederman, M.M., Deeks, S.G., Douek, D.C., 2006. Microbial
translocation is a cause of systemic immune activation in chronic HIV
infection. Nat. Med. 12, 1365–71. doi:10.1038/nm1511
Buller, N.V.J.A., Rosekrans, S.L., Westerlund, J., van den Brink, G.R., 2012.
Hedgehog Signaling and Maintenance of Homeostasis in the Intestinal
Epithelium. Physiology 27, 148–155. doi:10.1152/physiol.00003.2012
Burstone, M.S., 1958. Histochemical demonstration of acid phosphatases with
naphthol as-phosphates. J. Natl. Cancer Inst. 21, 523–538.
doi:10.1093/jnci/21.3.523
Carothers, A.M., Melstrom, K.A., Mueller, J.D., Weyant, M.J., Bertagnolli, M.M.,
2001. Progressive Changes in Adherens Junction Structure during Intestinal
Adenoma Formation in Apc Mutant Mice. J. Biol. Chem. 276, 39094–39102.
doi:10.1074/jbc.M103450200
Caruso, R., Warner, N., Inohara, N., Núñez, G., 2014. NOD1 and NOD2:
Signaling, host defense, and inflammatory disease. Immunity.
doi:10.1016/j.immuni.2014.12.010
Catalioto, R.-M., Maggi, C.A., Giuliani, S., 2011. Intestinal epithelial barrier
dysfunction in disease and possible therapeutical interventions. Curr. Med.
Chem. 18, 398–426. doi:10.2174/092986711794839179
Chang, L., Kamata, H., Solinas, G., Luo, J.L., Maeda, S., Venuprasad, K., Liu,
Y.C., Karin, M., 2006. The E3 ubiquitin ligase itch couples JNK activation to
TNFα-induced cell death by inducing c-FLIPL turnover. Cell 124, 601–613.
doi:10.1016/j.cell.2006.01.021

123

Chastagner, P., Israël, A., Brou, C., 2008. AIP4/Itch regulates notch receptor
degradation in the absence of ligand. PLoS One 3.
doi:10.1371/journal.pone.0002735
Chen, C., Matesic, L.E., 2007. The Nedd4-like family of E3 ubiquitin ligases and
cancer. Cancer Metastasis Rev. 26, 587–604.
Cheng, H., Leblond, C.P., 1974. Origin, differentiation and renewal of the four
main epithelial cell types in the mouse small intestine V. Unitarian theory of
the origin of the four epithelial cell types. Am. J. Anat. 141, 537–561.
doi:10.1002/aja.1001410407
Cho, K.R., Vogelstein, B., 1992. Genetic alterations in the adenoma–carcinoma
sequence. Cancer 70, 1727–1731. doi:10.1002/10970142(19920915)70:4+<1727::AID-CNCR2820701613>3.0.CO;2-P
Chwalinski, S., Potten, C.S., Evans, G., 1988. Double labelling with
bromodeoxyuridine and [3H]-thymidine of proliferative cells in small intestinal
epithelium in steady state and after irradiation. Cell Tissue Kinet. 21, 317–
329.
Clevers, H., 2009. Searching for adult stem cells in the intestine. EMBO Mol.
Med. 1, 255–259. doi:10.1002/emmm.200900034
Clevers, H.C., Bevins, C.L., 2013. Paneth Cells: Maestros of the Small Intestinal
Crypts. Annu. Rev. Physiol. 75, 289–311. doi:10.1146/annurev-physiol030212-183744
Cornell, M., Evans, D.A.P., Mann, R., Fostier, M., Flasza, M., Monthatong, M.,
Artavanis-Tsakonas, S., Baron, M., 1999. The Drosophila melanogaster

124

Suppressor of deltex gene, a regulator of the Notch receptor signaling
pathway, is an E3 class ubiquitin ligase. Genetics 152, 567–576.
De Mey, J.R., Freund, J., 2013. Understanding epithelial homeostasis in the
intestine: An old battlefield of ideas, recent breakthroughs and remaining
controversies. Tissue barriers 1, e24965. doi:10.4161/tisb.24965
Dehmer, J.J., Garrison, A.P., Speck, K.E., Dekaney, C.M., Van Landeghem, L.,
Sun, X., Henning, S.J., Helmrath, M.A., 2011. Expansion of Intestinal
Epithelial Stem Cells during Murine Development. PLoS One 6, e27070.
doi:10.1371/journal.pone.0027070
Delgado, M.E., Grabinger, T., Brunner, T., 2016. Cell death at the intestinal
epithelial front line. FEBS J. doi:10.1111/febs.13575
Di Marcotullio, L., Greco, A., Mazzà, D., Canettieri, G., Pietrosanti, L., Infante, P.,
Coni, S., Moretti, M., De Smaele, E., Ferretti, E., Screpanti, I., Gulino, A.,
2011. Numb activates the E3 ligase Itch to control Gli1 function through a
novel degradation signal. Oncogene 30, 65–76. doi:10.1038/onc.2010.394
Donaldson, G.P., Lee, S.M., Mazmanian, S.K., 2015. Gut biogeography of the
bacterial microbiota. Nat. Rev. Microbiol. 14, 20–32.
doi:10.1038/nrmicro3552
Durand, A., Donahue, B., Peignon, G., Letourneur, F., Cagnard, N., Slomianny,
C., Perret, C., Shroyer, N.F., Romagnolo, B., 2012. Functional intestinal
stem cells after Paneth cell ablation induced by the loss of transcription
factor Math1 (Atoh1). Proc. Natl. Acad. Sci. 109, 8965–8970.
doi:10.1073/pnas.1201652109

125

Eisenstein, E.M., Williams, C.B., 2009. The Treg/Th17 cell balance: A new
paradigm for autoimmunity. Pediatr. Res.
doi:10.1203/PDR.0b013e31819e76c7
Ellyard, J.I., Simson, L., Parish, C.R., 2007. Th2-mediated anti-tumour immunity:
Friend or foe? Tissue Antigens. doi:10.1111/j.1399-0039.2007.00869.x
Elphick, D.A., Mahida, Y.R., 2005. Paneth cells: their role in innate immunity and
inflammatory disease. Gut 54, 1802–9. doi:10.1136/gut.2005.068601
Etienne-Manneville, S., 2012. Adherens junctions during cell migration. Subcell.
Biochem. 60, 225–249. doi:10.1007/978-94-007-4186-7_10
Fang, D., Elly, C., Gao, B., Fang, N., Altman, Y., Joazeiro, C., Hunter, T.,
Copeland, N., Jenkins, N., Liu, Y.-C., 2002a. Dysregulation of T lymphocyte
function in itchy mice: a role for Itch in TH2 differentiation. Nat. Immunol. 3,
281–287. doi:10.1038/ni763
Fang, D., Elly, C., Gao, B., Fang, N., Altman, Y., Joazeiro, C., Hunter, T.,
Copeland, N., Jenkins, N., Liu, Y.-C., 2002b. Dysregulation of T lymphocyte
function in itchy mice: a role for Itch in TH2 differentiation. Nat. Immunol.
doi:10.1038/ni763
Fang, D., Elly, C., Gao, B., Fang, N., Altman, Y., Joazeiro, C., Hunter, T.,
Copeland, N., Jenkins, N., Liu, Y.-C., 2002c. Dysregulation of T lymphocyte
function in itchy mice: a role for Itch in TH2 differentiation. Nat. Immunol. 3,
281–287. doi:10.1038/ni763
Fanning, A.S., Jameson, B.J., Jesaitis, L.A., Anderson, J.M., 1998. The tight
junction protein ZO-1 establishes a link between the transmembrane protein

126

occludin and the actin cytoskeleton. J. Biol. Chem. 273, 29745–29753.
doi:10.1074/jbc.273.45.29745
Farkona, S., Diamandis, E.P., Blasutig, I.M., 2016. Cancer immunotherapy: the
beginning of the end of cancer? BMC Med. 14, 73. doi:10.1186/s12916-0160623-5
Fevr, T., Robine, S., Louvard, D., Huelsken, J., 2007. Wnt/β-Catenin Is Essential
for Intestinal Homeostasis and Maintenance of Intestinal Stem Cells. Mol.
Cell. Biol. 27, 7551–7559. doi:10.1128/MCB.01034-07
Flier, L.G. Van Der, Clevers, H., 2009. Stem Cells , Self-Renewal , and
Differentiation in the Intestinal Epithelium. Annu. Rev. Physiol. 71, 241–260.
doi:10.1146/annurev.physiol.010908.163145
Foersch, S., Neurath, M.F., 2014. Colitis-associated neoplasia: Molecular basis
and clinical translation. Cell. Mol. Life Sci. doi:10.1007/s00018-014-1636-x
Fre, S., Pallavi, S.K., Huyghe, M., Laé, M., Janssen, K.-P., Robine, S., ArtavanisTsakonas, S., Louvard, D., 2009. Notch and Wnt signals cooperatively
control cell proliferation and tumorigenesis in the intestine. Proc. Natl. Acad.
Sci. U. S. A. 106, 6309–6314. doi:10.1073/pnas.0900427106
Garcia, M.A., Nelson, W.J., Chavez, N., 2017. Cell–Cell Junctions Organize
Structural and Signaling Networks. Cold Spring Harb. Perspect. Biol.
a029181. doi:10.1101/cshperspect.a029181
Garrett, W.S., Gordon, J.I., Glimcher, L.H., 2010. Homeostasis and Inflammation
in the Intestine. Cell. doi:10.1016/j.cell.2010.01.023
Geissmann, F., Manz, M.G., Jung, S., Sieweke, M.H., Merad, M., Ley, K., 2010.

127

Development of monocytes, macrophages, and dendritic cells. Science 327,
656–61. doi:10.1126/science.1178331
Gerbe, F., Van Es, J.H., Makrini, L., Brulin, B., Mellitzer, G., Robine, S.,
Romagnolo, B., Shroyer, N.F., Bourgaux, J.F., Pignodel, C., Clevers, H.,
Jay, P., 2011. Distinct ATOH1 and Neurog3 requirements define tuft cells as
a new secretory cell type in the intestinal epithelium. J. Cell Biol. 192, 767–
780. doi:10.1083/jcb.201010127
Germann, M., Xu, H., Malaterre, J., Sampurno, S., Huyghe, M., Cheasley, D.,
Fre, S., Ramsay, R.G., 2014. Tripartite interactions between Wnt signaling,
Notch and Myb for stem/progenitor cell functions during intestinal
tumorigenesis. Stem Cell Res. doi:10.1016/j.scr.2014.08.002
Gersemann, M., Becker, S., Kübler, I., Koslowski, M., Wang, G., Herrlinger, K.R.,
Griger, J., Fritz, P., Fellermann, K., Schwab, M., Wehkamp, J., Stange, E.F.,
2009. Differences in goblet cell differentiation between Crohn’s disease and
ulcerative colitis. Differentiation 77, 84–94. doi:10.1016/j.diff.2008.09.008
Grabinger, T., Luks, L., Kostadinova, F., Zimberlin, C., Medema, J.P., Leist, M.,
Brunner, T., 2014. Ex vivo culture of intestinal crypt organoids as a model
system for assessing cell death induction in intestinal epithelial cells and
enteropathy. Cell Death Dis. 5, e1228. doi:10.1038/cddis.2014.183
Gregorieff, A., Stange, D.E., Kujala, P., Begthel, H., van den Born, M., Korving,
J., Peters, P.J., Clevers, H., 2009. The Ets-Domain Transcription Factor
Spdef Promotes Maturation of Goblet and Paneth Cells in the Intestinal
Epithelium. Gastroenterology 137. doi:10.1053/j.gastro.2009.06.044

128

Grimelius, L., 2004. Silver stains demonstrating neuroendocrine cells. Biotech.
Histochem. 79, 37–44. doi:10.1080/10520290410001715264
Groschwitz, K.R., Hogan, S.P., 2009. Intestinal barrier function: molecular
regulation and disease pathogenesis. J. Allergy Clin. Immunol. 124, 3-20–2.
doi:10.1016/j.jaci.2009.05.038
Gross, M., Salame, T.M., Jung, S., 2015. Guardians of the gut - murine intestinal
macrophages and dendritic cells. Front. Immunol.
doi:10.3389/fimmu.2015.00254
Guan, Y., Watson, A.J.M., Marchiando, A.M., Bradford, E., Shen, L., Turner, J.R.,
Montrose, M.H., 2011. Redistribution of the tight junction protein ZO-1 during
physiological shedding of mouse intestinal epithelial cells. AJP Cell Physiol.
300, C1404-14. doi:10.1152/ajpcell.00270.2010
Günther, C., Martini, E., Wittkopf, N., Amann, K., Weigmann, B., Neumann, H.,
Waldner, M.J., Hedrick, S.M., Tenzer, S., Neurath, M.F., Becker, C., 2011.
Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal
ileitis. Nature 477, 335–339. doi:10.1038/nature10400
Halbleib, J.M., Nelson, W.J., 2006. Cadherins in development: Cell adhesion,
sorting, and tissue morphogenesis. Genes Dev. doi:10.1101/gad.1486806
Hall, P. a, Coates, P.J., Ansari, B., Hopwood, D., 1994. Regulation of cell number
in the mammalian gastrointestinal tract: the importance of apoptosis. J. Cell
Sci. doi:10.1002/path.1711670106
Hanahan, D., Weinberg, R. a, Francisco, S., 2000. The Hallmarks of Cancer. Cell
100, 57–70. doi:10.1016/S0092-8674(00)81683-9

129

Hartsock, A., Nelson, W.J., 2008. Adherens and tight junctions: Structure,
function and connections to the actin cytoskeleton. Biochim. Biophys. Acta Biomembr. doi:10.1016/j.bbamem.2007.07.012
Hausmann, M., 2010. How Bacteria-Induced Apoptosis of Intestinal Epithelial
Cells Contributes to Mucosal Inflammation. Int. J. Inflam. 2010, 1–9.
doi:10.4061/2010/574568
Heller, F., Florian, P., Bojarski, C., Richter, J., Christ, M., Hillenbrand, B.,
Mankertz, J., Gitter, A.H., Bürgel, N., Fromm, M., Zeitz, M., Fuss, I., Strober,
W., Schulzke, J.D., 2005. Interleukin-13 is the key effector Th2 cytokine in
ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell
restitution. Gastroenterology 129, 550–564.
doi:10.1016/j.gastro.2005.05.002
Henriksson, J.T., Coursey, T.G., Corry, D.B., De Paiva, C.S., Pflugfelder, S.C.,
2015. IL-13 stimulates proliferation and expression of mucin and
immunomodulatory genes in cultured conjunctival goblet cells. Investig.
Ophthalmol. Vis. Sci. 56, 4186–4197. doi:10.1167/iovs.14-15496
Hermiston, M.L., Gordon, J.I., 1995. Inflammatory bowel disease and adenomas
in mice expressing a dominant negative N-cadherin. Science 270, 1203–7.
doi:10.1126/science.270.5239.1203
Hermiston, M.L., Wong, M.H., Gordon, J.I., 1996. Forced expression of Ecadherin in the mouse intestinal epithelium slows cell migration and provides
evidence for nonautonomous regulation of cell fate in a self-renewing
system. Genes Dev. 10, 985–996. doi:10.1101/gad.10.8.985

130

Ho, K.C., Zhou, Z., She, Y.-M., Chun, A., Cyr, T.D., Yang, X., 2011. Itch E3
ubiquitin ligase regulates large tumor suppressor 1 stability [corrected]. Proc.
Natl. Acad. Sci. doi:10.1073/pnas.1101273108
Huang, Y., Chen, Z., 2016. Inflammatory bowel disease related innate immunity
and adaptive immunity. Am. J. Transl. Res.
Huh, J.R., Littman, D.R., 2012. Small molecule inhibitors of RORγt: Targeting
Th17 cells and other applications. Eur. J. Immunol.
doi:10.1002/eji.201242740
Hustad, C.M., Perry, W.L., Siracusa, L.D., Rasberry, C., Cobb, L., Cattanach,
B.M., Kovatch, R., Copeland, N.G., Jenkins, N.A., 1995. Molecular genetic
characterization of six recessive viable alleles of the mouse agouti locus.
Genetics 140, 255–265.
Hustad, C.M., Perry, W.L., Siracusa, L.D., Rasberry, C., Cobb, L., Cattanach,
B.M., Kovatch, R., Copeland, N.G., Jenkins, N.A., 1995. Molecular genetic
characterization of six recessive viable alleles of the mouse agouti locus.
Genetics 140, 255–265.
Izcue, A., Hue, S., Buonocore, S., Arancibia-Cárcamo, C. V., Ahern, P.P.,
Iwakura, Y., Maloy, K.J., Powrie, F., 2008. Interleukin-23 Restrains
Regulatory T Cell Activity to Drive T Cell-Dependent Colitis. Immunity 28,
559–570. doi:10.1016/j.immuni.2008.02.019
Jin, H., Park, Y., Elly, C., Liu, Y.-C., 2013. Itch expression by Treg cells controls
Th2 inflammatory responses. J. Clin. Invest. 123, 4923–34.
doi:10.1172/JCI69355

131

Jin, H.S., Park, Y., Elly, C., Liu, Y.C., 2013. Itch expression by Treg cells controls
Th2 inflammatory responses. J. Clin. Invest. 123, 4923–4934.
doi:10.1172/JCI69355
Johansson, M.E. V., Hansson, G.C., 2016. Immunological aspects of intestinal
mucus and mucins. Nat. Rev. Immunol. 16, 639–649.
doi:10.1038/nri.2016.88
K.A., M., M., J., S., D., C., S., K.Y., K., 2015. Chronic infection drives
hematopoietic stem cell exhaustion through differentiation and a lowered
threshold for apoptosis. Blood 126, 2406.
Kathania, M., Khare, P., Zeng, M., Cantarel, B., Zhang, H., Ueno, H.,
Venuprasad, K., 2016. Itch inhibits IL-17-mediated colon inflammation and
tumorigenesis by ROR-γt ubiquitination. Nat. Immunol. 17, 997–1004.
doi:10.1038/ni.3488
Korinek, V., Barker, N., Moerer, P., Van Donselaar, E., Huls, G., Peters, P.J.,
Clevers, H., 1998. Depletion of epithelial stem-cell compartments in the
small intestine of mice lacking Tcf-4. Nat Genet 19, 379–383.
Kosiewicz, M.M., Nast, C.C., Krishnan, A., Rivera-Nieves, J., Moskaluk, C.A.,
Matsumoto, S., Kozaiwa, K., Cominelli, F., 2001. Th1-type responses
mediate spontaneous ileitis in a novel murine model of Crohn’s disease. J.
Clin. Invest. 107, 695–702. doi:10.1172/JCI10956
Kretzschmar, K., Clevers, H., 2016. Organoids: Modeling Development and the
Stem Cell Niche in a Dish. Dev. Cell. doi:10.1016/j.devcel.2016.08.014
Kühn, R., Löhler, J., Rennick, D., Rajewsky, K., Müller, W., 1993. Interleukin-10-

132

deficient mice develop chronic enterocolitis. Cell 75, 263–274.
doi:10.1016/0092-8674(93)80068-P
Langlands, A.J., Almet, A.A., Appleton, P.L., Newton, I.P., Osborne, J.M.,
Näthke, I.S., 2016. Paneth Cell-Rich Regions Separated by a Cluster of
Lgr5+ Cells Initiate Crypt Fission in the Intestinal Stem Cell Niche. PLoS
Biol. 14. doi:10.1371/journal.pbio.1002491
Langrish, C.L., Chen, Y., Blumenschein, W.M., Mattson, J., Basham, B.,
Sedgwick, J.D., McClanahan, T., Kastelein, R.A., Cua, D.J., 2005. IL-23
drives a pathogenic T cell population that induces autoimmune inflammation.
J. Exp. Med. 201, 233–240. doi:10.1084/jem.20041257
Leaphart, C.L., Cavallo, J., Gribar, S.C., Cetin, S., Li, J., Branca, M.F., Dubowski,
T.D., Sodhi, C.P., Hackam, D.J., 2007. A Critical Role for TLR4 in the
Pathogenesis of Necrotizing Enterocolitis by Modulating Intestinal Injury and
Repair. J. Immunol. 179, 4808–4820. doi:10.4049/jimmunol.179.7.4808
Lee, Y.K., Menezes, J.S., Umesaki, Y., Mazmanian, S.K., 2011. Proinflammatory
T-cell responses to gut microbiota promote experimental autoimmune
encephalomyelitis. Proc. Natl. Acad. Sci. 108, 4615–4622.
doi:10.1073/pnas.1000082107
Leoh, L.S., Daniels-Wells, T.R., Penichet, M.L., 2015. Ige immunotherapy
against cancer. Curr. Top. Microbiol. Immunol. 388, 109–149.
doi:10.1007/978-3-319-13725-4_6
Li, N., Yousefi, M., Nakauka-Ddamba, A., Jain, R., Tobias, J., Epstein, J.A.,
Jensen, S.T., Lengner, C.J., 2014. Single-cell analysis of proxy reporter

133

allele-marked epithelial cells establishes intestinal stem cell hierarchy. Stem
Cell Reports 3, 876–891. doi:10.1016/j.stemcr.2014.09.011
Li, W., Bengtson, M.H., Ulbrich, A., Matsuda, A., Reddy, V.A., Orth, A., Chanda,
S.K., Batalov, S., Joazeiro, C.A.P., 2008. Genome-wide and functional
annotation of human E3 ubiquitin ligases identifies MULAN, a mitochondrial
E3 that regulates the organelle’s dynamics and signaling. PLoS One 3.
doi:10.1371/journal.pone.0001487
Liao, B., Zhong, X., Xu, H., Xiao, F., Fang, Z., Gu, J., Chen, Y., Zhao, Y., Jin, Y.,
2013. Itch, an E3 ligase of Oct4, is required for embryonic stem cell selfrenewal and pluripotency induction. J. Cell. Physiol. 228, 1443–1451.
doi:10.1002/jcp.24297
Liu, Y.C., 2007. The E3 ubiquitin ligase Itch in T cell activation, differentiation,
and tolerance. Semin. Immunol. doi:10.1016/j.smim.2007.02.003
Lohr, N.J., Molleston, J.P., Strauss, K.A., Torres-Martinez, W., Sherman, E.A.,
Squires, R.H., Rider, N.L., Chikwava, K.R., Cummings, O.W., Morton, D.H.,
Puffenberger, E.G., 2010. Human ITCH E3 Ubiquitin Ligase Deficiency
Causes Syndromic Multisystem Autoimmune Disease. Am. J. Hum. Genet.
86, 447–453. doi:10.1016/j.ajhg.2010.01.028
Macpherson, A.J., Harris, N.L., 2004. Opinion: Interactions between commensal
intestinal bacteria and the immune system. Nat. Rev. Immunol. 4, 478–485.
doi:10.1038/nri1373
Maloy, K.J., Powrie, F., 2011. Intestinal homeostasis and its breakdown in
inflammatory bowel disease. Nature 474, 298–306. doi:10.1038/nature10208

134

Mankertz, J., Schulzke, J.-D., 2007. Altered permeability in inflammatory bowel
disease: pathophysiology and clinical implications. Curr. Opin.
Gastroenterol. 23, 379–383. doi:10.1097/MOG.0b013e32816aa392
Mantovani, A., Marchesi, F., 2014. IL-10 and macrophages orchestrate gut
homeostasis. Immunity. doi:10.1016/j.immuni.2014.04.015
Marchiando, A.M., Graham, W.V., Turner, J.R., 2010. Epithelial Barriers in
Homeostasis and Disease. Annu. Rev. Pathol. Mech. Dis. 5, 119–144.
doi:10.1146/annurev.pathol.4.110807.092135
Marchiando, A.M., Shen, L., Graham, W.V., Edelblum, K.L., Duckworth, C.A.,
Guan, Y., Montrose, M.H., Turner, J.R., Watson, A.J.M., 2011. The epithelial
barrier is maintained by in vivo tight junction expansion during pathologic
intestinal epithelial shedding. Gastroenterology 140, 1208–1218.
doi:10.1053/j.gastro.2011.01.004
Marino, A., Menghini, R., Fabrizi, M., Casagrande, V., Mavilio, M., Stoehr, R.,
Candi, E., Mauriello, A., Moreno-Navarrete, J.M., Gómez-Serrano, M., Peral,
B., Melino, G., Lauro, R., Fernandez Real, J.M., Federici, M., 2014. ITCH
deficiency protects from diet-induced obesity. Diabetes 63, 550–61.
doi:10.2337/db13-0802
Matesic, L.E., Haines, D.C., Copeland, N.G., Jenkins, N.A., 2006. Itch genetically
interacts with Notch1 in a mouse autoimmune disease model. Hum. Mol.
Genet. 15, 3485–3497. doi:10.1093/hmg/ddl425
McGee, D.W., Vitkus, S.J., 1996. IL-4 enhances IEC-6 intestinal epithelial cell
proliferation yet has no effect on IL-6 secretion. Clin. Exp. Immunol. 105,

135

274–277. doi:10.1046/j.1365-2249.1996.d01-750.x
Merritt, A.J., Potten, C.S., Watson, A.J., Loh, D.Y., Nakayama, K., Nakayama, K.,
Hickman, J.A., 1995. Differential expression of bcl-2 in intestinal epithelia.
Correlation with attenuation of apoptosis in colonic crypts and the incidence
of colonic neoplasia. J. Cell Sci. 108 ( Pt 6, 2261–71.
Metzger, M.B., Hristova, V.A., Weissman, A.M., 2012. HECT and RING finger
families of E3 ubiquitin ligases at a glance. J. Cell Sci. 125, 531–537.
doi:10.1242/jcs.091777
Miki, T., Yasuda, S., Kahn, M., 2011. Wnt/β-catenin signaling in embryonic stem
cell self-renewal and somatic cell reprogramming. Stem Cell Rev. 7, 836–46.
doi:10.1007/s12015-011-9275-1
Moran, G.W., Leslie, F.C., Levison, S.E., McLaughlin, J.T., 2008. Review:
Enteroendocrine cells: Neglected players in gastrointestinal disorders?
Therap. Adv. Gastroenterol. doi:10.1177/1756283X08093943
Mucida, D., Park, Y., Kim, G., Turovskaya, O., Scott, I., Kronenberg, M.,
Cheroutre, H., 2007. Reciprocal TH17 and Regulatory T Cell Differentiation
Mediated by Retinoic Acid. Science (80-. ). 317, 256–260.
doi:10.1126/science.1145697
Mukherjee, S., Vaishnava, S., Hooper, L. V., 2008. Multi-layered regulation of
intestinal antimicrobial defense. Cell. Mol. Life Sci. doi:10.1007/s00018-0088182-3
Murray-Zmijewski, F., Lane, D.P., Bourdon, J.-C., 2006. p53/p63/p73 isoforms:
an orchestra of isoforms to harmonise cell differentiation and response to

136

stress. Cell Death Differ. 13, 962–972. doi:10.1038/sj.cdd.4401914
Nalbantoglu, Ilk., Blanc, V., Davidson, N.O., 2016. Characterization of Colorectal
Cancer Development in Apc (min/+) Mice. Methods Mol. Biol. 1422, 309–27.
doi:10.1007/978-1-4939-3603-8_27
Nenci, A., Becker, C., Wullaert, A., Gareus, R., van Loo, G., Danese, S., Huth,
M., Nikolaev, A., Neufert, C., Madison, B., Gumucio, D., Neurath, M.F.,
Pasparakis, M., 2007. Epithelial NEMO links innate immunity to chronic
intestinal inflammation. Nature 446, 557–561. doi:10.1038/nature05698
Noah, T.K., Shroyer, N.F., 2012. Notch in the Intestine: Regulation of
Homeostasis and Pathogenesis. Annu. Rev. Physiol. 1–26.
doi:10.1146/annurev-physiol-030212-183741
Nunes, T., Bernardazzi, C., De Souza, H.S., 2014. Cell death and inflammatory
bowel diseases: Apoptosis, necrosis, and autophagy in the intestinal
epithelium. Biomed Res. Int. doi:10.1155/2014/218493
OKUMURA, R., TAKEDA, K., 2016. Maintenance of gut homeostasis by the
mucosal immune system. Proc. Japan Acad. Ser. B 92, 423–435.
doi:10.2183/pjab.92.423
Omenetti, S., Pizarro, T.T., 2015. The Treg/Th17 axis: A dynamic balance
regulated by the gut microbiome. Front. Immunol.
doi:10.3389/fimmu.2015.00639
Oniscu, a, Sphyris, N., Morris, R.G., Bader, S., Harrison, D.J., 2004. P73Alpha
Is a Candidate Effector in the P53 Independent Apoptosis Pathway of
Cisplatin Damaged Primary Murine Colonocytes. J. Clin. Pathol. 57, 492–

137

498. doi:10.1136/jcp.2003.012559
Paoli, P., Giannoni, E., Chiarugi, P., 2013. Anoikis molecular pathways and its
role in cancer progression. Biochim. Biophys. Acta - Mol. Cell Res. 1833,
3481–3498. doi:10.1016/j.bbamcr.2013.06.026
Parker, A., Maclaren, O.J., Fletcher, A.G., Muraro, D., Kreuzaler, P.A., Byrne,
H.M., Maini, P.K., Watson, A.J.M., Pin, C., 2017. Cell proliferation within
small intestinal crypts is the principal driving force for cell migration on villi.
FASEB J. 31, 636–649. doi:10.1096/fj.201601002
Parravicini, V., Field, A.C., Tomlinson, P.D., Basson, M.A., Zamoyska, R., 2008.
Itch-/- αβ and γδ T cells independently contribute to autoimmunity in Itchy
mice. Blood 111, 4273–4282. doi:10.1182/blood-2007-10-115667
Pastorelli, L., De Salvo, C., Mercado, J., Vecchi, M., Pizarro, T., 2013. Central
Role of the Gut Epithelial Barrier in the Pathogenesis of Chronic Intestinal
Inflammation: Lessons Learned from Animal Models and Human Genetics .
Front. Immunol. .
Peglion, F., Llense, F., Etienne-Manneville, S., 2014. Adherens junction
treadmilling during collective migration. Nat. Cell Biol. 16, 639–51.
doi:10.1038/ncb2985
Pelaseyed, T., Bergstr??m, J.H., Gustafsson, J.K., Ermund, A., Birchenough,
G.M.H., Sch??tte, A., van der Post, S., Svensson, F., Rodr??guez-Pi??eiro,
A.M., Nystr??m, E.E.L., Wising, C., Johansson, M.E. V, Hansson, G.C.,
2014. The mucus and mucins of the goblet cells and enterocytes provide the
first defense line of the gastrointestinal tract and interact with the immune

138

system. Immunol. Rev. doi:10.1111/imr.12182
Pellegrinet, L., Rodilla, V., Liu, Z., Chen, S., Koch, U., Espinosa, L., Kaestner,
K.H., Kopan, R., Lewis, J., Radtke, F., 2011. Dll1- and Dll4-mediated notch
signaling are required for homeostasis of intestinal stem cells.
Gastroenterology 140, 1230–1240. doi:10.1053/j.gastro.2011.01.005
Perez, J.M., Chirieleison, S.M., Abbott, D.W., 2015. An IκB Kinase-Regulated
Feedforward Circuit Prolongs Inflammation. Cell Rep. 12, 537–544.
doi:10.1016/j.celrep.2015.06.050
Perry, W.L., Hustad, C.M., Swing, D.A., O’Sullivan, T.N., Jenkins, N.A.,
Copeland, N.G., 1998. The itchy locus encodes a novel ubiquitin protein
ligase that is disrupted in a18H mice. Nat. Genet. 18, 143–146.
Perry, W.L., Hustad, C.M., Swing, D.A., O’Sullivan, T.N., Jenkins, N.A.,
Copeland, N.G., 1998. The itchy locus encodes a novel ubiquitin protein
ligase that is disrupted in a 18H mice. Nat. Genet. 18, 143–146.
doi:10.1038/ng0298-143
Peterson, L.W., Artis, D., 2014. Intestinal epithelial cells: regulators of barrier
function and immune homeostasis. Nat. Rev. Immunol. 14, 141–153.
doi:10.1038/nri3608
Pin, C., Parker, A., Gunning, A.P., Ohta, Y., Johnson, I.T., Carding, S.R., Sato,
T., 2015. An individual based computational model of intestinal crypt fission
and its application to predicting unrestrictive growth of the intestinal
epithelium. Integr. Biol. 7, 213–228. doi:10.1039/C4IB00236A
Popovic, D., Vucic, D., Dikic, I., 2014. Ubiquitination in disease pathogenesis and

139

treatment. Nat. Med. 20, 1242–1253. doi:10.1038/nm.3739
Potten, C.S., 1998. Stem cells in gastrointestinal epithelium: numbers,
characteristics and death. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 353,
821–830. doi:10.1098/rstb.1998.0246
Potten, C.S., 1990. A comprehensive study of the radiobiological response of the
murine (BDF1) small intestine. Int. J. Radiat. Biol.
doi:10.1080/09553009014552281
POTTEN, C.S., 1977. Extreme sensitivity of some intestinal crypt cells to X and γ
irradiation. Nature 269, 518–521. doi:10.1038/269518a0
Potten, C.S., Booth, C., Pritchard, D.M., 1997. The intestinal epithelial stem cell:
the mucosal governor. Int. J. Exp. Pathol. 78, 219–43. doi:10.1046/j.13652613.1997.280362.x
Powell, D.W., Pinchuk, I. V, Saada, J.I., Chen, X., Mifflin, R.C., 2011.
Mesenchymal cells of the intestinal lamina propria. Annu. Rev. Physiol. 73,
213–37. doi:10.1146/annurev.physiol.70.113006.100646
Powrie, F., Leach, M.W., Mauze, S., Caddle, L.B., Coffman, R.L., 1993.
Phenotypically distinct subsets of CD4+ T cells induce or protect from
chronic intestinal inflammation in C. B-17 scid mice. Int. Immunol. 5, 1461–
1471. doi:10.1093/intimm/5.11.1461
Ramon, H.E., Riling, C.R., Bradfield, J., Yang, B., Hakonarson, H., Oliver, P.M.,
2011. The ubiquitin ligase adaptor Ndfip1 regulates T cell-mediated
gastrointestinal inflammation and inflammatory bowel disease susceptibility.
Mucosal Immunol. 4, 314–324. doi:10.1038/mi.2010.69

140

Rathinam, C., Matesic, L.E., Flavell, R.A., 2011. The E3 ligase Itch is a negative
regulator of the homeostasis and function of hematopoietic stem cells. Nat.
Immunol. 12, 399–407. doi:10.1038/ni.2021
Renehan, A.G., Bach, S.P., Potten, C.S., 2001. The relevance of apoptosis for
cellular homeostasis and tumorigenesis in the intestine. Can. J.
Gastroenterol.
Rescigno, M., 2011. The intestinal epithelial barrier in the control of homeostasis
and immunity. Trends Immunol. doi:10.1016/j.it.2011.04.003
Roda, G., Jharap, B., Neeraj, N., Colombel, J.-F., 2016. Loss of Response to
Anti-TNFs: Definition, Epidemiology, and Management. Clin. Transl.
Gastroenterol. 7, e135. doi:10.1038/ctg.2015.63
Roda, G., Sartini, A., Zambon, E., Calafiore, A., Marocchi, M., Caponi, A.,
Belluzzi, A., Roda, E., 2010. Intestinal epithelial cells in inflammatory bowel
diseases. World J. Gastroenterol. 16, 4264–4271.
doi:10.3748/wjg.v16.i34.4264
Rossi, M., Aqeilan, R.I., Neale, M., Candi, E., Salomoni, P., Knight, R. a, Croce,
C.M., Melino, G., 2006. The E3 ubiquitin ligase Itch controls the protein
stability of p63. Proc. Natl. Acad. Sci. U. S. A. 103, 12753–12758.
doi:10.1073/pnas.0603449103
Rossi, M., De Laurenzi, V., Munarriz, E., Green, D.R., Liu, Y.-C., Vousden, K.H.,
Cesareni, G., Melino, G., 2005. The ubiquitin–protein ligase Itch regulates
p73 stability. EMBO J. 24, 836–848. doi:10.1038/sj.emboj.7600444
Rotin, D., Kumar, S., 2009. Physiological functions of the HECT family of

141

ubiquitin ligases. Nat. Rev. Mol. Cell Biol. 10, 398–409.
doi:10.1038/nrm2690
Sabates-Bellver, J., Van der Flier, L.G., de Palo, M., Cattaneo, E., Maake, C.,
Rehrauer, H., Laczko, E., Kurowski, M. a, Bujnicki, J.M., Menigatti, M., Luz,
J., Ranalli, T. V, Gomes, V., Pastorelli, A., Faggiani, R., Anti, M., Jiricny, J.,
Clevers, H., Marra, G., 2007. Transcriptome profile of human colorectal
adenomas. Mol. Cancer Res. 5, 1263–1275. doi:10.1158/1541-7786.MCR07-0267
Sandler, N.G., Koh, C., Roque, A., Eccleston, J.L., Siegel, R.B., Demino, M.,
Kleiner, D.E., Deeks, S.G., Liang, T.J., Heller, T., Douek, D.C., 2011. Host
response to translocated microbial products predicts outcomes of patients
with HBV or HCV infection. Gastroenterology 141.
doi:10.1053/j.gastro.2011.06.063
Sangiorgi, E., Capecchi, M.R., 2008. Bmi1 is expressed in vivo in intestinal stem
cells. Nat. Genet. 40, 915–920.
Sansom, O.J., Mansergh, F.C., Evans, M.J., Wilkins, J.A., Clarke, A.R., 2007.
Deficiency of SPARC suppresses intestinal tumorigenesis in APCMin/+
mice. Gut 56, 1410–4. doi:10.1136/gut.2006.116921
Sato, T., Clevers, H., 2013. Growing Self-Organizing Mini-Guts from a Single
Intestinal Stem Cell: Mechanism and Applications. Science (80-. ).
doi:10.1126/science.1234852
Sato, T., Clevers, H., 2013. Growing Self-Organizing Mini-Guts. Science (80-. ).
340, 1190–1195. doi:10.1126/science.1234852

142

Sato, T., van Es, J.H., Snippert, H.J., Stange, D.E., Vries, R.G., van den Born,
M., Barker, N., Shroyer, N.F., van de Wetering, M., Clevers, H., 2011.
Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts.
Nature 469, 415–418. doi:10.1038/nature09637
Sato, T., Vries, R.G., Snippert, H.J., van de Wetering, M., Barker, N., Stange,
D.E., van Es, J.H., Abo, A., Kujala, P., Peters, P.J., Clevers, H., 2009. Single
Lgr5 stem cells build crypt&#150;villus structures in vitro without a
mesenchymal niche. Nature 459, 262–265. doi:10.1038/nature07935
Schenk, M., Mueller, C., 2008. The mucosal immune system at the
gastrointestinal barrier. Best Pract. Res. Clin. Gastroenterol. 22, 391–409.
doi:10.1016/j.bpg.2007.11.002
Schneider, M.R., Dahlhoff, M., Horst, D., Hirschi, B., Trülzsch, K., Müller-Höcker,
J., Vogelmann, R., Allgäuer, M., Gerhard, M., Steininger, S., Wolf, E.,
Kolligs, F.T., 2010. A key role for E-cadherin in intestinal homeostasis and
paneth cell maturation. PLoS One 5. doi:10.1371/journal.pone.0014325
Scoville, D.H., Sato, T., He, X.C., Li, L., 2008. Current View: Intestinal Stem Cells
and Signaling. Gastroenterology 134, 849–864.
doi:10.1053/j.gastro.2008.01.079
Shembade, N., Harhaj, N.S., Parvatiyar, K., Copeland, N.G., Jenkins, N.A.,
Matesic, L.E., Harhaj, E.W., 2008. The E3 ligase Itch negatively regulates
inflammatory signaling pathways by controlling the function of the ubiquitinediting enzyme A20. Nat. Immunol. 9, 254–262. doi:10.1038/ni1563
Sheridan, B.S., Romagnoli, P.A., Pham, Q.M., Fu, H.H., Alonzo, F., Schubert,

143

W.D., Freitag, N.E., Lefrançois, L., 2013. γδ T Cells Exhibit Multifunctional
and Protective Memory in Intestinal Tissues. Immunity 39, 184–195.
doi:10.1016/j.immuni.2013.06.015
Shroyer, N.F., Wallis, D., Venken, K.J.T., Bellen, H.J., Zoghbi, H.Y., 2005. Gfi1
functions downstream of Math1 to control intestinal secretory cell subtype
allocation and differentiation. Genes Dev 19, 2412–2417.
Ślebioda, T.J., Kmieć, Z., 2014. Tumour necrosis factor superfamily members in
the pathogenesis of inflammatory bowel disease. Mediators Inflamm.
doi:10.1155/2014/325129
Smalley-Freed, W.G., Efimov, A., Burnett, P.E., Short, S.P., Davis, M.A.,
Gumucio, D.L., Washington, M.K., Coffey, R.J., Reynolds, A.B., 2010. p120catenin is essential for maintenance of barrier function and intestinal
homeostasis in mice. J. Clin. Invest. 120, 1824–1835. doi:10.1172/JCI41414
Smythies, L.E., Sellers, M., Clements, R.H., Mosteller-Barnum, M., Meng, G.,
Benjamin, W.H., Orenstein, J.M., Smith, P.D., 2005. Human intestinal
macrophages display profound inflammatory anergy despite avid phagocytic
and bacteriocidal activity. J. Clin. Invest. 115, 66–75.
doi:10.1172/JCI200519229
Steele, S.P., Melchor, S.J., Petri, W.A., 2016. Tuft Cells: New Players in Colitis.
Trends Mol. Med. doi:10.1016/j.molmed.2016.09.005
Stockwin, L.H., McGonagle, D., Martin, I.G., Blair, G.E., 2000. Dendritic cells:
immunological sentinels with a central role in health and disease. Immunol.
Cell Biol. 78, 91–102. doi:10.1046/j.1440-1711.2000.00888.x

144

Strikoudis, A., Guillamot, M., Aifantis, I., 2014. Regulation of stem cell function by
protein ubiquitylation. EMBO Rep. doi:10.1002/embr.201338373
Sun, C.-M., Hall, J.A., Blank, R.B., Bouladoux, N., Oukka, M., Mora, J.R.,
Belkaid, Y., 2007. Small intestine lamina propria dendritic cells promote de
novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204,
1775–1785. doi:10.1084/jem.20070602
Symons, A., Budelsky, A.L., Towne, J.E., 2012. Are Th17 cells in the gut
pathogenic or protective? Mucosal Immunol. 5, 4–6. doi:10.1038/mi.2011.51
Tan, D.W.M., Barker, N., 2014. Intestinal Stem Cells and Their Defining Niche.
Curr. Top. Dev. Biol. 107, 77–107. doi:10.1016/B978-0-12-416022-4.000032
Tao, M., Scacheri, P.C., Marinis, J.M., Harhaj, E.W., Matesic, L.E., Abbott, D.W.,
2009. ITCH K63-Ubiquitinates the NOD2 Binding Protein, RIP2, to Influence
Inflammatory Signaling Pathways. Curr. Biol. 19, 1255–1263.
doi:10.1016/j.cub.2009.06.038
Tao, M.F., Scacheri, P.C., Marinis, J.M., Harhaj, E.W., Matesic, L.E., Abbott,
D.W., 2009. ITCH K63-Ubiquitinates the NOD2 Binding Protein, RIP2, to
Influence Inflammatory Signaling Pathways. Curr. Biol. 19, 1255–1263.
doi:10.1016/j.cub.2009.06.038
Tetteh, P.W., Farin, H.F., Clevers, H., 2015. Plasticity within stem cell hierarchies
in mammalian epithelia. Trends Cell Biol. doi:10.1016/j.tcb.2014.09.003
Theivanthiran, B., Kathania, M., Zeng, M., Anguiano, E., Basrur, V., Vandergriff,
T., Pascual, V., Wei, W., Massoumi, R., Venuprasad, K., 2015. The E3

145

ubiquitin ligase Itch inhibits p38 a signaling and skin inflammation through
the ubiquitylation of Tab1. Sci. Signal. 8, 1–14.
doi:10.1126/scisignal.2005903
Tian, H., Biehs, B., Warming, S., Leong, K.G., Rangell, L., Klein, O.D., De
Sauvage, F.J., 2011. A reserve stem cell population in small intestine
renders Lgr5-positive cells dispensable. Nature 478, 1–6.
doi:10.1038/nature10408
Traweger, A., Fang, D., Liu, Y.C., Stelzhammer, W., Krizbai, I.A., Fresser, F.,
Bauer, H.C., Bauer, H., 2002. The tight junction-specific protein occludin is a
functional target of the E3 ubiquitin-protein ligase itch. J. Biol. Chem. 277,
10201–10208. doi:10.1074/jbc.M111384200
Tsui, Y.-M., Sze, K.M.-F., Tung, E.K.-K., Ho, D.W.-H., Lee, T.K.-W., Ng, I.O.-L.,
2017. Dishevelled-3 phosphorylation is governed by
HIPK2/PP1C&amp;#x03B1;/ITCH axis and the non-phosphorylated form
promotes cancer stemness via LGR5 in hepatocellular carcinoma.
Oncotarget 8, 39430–39442. doi:10.18632/oncotarget.17049
Tucker, J.M., Davis, C., Kitchens, M.E., Bunni, M.A., Priest, D.G., Spencer, H.T.,
Berger, F.G., 2002. Response to 5-fluorouracil chemotherapy is modified by
dietary folic acid deficiency in ApcMin/+ mice. Cancer Lett. 187, 153–162.
doi:10.1016/S0304-3835(02)00402-0
Tucker, J.M., Murphy, J.T., Kisiel, N., Diegelman, P., Barbour, K.W., Davis, C.,
Medda, M., Alhonen, L., Jänne, J., Kramer, D.L., Porter, C.W., Berger, F.G.,
2005. Potent modulation of intestinal tumorigenesis in Apcmin/+ mice by the

146

polyamine catabolic enzyme spermidine/spermine N1- acetyltransferase.
Cancer Res. 65, 5390–5398. doi:10.1158/0008-5472.CAN-05-0229
Turner, J.R., 2009. Intestinal mucosal barrier function in health and disease. Nat.
Rev. Immunol. 9, 799–809. doi:10.1038/nri2653
Uhlen, M., 2005. A Human Protein Atlas for Normal and Cancer Tissues Based
on Antibody Proteomics. Mol. Cell. Proteomics 4, 1920–1932.
doi:10.1074/mcp.M500279-MCP200
Ulluwishewa, D., Anderson, R.C., McNabb, W.C., Moughan, P.J., Wells, J.M.,
Roy, N.C., 2011. Regulation of tight junction permeability by intestinal
bacteria and dietary components. J. Nutr. 141, 769–776.
doi:10.3945/jn.110.135657
Vaishnava, S., Behrendt, C.L., Ismail, A.S., Eckmann, L., Hooper, L. V., 2008.
Paneth cells directly sense gut commensals and maintain homeostasis at
the intestinal host-microbial interface. Proc. Natl. Acad. Sci. 105, 20858–
20863. doi:10.1073/pnas.0808723105
van der Flier, L.G., Clevers, H., 2009. Stem Cells, Self-Renewal, and
Differentiation in the Intestinal Epithelium. Annu. Rev. Physiol. 71, 241–260.
doi:10.1146/annurev.physiol.010908.163145
Van Der Gracht, E., Zahner, S., Kronenberg, M., 2016. When Insult Is Added to
Injury: Cross Talk between ILCs and Intestinal Epithelium in IBD. Mediators
Inflamm. doi:10.1155/2016/9765238
Van Es, J.H., Clevers, H., 2014. Paneth cells. Curr. Biol.
doi:10.1016/j.cub.2014.04.049

147

van Es, J.H., Sato, T., van de Wetering, M., Lyubimova, A., Yee Nee, A.N.,
Gregorieff, A., Sasaki, N., Zeinstra, L., van den Born, M., Korving, J.,
Martens, A.C.M., Barker, N., van Oudenaarden, A., Clevers, H., 2012. Dll1+
secretory progenitor cells revert to stem cells upon crypt damage. Nat. Cell
Biol. 14, 1099–1104. doi:10.1038/ncb2581
van Wijk, F., Cheroutre, H., 2010. Mucosal T cells in gut homeostasis and
inflammation. Expert Rev. Clin. Immunol. 6, 559–566. doi:10.1586/eci.10.34
VanDussen, K.L., Carulli, A.J., Keeley, T.M., Patel, S.R., Puthoff, B.J., Magness,
S.T., Tran, I.T., Maillard, I., Siebel, C., Kolterud, A., Grosse, A.S., Gumucio,
D.L., Ernst, S.A., Tsai, Y.-H., Dempsey, P.J., Samuelson, L.C., 2012. Notch
signaling modulates proliferation and differentiation of intestinal crypt base
columnar stem cells. Development 139, 488–497. doi:10.1242/dev.070763
Vijayakumar, S., Liu, G., Wen, H., Abu, Y., Chong, R., 2017. Extracellular LDLR
repeats modulate Wnt signaling activity by promoting LRP6 receptor
endocytosis mediated by the Itch E3 ubiquitin ligase 8.
Vilgelm, A., El-Rifai, W., Zaika, A., 2008. Therapeutic prospects for p73 and p63:
Rising from the shadow of p53. Drug Resist. Updat. 11, 152–163.
doi:10.1016/j.drup.2008.08.001
Vindigni, S.M., Zisman, T.L., Suskind, D.L., Damman, C.J., 2016. The intestinal
microbiome, barrier function, and immune system in inflammatory bowel
disease: a tripartite pathophysiological circuit with implications for new
therapeutic directions. Therap. Adv. Gastroenterol. 9, 606–625.
doi:10.1177/1756283X16644242

148

Visvader, J.E., Clevers, H., 2016. Tissue-specific designs of stem cell
hierarchies. Nat Cell Biol 18, 349–355. doi:10.1038/ncb3332
Vlantis, K., Wullaert, A., Sasaki, Y., Schmidt-Supprian, M., Rajewsky, K.,
Roskams, T., Pasparakis, M., 2011. Constitutive IKK2 activation in intestinal
epithelial cells induces intestinal tumors in mice. J. Clin. Invest. 121, 2781–
2793. doi:10.1172/JCI45349
Vooijs, M., Liu, Z., Kopan, R., 2011. Notch: Architect, landscaper, and guardian
of the intestine. Gastroenterology 141, 448–459.
doi:10.1053/j.gastro.2011.06.003
Watson, A.J., Hughes, K.R., 2012. TNF-alpha-induced intestinal epithelial cell
shedding: implications for intestinal barrier function. Ann N Y Acad Sci 1258,
1–8. doi:10.1111/j.1749-6632.2012.06523.x
Wehkamp, J., Koslowski, M., Wang, G., Stange, E.F., 2008. Barrier dysfunction
due to distinct defensin deficiencies in small intestinal and colonic Crohn’s
disease. Mucosal Immunol. 1, S67–S74. doi:10.1038/mi.2008.48
Wei, W., Li, M., Wang, J., Nie, F., Li, L., 2012. The E3 Ubiquitin Ligase ITCH
Negatively Regulates Canonical Wnt Signaling by Targeting Dishevelled
Protein. Mol. Cell. Biol. 32, 3903–3912. doi:10.1128/MCB.00251-12
Welz, P.-S., Wullaert, A., Vlantis, K., Kondylis, V., Fernández-Majada, V.,
Ermolaeva, M., Kirsch, P., Sterner-Kock, A., van Loo, G., Pasparakis, M.,
2011. FADD prevents RIP3-mediated epithelial cell necrosis and chronic
intestinal inflammation. Nature 477, 330–334. doi:10.1038/nature10273
Wen, L., Ley, R.E., Volchkov, P.Y., Stranges, P.B., Avanesyan, L., Stonebraker,

149

A.C., Hu, C., Wong, F.S., Szot, G.L., Bluestone, J.A., Gordon, J.I.,
Chervonsky, A. V., 2008. Innate immunity and intestinal microbiota in the
development of Type 1 diabetes. Nature 455, 1109–1113.
doi:10.1038/nature07336
Wenzel, U.A., Magnusson, M.K., Rydström, A., Jonstrand, C., Hengst, J.,
Johansson, M.E. V, Velcich, A., Öhman, L., Strid, H., Sjövall, H., Hansson,
G.C., Wick, M.J., 2014. Spontaneous colitis in Muc2-deficient mice reflects
clinical and cellular features of active ulcerative colitis. PLoS One 9.
doi:10.1371/journal.pone.0100217
Williams, J.M., Duckworth, C.A., Burkitt, M.D., Watson, A.J.M., Campbell, B.J.,
Pritchard, D.M., 2015. Epithelial Cell Shedding and Barrier Function. Vet.
Pathol. 52, 445–455. doi:10.1177/0300985814559404
Williams, J.M., Duckworth, C.A., Burkitt, M.D., Watson, A.J.M., Campbell, B.J.,
Pritchard, D.M., 2015. Epithelial cell shedding and barrier function: a matter
of life and death at the small intestinal villus tip. Vet. Pathol. 52, 445–55.
doi:10.1177/0300985814559404
Wong, M.H., Hermiston, M.L., Syder, A.J., Gordon, J.I., 1996. Forced expression
of the tumor suppressor adenomatosis polyposis coli protein induces
disordered cell migration in the intestinal epithelium. Proc. Natl. Acad. Sci.
93, 9588–9593. doi:10.1073/pnas.93.18.9588
Wu, H.J., Ivanov, I.I., Darce, J., Hattori, K., Shima, T., Umesaki, Y., Littman,
D.R., Benoist, C., Mathis, D., 2010. Gut-residing segmented filamentous
bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 32, 815–

150

827. doi:10.1016/j.immuni.2010.06.001
Wullaert, A., Bonnet, M.C., Pasparakis, M., 2011. NFκB in the regulation of
epithelial homeostasis and inflammation. Cell Res. 21, 146–158.
doi:10.1038/cr.2010.175
Yousefi, M., Li, L., Lengner, C.J., 2017. Hierarchy and Plasticity in the Intestinal
Stem Cell Compartment. Trends Cell Biol. doi:10.1016/j.tcb.2017.06.006
Yu, H., Yuan, Y., Shen, H., Cheng, T., 2006. Hematopoietic stem cell exhaustion
impacted by p18INK4C and p21Cip1/Waf1 in opposite manners. Blood 107,
1200–1206. doi:10.1182/blood-2005-02-0685
Zaika, a I., El-Rifai, W., 2006. The role of p53 protein family in gastrointestinal
malignancies. Cell Death Differ. 13, 935–940. doi:10.1038/sj.cdd.4401897
Zhang, P., Wang, C., Gao, K., Wang, D., Mao, J., An, J., Xu, C., Wu, D., Yu, H.,
Liu, J.O., Yu, L., 2010. The ubiquitin ligase itch regulates apoptosis by
targeting thioredoxin-interacting protein for ubiquitin-dependent degradation.
J. Biol. Chem. 285, 8869–8879. doi:10.1074/jbc.M109.063321
Zihni, C., Mills, C., Matter, K., Balda, M.S., 2016. Tight junctions: from simple
barriers to multifunctional molecular gates. Nat. Rev. Mol. Cell Biol. 17, 564–
580. doi:10.1038/nrm.2016.80

151

